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GENERAL INTRODUCTION 
This thesis deals with two therapeutic modalities for patients with an irreversible short 
bowel syndrome: improvement of adaptation and small-bowel transplantation. Thereby, 
emphasis is put on the role of these therapeutic modalities for children. 
The irreversible short bowel syndrome may arise if, after massive small-bowel resection, 
the remaining intestine is not able to adapt sufficiently to the loss of bowel. The process 
of functional intestinal adaptation after small-bowel resection is a complex process which 
is poorly understood and therefore it is difficult to manipulate the outcome of the 
adaptation phase. The importance of oral intake as a positive stimulus to the adaptive 
stage of the remaining bowel has been recognized. Predigested food became the standard 
treatment of choice when starting oral refeeding but it is still disputed whether this is 
more effective than non-predigested food in stimulating adaptation, and thus further 
research is mandatory. 
Although long-term total, parenteral nutrition provided the flISt satisfactory treatment for 
the short bowel syndrome, its complications including metabolic, infectious, anti 
psychologic aspects, form the main reason to envision this therapy as a temporary 
solution. 
Recently, small-bowel transplantation in man has become feasible and therefore children 
with irreversible intestinal failure would also be suitable candidates for a small-bowel 
graft. However, before a clinical small-bowel transplantation program in children is 
justified, it must be demonstrated that a small-bowel transplant can give adequate 
nutritional support to a growing individnal with the short bowel syndrome. 
This thesis evaluaxes a method to monitor the process of junctional i1l1estinal adaptation in 
r01S subjected to near total SlTU2l1-bowel resection and unravels the role of diet 
composition and/or complexity on adaptation. 
Funhermore, it outlines the role of total and segme1l1al onhotopic SlTU2l1-bowel 
transplamation in the trearment of shon bowel syndrome in e1l1erectomized young dogs, 
and prese1l1S experiments on the folluw-up of a SlTU2l1-bowel graft including monitoring of 
rejection and the histologic, bacteriologic, and junctional st01US of a graft in both r01s 
and dogs. 
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lNTRODUCTION 
A variety of pathophysiologic circumstances in childhood necessitate extensive smaIl-
bowel resection (1-4). Developmental abnormalities of the small bowel include intestinal 
atresia. gastroschisis, malrotation and volvulus. Major causes in the postnatal period are 
necrotizing enterocolitis, midgut volvulus aod inflammatory bowel disease. 
The clinical course after extensive small-bowel resection can be subdivided into three 
main stages (5). Directly after resection, severe diarrhea, steatorrhoea, malabsorption aod 
fluid aod weight loss is seen. During this stage, total parenteral nutrition is intlispensable 
to provide sufficient calories. In the second stage. after a few months to over one year. 
the remaining intestine gradually adapts to the loss of bowel aod oral intake is gradually 
increased until intravenous alimeutation can be stopped. Unfortunately, some of these 
patients never reach this third stage, and develop the short bowel syndrome (6). 
The short bowel syndrome is characterized by irreversible small-intestinal failure, which 
is defined as inability to maintain nutritional sta!Ils andlor positive fluid aod electrolyte 
balance without special measures. 
1 TOTAL ADAPTATION AFTER MASSIVE SMALL-BOWEL RESECTION 
ORNOT? 
The likelihood of developing the short bowel syndrome depends on several estshlished 
factors, including the length and anatomic identity of the enteric remnant and the presence 
of residnal disease (7,8). The time it takes to reach a state of maximal adaptation in the 
remaining small bowel is influenced by both non-nutritive and nutritive stimuli. 
in general, following small-bowel resection, there is an increase in both epithelial cell 
proliferation rate in the crypts and migration rate of the cells onto the villi, resulting in 
enlarged villi and deeper crypts (9). The villus hyperplasia is characterized by an increase 
in mucosal cell mass and in DNA, RNA aod protein content. It has been reponed that 
following jejunal resection, from a functional point of view, in ileum more effective 
adaptation takes place than in the reverse situation (10). 
Non-nutritional factors. of importance in stimulating intestinal adaptation, are endogenous 
secretions, hormones, and neurovascular components (summarized in Table 1). There was 
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speculative, indirect evidence on the strong enterotropic capacity of enteroglucagon. In 
contrast to this, Gregor and associates (14) showed that innnnnoneutralization of 
circulating endogenous enteroglucagon had no effect on the adaptive response. The results 
concerning the role of gastrin and cholecystokillin are controversial and these hormones 
are not considered as key determinants of the adaptive response so far. In addition, the 
role of epidennal growth factor, insulin, vasoactive intestinal polypeptide, bombesin, 
corticosteroids, and pancreatic peptide remains to be elucidated. So there are still many 
candidates for the role of "enterotrophin-like hormone". Most probably the hormones 
involved will function in concert with the neurovascular effects responsible for refinement 
of the major adaptive changes. These non-nutritional factors however, are mostly under 
influence of luminal nutrition themselves. Therefore, the role of nutrients in intestinal 
adaptation, being major regulating factors, is discussed in detail below. 
1.1 The role of nutrients in intestinal adaptation 
The effect of nutrition on intestinal adaptation following resection has been widely 
recognized. By now, experimental approaches have been devoted to the relative 
coutribution of three nutritional aspects: the presence of food in the gut lumen, the 
complexity of the diet, and the role of a specific nutritional component. 
Presence of enIeral nutrition 
The importance of oral food intake in maintainjng both gut structure and function is 
beyond dispute. Dietary manipulation such as hyperphagia increases the intestinal 
epithelia! cell renewal and leads to an increase in small-bowel mass (24). In contrast, 
hypoplasia is found after fasting or protein depletion (25). 
More than 25 years ago, with the advent of total parenteral nutrition, the importance of 
luminal nutrition in intestinal adaptation became a field of interest (26). The presence of 
luminal nutrients is considered as a prerequisite in achieving adaptive postresectional 
hyperplasia. In growing rats, subjected to small-bowel resection and receiving total 
parenteral nutrition for 8 days, a lower mucosal mass, providing lower absorptive 
capacity per centimeter of intestine, was found compared to rats receiving luminal 
nutrition (27). In contrast, increased specific transport activity of alanine was found in 
parenterally nourished rats. Ford et aI (28) demonstrated in young rats that total 
parenteral nutrition inhibits adaptive hyperplasia following resection and even cansed a 
decrease in ileal crypt depth and jejunal as well as ileal DNA and RNA contents 
compared to unoperated rats after 10 days of total parenteral nutrition. However, ileal 
sucrase activity was siguificandy elevated compared to nonoperative values at that time. 
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Table 1 Non-nutritive factors affecting intestinal adaptation following 
small-bowel resection 
Factor Model Time Response 
En4cgenous 
secretions 
Bile ~ pancreas * 50% jejunal resection *4 * intensifies ileal 
secrenons +~~:onof weeks hyperplasia duodenal ilia 
Gastric secretion ... 40 % ileal resection • 6-8 ... increased gastric 
weeks 
secretion ~=f intestinal h !asia 
Honnones 
PGEZ t * 70% jejunoileal * 12 * inhibition of 
resection + aspirin days mucosal weight. DNA, 
admin.istration 20 protein and maltase ;;;;jk.jiJ hr levels in distal ileum 
EnterogIucagon" * 70% jejunal resection *2 ... normal hyperplasia 
+ weeks 
Unmrunon~onof 
EG 
Oro_stimulating * 50% jejunal resection * 4 days ... associaIed with 
activity t proliferation of intestinal 
e"ithelial cells 
Testosterone ... 50% jejunoileal *4 * enhanced weight ~ 
~,n+O.35 weeks increased hyperplasia 
me/k: wk testosterone 
Growth hormone t ... 70% jejunoileal *2 ... mucosal weight, DNA, 
resection + PGF weeks protein and sucrase 
treaImeIlt activitvincreased 
Somatostatin * 50% proximal jejuna- * 96 * inhloits post 
ileal. resection + hours resectional hyperplasia 
continuous infusion 
~~=mtin 1667 n mID 
Neurovascular effeas 
Non\!llt hormones 
Blood flow * 50% midbowel * 2 days * increased ileal blood 
resection and 2 flow preceding 
months hypertrophy 
* 1,2.3 * hyperplastic response 
... 80% midbowe1 and 5 not directly caused by 
resection days hemodynamic changes 
Adrenergic ... 50 % midenterectomy ... 2 days ... 50% reduction 
denervation and 2 endogenous 
months C3Iecholamine activity 
and corresponding 
decrease in density of 
adrenergic terminals 
Mesenchymal * in vitro culturing of * not * mesenchyme required 
regulations small imestine reponed for maintainjng mucosal 
architecture 
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Thus, although tOIal parenteral nutrition leads to a state of morphologic atrophy, the 
specific transport activity of a component may increase during parenteral feeding, 
indicating that adaptation of transport function at the cellular level may be independent of 
oral feeding. Resumption of oral diet reverses the decrease in villus height, crypt depth, 
and mucosal DNA and RNA contents, and even results in augmented final body weight 
and intestinal length after 4 weeks, compared to rats fed rat chow from the start. These 
findings support previous work by Wilmore et aI (29), who found that both long-tertn 
somatic growth and intestinal growth are improved after providing essential nutrients i. v. 
for 30 days compared to enteral feeding from the start, following massive intestinal 
resection in growing dogs. 
The complexity of the diet 
The belief that small-bowel hyperplasia occurs only if luminal nutrition is provided led to 
early introduction of enteral alimentation during the intestinal adsptation process following 
resection (30). The short bowel syndrome is a possible indication for using an elemenlal, 
predigested diet also known as "space diet" or chemically defined diet. The reasoning 
behind this suggestion is that an elemenlal diet requires less digestion and is absorbed 
over shorter lengths of bowel (31). Until now, only some uncontrolled clinical trials have 
been reported from which it is unclear whether an elemenlal diet has any effect different 
from that of whole food (32,33,34). On the top of that, there is no anintaI study showing 
benefit of an elemenlal diet used in this manner. Several investigators (35,36) have 
demonstrated that after small-bowel resection, both in adult and growing rats, adaptive 
changes take place with elemen1al diet, but less well than with normal rat chow. The 
validity of their conclusion that a complex diet is superior over an elemenlal diet may be 
questioned because the relative composition of the dietS also differed. 
The composition of the diet 
Various studies show that the composition of the diet also influences intestinal adaptation 
in the rat (37-47). Investigators have studied the effects of bulk andlor fiber, lipid, 
carbohydrate, and antino acid supplemented diets in supporting the intestinal adaptation 
process in comparison with non-supplemented diets. 
The addition of non-soluble fiber, which contributes to fecal bulk, had no influence on 
both small-intestinal morphology and cell renewal in the rat (48). In conttast, elemen1al 
diet supplementation with soluble non-cellulosic dietary fiber, which is completely 
fermented by colonic bacteria and does not contribute to fecal bulk, enhanced intestinal 
adaptation in both small bowel and colon, as was confirmed by significantly increased 
mucosal growth and improved maintenance of body weight (39). It has been shown that 
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intralumIDa! infusion of short chain fatty acids (SCFAs), the components mainly produced 
by fermentation of soluble fiber, stimulates colonic mucosal proliferation (49) and 
increases intestinal blood flow, which may facilitate small and large intestinal adaptation 
(50). In a recent rat study on short bowel syndrome in rats, the effect of an elemental diet 
supplemented with short chain triglycerides (SCTs), reduced to SCF As by fermentation, 
was compared to medium chain triglycerides (MCTs) or non-supplementation. The results 
showed enhancement of colonic and jejunal adsptation, revealed by increased segmental 
weight and mucosal protein in the SCT gronp compared to the other diet groups (40). 
For the treatment of the short bowel syndrome the use of MCTs as part of a restricted 
fat, high-<:arbohydrate diet was recommended (51). Various clinical studies were unable 
to confirm the advantages of replacing long chain triglycerides (LCTs) by MCTs or 
carbohydrates (52). In a rat study, the effect of an elemental diet containing 83 % of the 
fat in the form of MCTs was compared with a diet containing 40% of the fat in the form 
of MCTs (45). The remaining fat in both diets consisted of LeTs. This study 
demonstrated greater morphologic mucosal adaptation, increased sucrase activity and 
leucine uptake, and improved weight gain after feeding the high-percentage LeT diet, in 
spite of more easy absorbance of MCTs. In addition, Grey et al. undertook a study of the 
relative efficacy of intragastrical supplementation of free fatty acids (F As) or LCTs in 
parenterally nourished rats with a 50% small-bowel resection (37). They found that FAs 
were more effective in promoting adaptation by measuring DNA and protein contents in 
different small-bowel segments. Moreover, DNA and protein contents of the FA gronp 
equalled the values found in the orally fed animals. Hart et al (53) investigated the effect 
of essential fatty acids (EF A) on imestinal adaptation after small-bowel resection in the 
rat. Feeding the EFA-poor diet resulted in significantly lowered hyperplastic response in 
comparison with feeding the control diet. Reversal to the control diet for two weeks 
increased the mucosal adaptation process significantly. Morin et al (54) showed that LCTs 
given intragastrica!ly enhance intestinal adaptation more than protein, polysaccharide or 
MCT. Intraluminal infusion of antino acids and dextrose in parenterally nourished rats 
showed that amino acids are more effective than dextrose in maintaining the small-bowel 
mass (46). Vanderhoof investigated the relative trophic effect of glutamine, glycine or 
glucose in rats subjected to 70% proximal jejune-ileal resection (44). The different 
components were supplemented (5% of total amount of calories) to enterally given 
powdered rat chow. This study learned that large amounts of glutamine may produce 
negative effects on the adaptation, possibly mediated by excess of ammonia production. 
Other studies showed that glutamine-enriched diets prevent imestinal atrophy and thus 
optimal dosing of this enteral fuel is of utmost importance. Together, all these 
observations show the relative importance of fat in promoting imestinal adaptation and 
W ~I 
indicate that more research is necessary to find the optimal combination of diet 
supplemeDtation with substances like glutamine. 
1.2 The interrelationship between histologic changes and function 
In the literature, there are indications that there is a separation between the regulation of 
mOtphologic and functional mucosal growth. Urban et al (55) examined the transport of 
sodium, chloride, water and galactose in relation to mucosal growth, both 2 and 4 weeks 
after 70% small-bowel resection in rats. This study showed that maximal motphologic 
growth occurs 2 weeks after 70% small-bowel resection and precedes functional 
adaptation, which was demonstrated by unaltered transport capacities per amount 
intestine. In addition, functional adaptive mechanisms may be localized to specific regions 
of the remaining intestine as indicated by specific increases of electrolyte and water 
transport in the duodenum and of galactose transport in the ileum 4 weeks after resection. 
Bury et al (56) evaluated carbohydrate absotption 2, 6 and 12 weeks after an 80% 
resection in rats. A progressive rise, lagging behind the motphologic changes, was first 
seen by 6 weeks in both jejunal and ileal remnants. 
1.3 Mechanisms responsible for intestinal adaptation 
Unravelling the identity of both nutritive and non-nutritive signals capable of inducing 
adaptive changes of the intestine has been subject of descriptive studies. Recently, 
attention has turned to the mechanisms responsible for the adaptive mOtphologic and 
functional changes occurring in response to a signal. MechanisticallY, changes may occur 
at the pretranslational, translational and posnranslational level. These changes may result 
in alterations in mucosal growth as well as in biochemical and biophysical properties. 
Polyantines are essential substances for vital processes of cell proliferation, as phase-
specific rises in polyamine amount are a prequisite when entering the Gl phase, at the 
time of initiation of DNA synthesis and prior to cell division. Although the cellular 
mechanisms controlling intestinal adaptation are poorly understood, it has been 
hypothesized that intestinal polyamine levels, regulated by key enzymes controlling their 
synthesis (ornithine decarboxylase; OOC) and degradation (diantine oxidase; DAO) playa 
major regulating role in intestinal mucosal growth. These key enzymes, in tum, may be 
up- and down regulated (in)directiy by trophic factors like the nutritive and non-nutritive 
factors. 
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A recent rat study of Rountree et aI (57) analyzed the proglucagon and ODC messenger 
RNAs after 80 % jejunoileal resection before and after refeeding. In ileum both mRNAs 
increased before refeeding within 2 hours after resection, indicating nutrient-independent 
components of the adaptive bowel response. The ODC mRNA remained elevated for 24 
hours after resection. This was in contrast to the elevation in proglucagon mRNA, which 
was sustained for up to 8 days. Taylor et aI (58) observed a rapid increase in glucagon 
mRNA levels, reaching maximal levels 2 days after small-bowel resection in rats. In 
animals fasted after the resection, elevation of glucagou mRNA, but not of ODC mRNA, 
was significantly lower compared to fed animals 48 hours after the resection. Compared 
to glucagon, a similar less abundant pattern of changes has also been recognized for the 
expression of the Cholecystokinine (CCK) gene. In jejunum, however, no changes in 
either glucagon or CCK mRNA levels are found after resection, while morphologic 
changes are seen. 
Rokkas et aI (59) found that inhibition of DAO, by administering antinoguanidine 
subcutaneously (25 mglkglday), enhanced the adaptive intestinal mucosal growth after 
80% proximal small-bowel resection. Blocking ODC, using difluoromethylornithine, 
markedly inhibited the adaptive hyperplasia nonnally found 4 days after 50% proximal 
small-bowel resection in the rat (60). 
AU these observations underline the hypothesis tho.t a cascade of events, initiated by both 
nutritive and non-ruaritive factors, result in increased polyamine synthesis which in turn 
upregulates DNA, RNA and protein synthesis, crypt cell proliferation and finally leads to 
villus hyperplasia (61). 
1.4 Concluding remarks 
This overview demonstrates that non-nutritive as well as nutritive factors are involved. in 
stimulating the adaptation process of the remaining intestinal remnant following smaII-
bowel resection. The importance of oral food intake is underlined and the indistinctness of 
the role of food complexity is expressed. Moreover, the importance of diet composition is 
pointed out. 
By now, little information is available on the precise functioning of the complicated 
regulatory nerwork operative in intestinal adaptation found after small-bowel resection. 
Although it is generally accepted that the factors discussed affect the adaptation of the 
residual small bowel, the mechanistic basis has until recently received relatively little 
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attention. Presently, we begin to unravel the cellular eveDlS that regulate the adaptive cell 
growth, recognizing the conducting role of the polyamines. It is realized that suppression 
of DAO may be helpful in stimulating hypetplasia after major resections. The precise 
patterns, and signals responsible for region-related functional alterations in intestinal 
DUtrient uptake in response to howel resection have yet to be established. 
At this stage, it is impossible to answer questions like which diet is optimal, or whether 
the adaptation response can be maximized. Future studies in transgenic animals that 
overexpress or underexpress a specific factor will provide direct information about the 
effect on the adaptive response. In addition, it has to be realized that following intestinal 
resection not only adaptive changes occur at the level of the small intestine but that in fact 
the total organism tries to fmd a new homeostatic balance. 
2 IRREVERSIBLE INTESTINAL FAILURE 
If ultimately the remaining small intestine does not sufficiently adapt irreversible intestinal 
failure will develop leaving the patient totally dependent on total parentetal Dlltrition. 
2.1 Limitations of total parenteral nutrition 
Patients on home total parentetal DUtrition are limited in their lifestyle and, more 
importantly, they have a considerable risk of serious complications such as sepsis, 
thromhosis, liver impairment and metabolic disorders (69,70). Especially in children the 
long-term outlook is less favorable (14-31 % mortality rate) because compared to adults 
they have a higher risk of liver impairment, have limited adequate venous access, and 
need more specific nutrition to grow and develop normally (71). 
Considering these long-term complications of total parenteral nutrition it will be clear that 
this form of therapy, albeit very effective and life-saving, should only be employed as a 
temporary solution. Therefore, researcb is undertaken to find other ways of treating 
irreversible intestinal failure (72,73). One sucb option is small-bowel transplantation. 
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2.2 Incidence in the Netherlands 
In the Netherlands, contrary to the United Kingdom (67) and the United States (68), there 
is no Home Parenteral Nutrition registry in which all patieots receiving home parenteral 
nutrition are listed. Therefore, the incidence of irreversible intestinal failure in the 
Netherlands can only be estimated. Extrapolating the number of patients recorded in the 
university hospital Rotterdam (Sophia Children's Hospital for children and Hospital 
Dijkzigt for .dnlts), being about 3 patients/year, the estimated incidence of irreversible 
intestinal failure in the Netherlands is 2-3 cases per million of the population per year, 
leading to a total of 30-45 patients per year. 
3 EXPERIMENTAL BASIS FOR SMALL-BOWEL TRANSPLANTATION 
Although experimental smaJl-bowel transplantation has already been introduced by 
Lillehei et al in 1959 (74), convincing evidence that the smaJl bowel can be transplanted 
in humans has not been obtained until recently. After initial unsuccessful attempts with 
"classic" innnunosuppression like azatbioptine and methylprednisolone some thirty years 
ago (reviewed by Kirkman 75), interest in smaJl-bowel transplantation dwindled. For 
years, major obstacles including technical complications, rejection, graft-versus-host 
disease and sepsis have bindeted clinical examples of a functioning smaJl-bowel graft. 
The introduction of cyclospotine A (CsA), which appeared capable of preventing rejection 
of smaJl-bowel grafts in several animal studies, provided a rationale for further 
experimentation to determine the feasibility of clinical small-bowel transplantation. 
The experimental basis for clinical trials of smaJl-bowel transplantation includes the 
search for an optimal method and tools to monitor rejection and functional status of the 
graft. Table 2 illustrates the results obtained so far of experimental research for providing 
a valuable clinical model. 
3.1 Towards an opthnal method 
Experimental research in smaJl-bowel transplantation was carried out in many ways 
including a variety of experimental models, modalities of immunosuppression, and 
methods to alter the innnunogeoicity of the graft. 
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Table 2 Comparison of methodologic factors: 
smmnary of experimental research in smaIloobowei transplantation 
Outcome Cm terms of) Experimental model A Experimental model B References 
Orthotopic SBT Heterotopic SBT 76,77,78 
Operative time - + 
Complications - + 
Graft removal - + 
Mucosal atrophy + 
-
Graft penneability + 
-
Portoportai drainage PortocaV31 drainage 79,80,81 
Physiologic route + -
Metabolic complications + -
TechD.ical complications - + 
Immunologically advantageous +? -
Isolated SRI' Combined SBLT 82,83 
Technical complications + -
Rejection incidence - +? 
CsA FK506 84 
Therapeutic window + -
Toxicity + -
Long-term survival - + 
Quality of life - + 
Effects on growth + -
Synergistic capacity + -
Chronic rejection 
-
+ 
MIle matched Non-MBC matched 85,86 
Long-term survival + -
Graft-versus-host disease ? ? 
Jejunal graft lIeal graft 87,88 
Nutritional function - + 
Immune function + -
Adaptive capacity - + 
Abbreviations used: small-bowel transplantation; SBT, small-bowel-liver transplan:ta:tion; SBLT 
+ = a more positive outcome (e.g shorter operative time, less complications) in comparison with-
- = a less positive outcome (e.g longer operative time, more complications) in comparison with + 
+? = not conclusively documented 
Position of the graft 
Table 2 demonstrates that at first stage a heterotopic transplant is preferable. In this 
manner less complications will arise and it is possible to remove the graft with less severe 
morbidity and mortality in case of rejection (76,77,78). It has been reported that a 
heterotopicaJly placed graft may induce increase in permeability and subsequent bacterial 
translocation although luminal nutrition is expected to mjnimize this. Later on. these 
experimental studies were combined in the so-caJled two-stage operative teclmique. The 
Short bowel syndrome in infancy 15 
first stage is the heterotopic small-bowel transplantation, in which the graft is transplanted 
alongside the recipient's own bowel. With respect to the ends of the intestinal graft there 
are several possibilities: 1) they both are sutured to the ahdominal wall as an enterostoma; 
2) the oral end is either ligated, or exteriorized with the aboral end anastomosed to the 
recipient's disraI bowel; 3) the oral end is anastomosed end-to-end to the recipient's 
proximal bowel with the disraI end either ligated or exteriorized. The recipient's own 
bowel is removed and the graft is interposed several weeks after heterotopic small-bowel 
transplantation. 
Drainage oj the graft 
The graft's superior mesenteric vein can be anastomosed either to the portal vein (portal 
drainage) or to the inferior vena cava or iliac vein (systemic drainage). It has been 
reported that both techniques can be used, as only minor metabolic complications occur 
following systemic drainage (79,80,81). However, portal drainage, being the more 
physiologic route, is preferred. 
InrmuJU)logic aspects 
Several studies have demonstrated an immunologic advantage of combined smalI-bowel-
liver transplantation over small-bowel transplantation alone (82,83). However, this topic 
deserves further study because not all patients on total parenteral nutrition have severe 
liver damage, and replacing a normal functioning liver by an allograft seems not the most 
ideal treatment. 
In Paris, at the International Symposium on Organ Transplantation in 1992, StaI:zJ. 
compared FK 506 with CsA and concluded that both drugs should be used, as each has its 
own advantages and drawbacks (84). Major histocompanoility complex (MHC)-matcrung 
benefits the long-term graft survival in dogs and it may reduce the occurrence of graft-
versus-host disease as this is most commonly caused by MHC antigen differences (85,86). 
Composition oj the graft 
The use of a segmental graft seems feasible and it possesses sufficient adaptive absorptive 
capacity to give adequate nutritional support. Because of the specialized functional 
capacities of the ileum, for absorbing bile acids and vitamin B12, the ileum is preferable 
to a jejunal graft. Theoretically, an ileal graft, containing a greater amount of lymphoid 
tissue, is more immunogenic than a jejunal graft. Notwithstanding the potential risk of 
rejection, it seems prudent to use an ileal graft or, if the abdominal cavity has no spatial 
constraints, a jejunoileal graft in combination with potent immunosuppressive drugs 
(87,88). 
In su:mmary, from a methodologic poim oj view rhe experimental dora suggest thot a 
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MHC-moJ;ched jejunoileal graft, transplanted using the two-stage tecJuzique with 
ponoponal drainage is the optimal staning poirrt. The necessity of transplanti.ng a liver as 
well is questioTUIble, and the use of either CsA or FK 506 can be recommended. 
Preservation 
In the field of intestinal preservation, pioneering work was already started in 1959 by 
Lillehei et al (74), and although several factors were extensively studied, the results of 
SIDall-intestinai preservation remained poor until recently. Research Included the effect of 
several vascular perfusates, preservation temperatures, cryopreservation and flushing 
pressures (89,90,91). These studies learned that short-term preservation (up to 6 hours) 
can be obtained with various methods and solutions. It is felt at present that University of 
Wisconsin solution is best to preserve the bowel. Attention is now given to the role of 
free radical scavengers (92) and membrane stabilizers (93) to prolong the viability of the 
intestine. 
Strategies to overcome postoperative problems 
Frequent problems following SIDall-bowel tt:msplaotation include rejection, infection, and 
gtaft-versus-host disease. Acute rejection, chatactetized both clinically and histologically, 
can be suppressed by using efficient innnunosuppressive agents, by decreasing gtaft 
antigenicity, and preconditioning of the recipient (94,95). 
The use of currently available non-specific inununosuppression has, however, specific 
side-effects. It was shown in a rat model that esA treatment may be the critical factor 
that predisposes to sepsis following SIDall-bowel tt:msplantation (96). It is likely that 
bacterial translocation is an active process. This was investigated by comparing particles, 
from which it is known that they translocate passively, with bacterial translocation. It was 
then found that such particles do not translocate as bacteria do (97). In addition, Grant et 
al (98) showed that breakdown of the gut barrier during an episode of rejection is 
associated with bacterial translocation, possibly being the etiologic agent of infectious 
complications. Some investigations on the process of chronic rejection, becoming a 
predominant cause of gtaft loss in the long run, bave been started recently (99). Graft-
versus-host disease is the clinical manifestation of the innnunologic reaction of gtaft T-
lymphocytes against host antigens following SIDall-bowel transplantation. This 
phenomenon has been well descnoed in rat studies (100), and it is thought that a balance 
exists between rejection and gtaft-versus-host disease in such a way that prevention of 
gtaft-versus-host disease accelerates gtaft rejection (101). This implies that the occurrence 
of gtaft-versus-host disease should be manipulated, by means of donor pretreatment (102), 
topreventthe clinical symptoms and simultaneouslymairrrajningtheimmunosuppressive capacities. 
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3.2 Monitoring for rejection and function 
In Table 3, the tools for monitoring the rejection and/or function of the graft are 
summarized. 
Table 3 Studied tools to monitor rejection! andJor function: 
I Tool I llisadvantages j Advantages I References I 
Biopsy based 
Histology''' • p3!Chy charaaer '" reliable 103,104,105 
'" perforation risk 
'" presence stoma 
Ino:aepitheliallymphocytesl '" sensitive 106 
'" increased during 
rejection 
Immunohistology' * presence stoma '" increased sensitivity 107,108 
* perforation risk compared to histology 
Brosh border enzyme * does not precede * indicares carbohydraIe 109,110 
activity''' histology absorptive capacity 
* presence stoma 
Absorption based 
Transepithelial potential. * presence stoma '" non-invasive 111,lU,113 
differencesl ': '" parallels histology 114 
'" reflects graft function 
Maltose absorption1': * oral administration '" controversy on its 115,116 
test solution reliability 
• bloodsampling 
D-Xylose absorptionu '" oral. administration of 117 
test solution 
• blood sampling 
'" sensitive to infection 
La.ctulose-MaDnitol '" oral administration '" insensitive to infection Cbapter7 
absorptionl '" detection in urinary 
sample 
l~~labeled Glucose '" non~specific '" p3J.'allels histology 118 
absorptionl ': 
Cyc1osporine absotption1': '" not useful under FK 506 118 
• bloodsampling 
'" far soluble 
* unreliable 
Fecal far absorption: '" inexpensive 119 
'" stool assay 
18 Chopter 1 
Table 3 continued 
Tool Disadvantages Advantages References 
alpha 1 - antitrypsine1 * stool assay 119 
* inexpensive 
* sensitive 
PerJn£ability based 
Polyethylene glycol * oral administrarion * detection .in urine 120 
leakage' test solution 
* non-specific 
"Cr-EDTA leakage' * oral administration * detection in urine 121 
test solution * increasing during 
* expensive rejection 
* sensitive 
Hyaluron leakagel * luminal fluid sampling 122 
* non-specific 
Peripheral bwod based. * inexpensive 
Monocyte procoagulant * not conclusively 123 
activityl reponed 
N-Acetylhexosamini~ * does not precede * non-specific 124,125 
histology 
ILl and lL2 leveIs' * do not increase 126 
NOz-IN03- levelsl * specificity questionable * increased during 127 
rejection 
Cytoimmunologyl * probably sensitive, 128 
reliable 
This Table shows that histology is reliable for monitoring the rejection process and that 
its sensitivity can be improved using immunohistochemical staining. Considering the 
disadvantages of histology including the need of taking full thickness biopsies and the 
patchy character of the rejection process, functional tests have been examined for their 
use in recognizing rejection. With respect to the use of an absorption methOd, a test based 
on different absotptive substances is preferable in that it gives an increased specificity. 
These methods are unlikely to be useful in acnte rejection because the patient has not 
returned to enteral feeding in that space of time. But an absorptive method may have 
some value in the search for chronic rejection. A permeability-based method, not useful 
for functional monitoring of the graft, seems to be reproducible and reliable because the 
permeability is increased during rejection. However, it is non-specific at the same time, 
also being altered during some infections. A reliable serum marker as early detector of 
rejection has not been found yet, although many substances including monocyte 
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procoagulant activity, N-Acetylhexosaminidase, cytokine, and NO,-IN02-levels have been 
advocated. 
Margreiter suggested that monitoring of neoptrin in serum is possibly less masked by 
infection than NO,-INO,- levels. Recent work suggests that the use of cytoimmunologic 
monitoring of the peripheral blood is valuable for monitoring rejection and thus deserves 
further study. 
It is imponaru to realize tluzt it is uncenain whether the sensitivity and/or specificity of 
the stUdied parameters are preserved in human small-bowel tremsplanuaion. Therefore, 01: 
this stage, the combined use of all availl1ble tools is probably the best to establish 
rejection with the highest sensitivity and specificity. It is not easy to distinguish between 
graft-versus-host disease and rejection on the basis of clinical signs, as their symptoms are 
often the same and both may be present at the same time or in each other's absence (87). 
A relatively non-invasive test for cliagnosing graft-versus-host disease is still lacking. In 
late graft-versus-host disease, a skin biopsy that demonstrates lymphocytic infi1tration at 
the dermal-epidermal junction together with basal-cell degeneration is helpful in malring 
the distinction with rejection possible. In conttast, no histologic confinnation of graft-
versus-host disease is possible in case of humoral graft-versus-host disease (with anti-host 
hemolytic anaemia). 
Smdies on graft function have addressed immunologic, nutritional, motor and hormonal 
aspects (U9). The immunologic status of transplanted intestine has not been well defined 
yet. Normal1y, the small bowel has a significant role in the host immune defense. One 
component of this important function is the production of secretory 19A (sIgA), the 
predominant local antIbody. Normal levels of total sIgA have been found following small-
bowel transplantation, but allografts fail to respond to a new antigen with production of a 
specific slgA (130). 
However, priming of the recipient abrogates the inhibitory effect of CsA on specific slgA 
production (131). T lymphocytes are thought to carty out important effector functions in 
the intestinal immune system and it is known that even in the absence of rejection donor-
lymphOcytes are replaced by recipient-lymphOcytes, which implies that mucosal immune 
function may be mecliated by host-<ierived ceIls (132). 
Monitoring weight gives a sensitive indication of the functional competence of the graft 
following small-bowel transplantation and in addition a battery of absorption-based 
function tests is available (Table 3). Long-term studies in adult animals showed that the 
overall nutritional status can be mainutined satisfactorily, although late effects on both 
fecal fat absorption and D-xylose absorption were noted (U9,133). More studies are 
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needed, both in auto- and allotransplantation models, to determine the precise long-term 
consequences of sma!I-bowel transplantation and how compromised functions can be 
restored, Grant et aI (134) demonstrated in growing pigs that transpIantation of the emire 
sma!I bowel enabled normal weight gain, In contrast, Kimura demonstrated that 
transplanting a segmental jejuna! allograft showed reduced weight gain (129,135). Grant 
et ai, however, did not create short gut controls and Kimura did not include a norma! 
healthy control group, which makes it impossible to conclude that a segmental graft is 
less able to increase weight. Thus, so far, it has still not been established whether a 
segmental groft provides sufficienI junctional capacity to maintain a normal growth 
pattern and nutritional status. 
The imerdigestive motility activity of the sma!I bowel (termed the migrating motor 
complex; MMC) is a well-defined, spontaneous aud recurring cycliC pattern. Sarr et aI 
(136) demonstrated in a canine jejunoileal autotransplantation model that the characteristic 
MMC was present in both the hmervated duodenum and the transected jejunoileum, but 
that coordination between these regions was lacking. The physiologic fimction of the 
MMC is to clear the sma!I bowel of non-indigestible intraluminal debtis and lacking of 
MMC coordination throughout the gastrointestinal tract, due to permanent extrinsic 
denervation, is thought to be responsible for eventual bacteria! overgrowth (137). 
Moreover, extrinsic denervation may result in the loss of inhibitory and! or excitatory 
neuta! fibers present in the gut aud having an extrinsic origin. Nelson et aI (138) reported 
alterations in tissue neuropeptide concentrations that may indicate long-term cltanges of 
denervated transplanted bowel. 
4 CLINICAL EXPERIENCE WITH SMALL-BOWEL TRANSPLANTATION 
The reported sma!I-bowel transplantations in pediatric recipients have been catried out in 
Paris aud Pittsburgh between 1987 aud 1992 (see Table 4). In all cases cadaveric donors 
of similar or smaller size were used. 
4.1 Paris; transplantation under ryclosporin-based immunosuppression 
RecipienIs 
The Ethical Committee of the French H6pital Necker Eofants Ma!ades authorized the start 
of a clinical sma!I-bowel transplantation program in 1987. The consent was partly based 
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Table 4 Clinical characteristics of transplanted pediatric patients 
Fatieot Age (yr) Etiology Remaining Anatomy Duration Home toW __
nutrition (months) 
1 (male)' 0.75 neonatal total volvulus 10 em duodenum 6 and 12 
entire colon respectively 
2 (femaIe)' 9 secondary total IS em jejunum. 5 em 72 
volvulus after ileum and entire colon 
ileoceoal 
intussusception at 3 
years of age 
3 (male)' 5 total volvulus 10 em jejunum., 5 em 12 
ileum. entire colon 
and ileocecal valve 
4 (femaIe)' 0.5 total volvulus duodenum and colon 6 
no ileocecal valve 
5 (male)' ? total volvulus duodenum and colon not reponed and 12 
no ileocecal valve respectively 
6 (male)' 4 small-bowel atresia 20 em jejunum 48 
7 (male)' 0.8 volvulus duodenum and colon 10 
no ileocecal valve 
8 (femaIe)' 2.3 necrotizing duodenum and colon 38 
enterocolitis 
9 (male)' 4.3 gastroschisis 10 em jejunum and 52 
colon 
10 (male)' 2.8 intestinal atresia duodenum and colon 33 
11 (female)2 0.6 intestinal atresia not reponed 6 
12 (femaIe)' 1.1 volvulus not reponed 12 
13 (femaIe)' 1.7 volvulus not reponed. 18 
14 (femaIe)' 2.5 microvillus inclusion not reponed 29 
15 (male)' 1.3 intestinal atresia not reported 15 
16 (femaIe)' 10.2 chronic mtestinal not reponed 132 
pseudo obstruction 
, Data from Revillon et al. 1992 (141); , Data from Todo et al. 1992 (149) 
on positive results obtained in piglets since 1975 (139,140). 
The clinical characteristics of the patients are shown in Table 5. Nine isolated smaII-
howel transplantations were perfonned in 7 children. In all cases the patient was on long-
tenn total parenteral nutrition before undergoing small-bowel transplantation and was 
considered to bave irreversible small-intestinal failure. 
Transplarrt protocol 
In the perfonned transplantations, donor and recipient were ABO compatible in all 
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patients except in patient 5 in which donor was O· and recipient A·. All grafts used were 
harvested from human leucocyte antigens (HLA)-mismatched donors ranging from 
neonates (n=3) to 17-year-old children (n=6) (141). Grafts were harvested during 
multiple-organ harvesting and prepared by in situ vascular flushing of the small bowel 
with Collin's or University of Wisconsin solution at 4'<:. The small-bowel graft included 
a jejunoileal segment of 90 to 120 centimeters on a vascular pedicle of the superior 
mesenteric vessels. The graft was always placed heterotopically at first ins1ance to 
facilitate eventual removal of the graft in case of complications. The vascular washing 
solution included CsA (100 mglL) and anti-thymocyteglobulin (50 mg/L). 
Postoperative immunosuppression included CsA, usually combined with methyl-
prednisolone (2 mg/kg/d). In all except the first two cases antithymphocyreglobulin 
(5mg/kgld over a 6 hr infusion) was given for 15 days and Azathioprine (1.5 mg/kg/d) 
was included from day 6 onwards. 
Ann'biotic treatment consisted of administration of systentic antibiotics, including 
ceftazi:midime (100 mg/kg/d), phosphomycin (200 mg/kg/d) and ornidazole (30 mg/kgld) 
and, total decontamination of the recipient bowel by using vancomycin (100 mg), 
colimycin (1 million units), tobramycin (100 mg) aod nystatin (500 mg) four times a day. 
Postoperative course 
Rejection. The graft was monitored by regularly observing the stoma for early histologic 
signs of rejection (villus edema and mucosal sloughing) and alterations in 
immuoohistochentically stained biopsy specimens (increased T-cell infiltrates and 
increased HLA-DR expression on crypt entetocytes) the graft was monitored. 
Early acute rejection was observed in two patients (2 and 5) and was marked by increased 
ileostomy output. A prompl increase in immuoosuppression (ATG 5 mg/kgld) reversed 
the rejection process in patient 2. Patient 5 was treated unsuccessfully with 0KT3 after 
which the graft had 10 be removed. 
Delayed acute rejection was successfully treated with OKD in twO cases (patient 3 aod 
4). No attempt 10 reverse rejection was undertaken in patients 1 and 2 because of the Jife-
threalening condition of the patients at thaI time. 
Graft-versus-host disease. Using CsA combined with methylprednisolone and azathio-
prine, rejection occurred in all cases whereas no signs of graft-versus-hosl disease were 
seen. 
Infection. The infectious complications observed were opportunistic infections with 
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Pneumocystis carinii and Cytomegalovirus and can therefore be attributed to the 
iromunocompromised condition of the recipient and not to rejection. 
Graft function. In!estinal continuity was reestablished if a patient had good clinical 
condition without signs of rejection and tolerated enteral feeding. In patient 3. the graft 
was brought in orthotopic position in the 11th postoperative month. This infant was able 
to maintain a normal eating pattern for several months. Six months after the orthotopic 
placement of the graft. the patient developed chronic rejection necessitating removal of 
the graft. 
In patient 4. better known as Virginie. intestinal continuity was reestablished at 8 months. 
Total parenteral nutrition was progressively dimjnished and discontinued at 10 months. A 
recent report (142) describes the first 26 months in detail. The results show norma! 
growth and height curves. Intestinal transit time studies demonstrated norma! barium 
through flow. The fat absorption rate was also in the norma! range. The patient is now 
totally enterally fed and is receiving oral immunosuppression. 
4.2 Pittsburgh; transplantation under FK S06-based immunosuppression 
Recipie1l1s 
In several rat small-bowel transplantation models (143,144,145) the usefulness of FK 506 
was demonstrated to be superior to the immunosuppressive capacity of CsA. This finding 
prompted the Pittsburgh group to initiate a clinical tria! of combined small-bowel-liver 
transplantation in May 1990. 
The pretransplant clinical characteristics of the pediatric recipients are summarized in 
Table 5. All patients were on total parenteral nutrition for a certain period, varying from 
1 to 132 months. Three patients received an isolated small-bowel graft. The other six 
patients had experienced severe liver damage (total bilirubin from 6.3 to 50 mglDL) and 
therefore received a combined small-bowel-liver transplant (146). 
Transplant protocol 
The donors were ABO-identical with the respective recipients. As in Paris, HLA 
matching was random and resulted in two cases in which lymphocytotoxic cross-matching 
was positive. Graft harvesting and techuical details of the construction of liver 
engraftment and heterotopic placement of the small bowel have been descn'bed in detail 
by Starzl et aI (147). The small-bowel graft consisted of almost its entire length, from a 
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Table 5 Transplantation-related features of individual patients 
Patient and date Com~n Postoperative complications Gl"2ft TPN 
of transplantation of the t Survival 
101109187 small bowel * graft necrosis and subsequent 3 hours 
hemodynamic disorders 
03126189 small bowel * no early complications 
* week 7: deve1dl':ment of sepsis, 8 weeks 
oneumonia an 'rejection 
203121187 small bowel * no early complications 
* day IS: acute rejection 
* day 205: graft rejection and 
subsequent renal insufficiency. major 
liver disease and hematologic 
disorders 
205 days 
302118188 small bowel * no early complications 17 months 
* day 30: CMV infection 
* day 60-64: recurrent pancrea:ritis 
* day 150: subacute rejection 
* month 17: chronic ~ection 
403118189 small bowel * rejection episodes (ar 3, 5 and 19 > 3 years free 
months) 
* -pneumOcystis. infection 
506130189 small bowel * day 8: severe rejection 25 days 
?1?/90 small bowel * hemodynamic disorders leading to 
death 
none 
6 ?1?189 small bowel * no early complications 7 months 
* month 5: acute rejection 
* month 7: chronic reiection 
7 ?1?19O small bowel * no early complications 30 days 
* day 30: acut~_~ection 
807124190 small bowel * rejection episodes: 3 (SB), 1 (L) > 2 years free 
and liver • mfectious episodes, 3(b), I (v), 2 (t) 
* refused. to eat 
9 11124190 smaII bowel * spinal cord injury after spinal tip > 2 years free 
and liver • rejection episodes, I (SB). 6 (L) 
• mfectious episodes, 3 (b), 2 (v), 2 (t) 
* pylorospasm 
1003124191 small bowel * paralysis of the right hemidiaphragm > 1.5 free 
and liver • rejection episodes, 4 (SB), 6 (L) years 
• mfectious episodes, 3 (b), 2 (v). 2 (t) 
11 08/09191 small bowel * anastomotic bowel leak died of sepsis 23 days 
and liver and possible graft-versus-host disease 
1208110191 small bowel * no complications > 1 year free 
and liver 
13 08/12191 small bowel .. no complications > 1 year free 
and liver 
14 10131191 small bowel * not reported > 1 year free 
15 12125191 small bowel .. not reponed > 10 free 
months 
16 ? small bowel .. not reported ? partial 
.. TPN = total parenteral nutntlon, SB- small bowel. L- lIver, b - bacterial. v = viIal. t = translocatlon 
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few centimeters distal to the ligament of Treitz to a few centimeters proximal to the 
ileocecal valve. The graft was perfused in isolation with cold University of Wisconsin 
solution but no luminal wasbing was performed. No effort on donor pretreatment 
(inununomodulation) was made. 
Administration of FK 506, the basic inununosuppressive therapy, was started inunediately 
after graft revascularisation by continuous intravenous infusion (0.1 to 0.15 mg/kglper 
day) (148). intravenous administration of the drug was switched to enteral administration 
(twice daily with a total dose of 0.3 mg/kglper day) a few days after enteral feeding was 
restarted. Low dose methylprednisolone, 200 mg at first dose tapered to a 20 mg/day 
maintenance level over 5 days, was given additionally. From patient 14 on, prostaglandin 
EI infusion (0.6 to 0.8 g1kglhour) was added to the inununosuppressive cocktail. 
Selective intestinal decontamination was the same in donor and recipient and consisted of 
a mechanically given mix1llre of amphotericin B, tobramycin and polymyxin E given four 
times a day for a period of 4 to 6 weeks. Systemic antibiotics included ampicillin and 
claforan and was given the first five postoperative days. 
Postoperative course 
Rejection. Endoscopy was performed and biopsy material was obtained if clinical 
symptoms of intestinal rejection, including fever, malaise, dysmotility (ileus or diarrhea) 
of the graft or malabsorption were present. On base of these findings (clinical, endoscopic 
and biopsy) the degree of rejection was diagnosed (149), and treatment was adjusted if 
necessary. Treatment resulted in comrol of rejection in all cases. In Table 5, rejection 
episodes are shown for each patient for both intestine and liver. 
The incidence of graft rejection appeared to be lower, after isolated small-bowel 
transplantation than after combined small-bowel-liver transplantation, at least in the early 
postoperative period (150). 
Graft-versus-host disease. Patient 11 possibly died of graft-versus-host disease, because 
clinical findings of graft-versus-host disease, including apoptosis and infiltration of the 
skin with lymphocyteS of donor phenotype, were found one day before death. The patient 
died 23 days after the operation after having developed sepsis and multiple organ failure. 
In the other patients no signs of graft-versus-host disease were encountered. 
Infection. Four patierns developed in total 6 infectious episodes in which microorganisms 
detected in the blood were proven the same as present in the stOOl. In half of these 
occasions, translocation could be associared with rejection. It appeared that isolated smaII-
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bowel grafted recipients bad an incidence of infectious complications compaIable to small-
bowel-liver grafted ones. Patient 10 developed an opportwristic adenovirus infection. 
Graft function. Reestablishment of the intestinal continuity was established 8 to 16 weeks 
after heterotopic placement of the graft. All but one patient (16) bad become independent 
of total parenteral nutrition (149). These updated results are more optimistic than those 
reported previously by the same group (151). At that rime only two of nine patients were 
totally independent of total parenteral nutrition. Initially, all patients had aversion to food 
aod had to be taught to eat. By now, patients 11 aod 13 still refuse to eat normally. The 
graft's function was assessed by means of histology, intestinal graft transit rime studies 
and several absorptive tests (fecal fat excretion, FE: 506 kinetics aod D-xylose 
absorption) . 
Fat absorption was abnormal in all patients, even as long as one year after transplantation 
(149). In the early postoperative period both accelerated aod prolonged intestinal transit 
rime were found which improved later on. The D-xylose absorption test showed slightly 
abnormal results in patient 12 aod 13 on 111 and 73 days postoperatively respectively. 
The other patients had normal D-xylose absorption. The available weight data are 
summarized in Table 6, which shows that all patients gained weight after being fed 
enterally. 
Table 6 
Patient 
8 
9 
10 
12 
13 
14 
IS 
Results on start of oral feeding after heterotopic placement and subsequent weight 
gain after orthotopic placement of intestinal graft (56-112 days after heterotopic 
pia ..... ""') updated to January 1992 , 
Starting Complete Preoperative Cnrrem Postoperative 
enteral enteral weight (kg) Weight (kg) surril'3! 
feedIDg (days) feedIDg (days) (days) 
Il 60 12.8 14.8 > SS7 
23 210 19.6 20.2 > 434 
37 200 14.8 19.3 > 314 
16 60 10.8 12.7 > 175 
30 45 10.8 12.7 > 175 
9 49 12.4 14.6 > 93 
5 14 12.6 12.8 > 38 
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4.3 Discussion 
The experimental basis obtained by the Paris group was not very convincing for starting a 
cliIrical trial. Their average failure rate was 20 out of 44 operations and the cliIrical 
immunosuppressive protocol was based on only 4 long-term surviving animals. In the 
cliIrical cases described, no anention was given to HLA matching. No comment can be 
made on the benefits of tissue matching for small-bowel transplantation on the basis of 
cliIrical experience. However, concerning the results of HLA matching in case of other 
solid organ transplant programs and those obtained in large anintals a potential effect of 
tissue matching on graft survival can certainly not be excluded (152,153). The bad results 
obtained in the nine performed transplantations led to a stop of the cliIrical transplantation 
programm in Paris. 
The Pittsburgh transplant protocol included no efforts on immunomodulation of the graft. 
Such policy, regarding the immunogenicity of the graft, may be expected to result in a 
high incidence of graft-versus-host disease. However, their experimental work has 
routinely demonstrated prevention of graft-versus-host disease in rats treated with FK 506 
(144). The one patient that developed cliIrical graft-versus-host disease was receiving 
decreased immunosuppression because of a technical complication. 
The cliIrical results show that successful intestinal transplantation is now feasible from a 
technical point of view. The postoperative course was stormy in most patients, rejection 
still being a major barrier, even under FK 506 immunosuppression. Surveillance 
endoscopy is indispensable for early diagnosing rejection with the "official" tools as 
confirming instruments. Infectious complications, in some cases early indicators of graft 
rejection, were often encountered. These problems underline the complexity and 
difficulties in managing the early postoperative phase after small-bowel transplantation. 
The studied parameters on functioning of the. transplanted intestine were satisfying, 
although the abnormal results on fecal fat excretion give reason for caution with respect 
to long-term functioning. 
At this moment, the available data on weight gain do not indicate that a small-bowel 
transplant can provide for adequate nutritional support to a growing individual with short 
bowel syndrome. Besides, vety recently it has been decided to stop the cliIrical smalI-
bowel-liver transplantation programm in Pittsburg also as a consequence of the bad 
overall results in the long run. 
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A. SCOPE OF THE ADAPTATION-RELATED STUDIES 
After extensive small-bowel resection. the remaining intestine will adapt to the loss of 
absorptive area. The adaptive changes include alterations in gut morphology as well as 
gut function. The overall process, which is very complex, is still not precisely 
understood. A tool for monitoring the functional status of the intestioe is still missing. 
This is why it is still impossible to study the effect of factors that might affect the 
functioning of the intestine. There is evidence that enteral nutrition is a major stimulator 
of intestinal adaptation. However, the belief that an predigested diet is the optimal 
treatment of the short bowel syndrome is not based on any well-desigued experimental 
study. 
The adaptation-related experiments descnbed in this thesis were perfonned to answer the 
following questions: 
* Is it possible to monitor the junctioruzl process of inIestiruzl adaptation after 
massive small-bowel resection ? 
* 
This was investigated. in rats that underwent near-total small-bowel resection; we 
developed a non-invasive method for in vivo measurement of transepithelial 
potential differences (Chapter 3). 
What is the role of the complexity and composition of enteral nutrition on the 
morphologic and junctioruzl adaptation after massive small-bowel resection ? 
This was investigated in rats that underwent small-bowel resection; the rats were 
fed either nortnal rat chow, a diet with intact or partial hydrolyzed proteins, or a 
non-identinal polymeric diet (Chapter 4). 
B. SCOPE OF THE TRANSPLANTATION-RELATED STUDIES 
Small-bowel transplantation in man is now technically feasible. Before a clinical small-
bowel transplantation program in children is justified, it must have been ascertained that a 
small-intestinal transplant can give adequate nutritional support to a growing individual 
with the short bowel syndrome. There are a number of aspects that are involved in the 
functioning of the small intestioe. Firstly, the transplantation procedure itself may 
temporarily or permanently alter the small-intestioal function in such a way that intestioaI 
transplantation is not a realistic treatment modality. Secondly, optimally MHC-matched 
persons could donate allogeneically identical segments of intestine to serve as grafts for 
persons with severe short bowel syndrome. In growing individnals this approach is only 
beneficial if a segmental graft adapts sufficiently to treat the short bowel syndrome and to 
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sustaill growth and development. 
Major problems in human small-bowel transplantation are the stormy postoperative 
conrse, requiring multidisciplimry management, and the lack of an early, simple rejection 
marker. A simple test indicating the functional capacity of the graft is also not available at 
present. 
The transplantation-related studies were performed to answer the following questions: 
* Can normal growth and developmem be expected after peJjorming total onhotopic 
small-intestinal. autotransplantation in growing individuals ? 
• 
* 
* 
* 
* 
This was investigated in growing dogs by performing one-step total orthotopic 
small-intestinal autotransplantation (paragraph 5.1). 
lWzat are the long-term effects of the small-bowel transplantation procedure on 
junction, morphology, and bacteriology of the small intestine of a grawing 
iJuiividual ? 
This was evaluated by long-term analysis of the functional, morphologic, and 
bacterial status of the small intestine after one-step total orthotopic small-intestinal 
autotransplantation in growing dogs (paragraph 5.2). 
Is ultrasonography of value in the follow up of small-bowel transplantation ? 
This was determined in growing dogs, by means of ultrasonography, to evaluate 
the postoperative conrse after a two-stage segmental small-intestinal 
allotransplantation (Chapter 6). 
lWzat is the role of a MHC-maJ;ched segmemal small-intestinal allotransplantation 
model in the treatmem of the shon bowel syndrome in grawing iJuiividuals ? 
This was investigated in growing dogs by performing a two-stage MHC matched 
segmental intestinal allotransplantation (Chapter 7). 
Is it possible to detect acute intestinal rejection at an earty stage by use of a senun 
marker? 
The value of diamine oxidase as serum marker of acute rejection was studied in 
rats after performing fully allogeneic total orthotopic small-bowel transplantation 
(paragraph 8.2). 
Is it possible to evalUOIe intestinal graft fwzction by use of a simple test ? 
The value of assessing postheparin diamine oxidase release as indicator of graft 
function was determined after fully allogeneic total orthotopic small-bowel 
transplantation in rats (Paragraph 8.3). 
PART A. ADAPTATION 
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THE VALUE OF IN VIVO ELECTROPHYSIOWGIC MEASUREMENTS FOR 
MONITORING FUNCTIONAL ADAPTATION AFTER MASSIVE SMAIL-BOWEL 
RESECTION IN THE RAT 
Abstract 
The process of functional adaptation after extensive small-bowel resection is complex and 
imprecisely understood. We set out to evaluate the value of in vivo electrophysiologic 
measurements for monitoring the functional adaptation process after massive small-bowel 
resection in Brown-Norway rats. Rats underwent either a sham operation (sham-operated 
rats) or a 90% small-bowel resection (small-bowel resected rats). Standard rat chow was 
fed ad libinnn. At 3 or 10 weeks postoperatively, jejunal and ileal ttaIlSepithelial potential 
differences (in m V) were deterntined. Electrogenic ion transpOrt in villus and crypt was 
measured after glucose (sodimn-coupled active glucose absorption) and theophylline 
iofusion (theophylline-stimulated chloride secretion) respectively. Biopsies were obtained 
simultaneously. Each experimental group consisted of 3 to 5 animals. At 3 weeks the 
theophylline-stimulated chloride secretion and the sodium-coupled active glucose 
absorption in small-bowel resected rats were significantly lower than in sham-operated 
rats in both jejunal and ileal segments. At 10 weeks the theophylline-stimulated chloride 
secretion and the sodium-coupled active glucose absorption were significantly djminished 
in the jejunal segment of the small-bowel resected rats as compared to the sham-operated 
rats. However, the values of theophylline-stimulated chloride secretion and sodimn-
coupled active glucose absorption in the ileal segments were not different anymore 
between the two groups. Three and ten weeks postoperatively the villus length in the 
small-bowel resected group was increased significantly as compared to the sham-operated 
controls. These results indicate that in the early phase of adaptation in vivo 
electrophysiologic parameters do not correlate with histologic changes in the small-bowel 
resected rats. This might be due to cell immaturity resulting from an increased cell 
turnover rate andlor lack of intercellular tight junctions. This hypothesis is supported by a 
recovery of transepithelial potential differences, in response to stimulation, in the ileum 
10 weeks after resection. 
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Introductiou 
Extensive small-bowel (SB) resection triggers complex adaptive changes (1,2). Initially, 
all resected patients need intravenous infusion to avoid the development of malnutrition 
while oral feeding is being attempted (3). Most negatively, the markedly reduced 
absorptive surface results in the short bowel syndrome, wlrich is defined as incapability to 
tbrive through oral nutrition. Most positively, the remaining bowel adapts sufficiently to 
provide essential nutritional support. Manipulating the outcome is difficult, as the procesS 
of functional adaptation after extensive SB resection is not fully understood. 
Intestinal adaptation bas been described as the proliferative, morphologic and functional 
response to a variety of internal and external stimuli to maintain equilibrium in the 
gastrointestinal tract (4). After intestinal resection, hyperplastic changes caused by 
increased cell turnover in the proliferative zone of the crypts, are generally seen in the 
enteric remnant (5). There is evidence that the unchanged number of cells per unit length 
may indicate irnmanIre enterocytes (5,6,7), but increased absorptive capacity per unit 
length bas been reported as well (8,9). These divergent results may be ascribed to 
chronologie differences in the studies performed. Urban et al postulated that morphologic 
growth precedes functional components of intestinal adaptation after resection (10). 
However, the exact interrelationslrip between histologic changes and function, possibly 
regulated by different factors that may be sequentially interrelated, is unknown. The 
purpose of this study was to determine the value of in vivo electrophysiologic 
measurements for monitoring functional intestinal adaptation. 
E1ectrophysiologic responses are reliable indicators of SB function (11). We developed an 
in vivo technique, measuring transepithelial potential differences (PD) evoked by sodium-
coupled active glucose absorption, which is an index of villus function, and cAMP 
mediated chloride secretion, predominantly reflecting crypt cell function. 
Moreover, lristologic specimens were collected to explore the imerrelationslrip between 
morphologic and functional cbanges during the adaptation phases studied in this 
investigation. 
Material and Methods 
Animals 
Male rats of the inbred Brown-Norway (BN) strain (Harlan CPB, Zeist, The Netherlands) 
were used. The animals weighed 250-400 g and were bred under specific pathogen-free 
conditions. The animals underwent either a sbam operation (SR), a 90% SB resection 
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(SBr), or were negative control animals (IS). During the experimental period, all animals 
were kept under standard laboratory conditions (12 hours lightl12 hours dark) and were 
given water and standard rat chow (AM-II; Hope Farms, Woerden, The Netherlands) ad 
libitum. 
Ethics 
The experimental protocols adhered to the rules laid down in "The Dutch Animal 
Experimentation Act" (1977) and the published "Guidelines on the Protection of 
Experimental Animals" by the Council of the E.C. (1986). Specific protocols were 
approved by the Commitee on Animal Research of the Erasmus University, Rotterdam. 
Permission was given as the expected animal harm was considered ntinor to the expeered 
social benefit. 
Operation procedure 
The rats were anesthetized with ether after which a midline laparotomy was performed. 
SBr rats were created by near total SB resection, i.e from 2.5 em distally from the 
ligament of Treitz to 2.5 em proximally from the ileocecal valve. A sham operation was 
performed by transection midway ileum and jejunum, without removal of bowel mass. 
After each procedure gastrointestinal corninuity was restored in an end-to-end fashion, 
using Ethicon 7-0. After the operation, all animals were given 1 ml (10% v/v in PBS) 
Depomycin 20/20 (Gist-Brocades, Animal Health b.v., De Bilt) subcutaneously. Half of 
the animals in each group underwent electrophysiologic monitoring and were sacrificed 3 
weeks postoperatively (SH I , n=5 and SBr" n=7), the other animals (SH" n=5 and SBr" 
n=5) 10 weeks postoperatively. A third group of animals (IS, n=3) were not sub jeered to 
any operation. In these rats the superior mesenteric artery was clamped two hours before 
starting the electrophysiologic measurement in order to provoke ischemic intestinal injury. 
The intestinal segment selected for measuring was anatomically identical in all rats. 
Techniques 
Growth assessment. Postoperatively. the animals were weighed three times a week. 
Electrophvsiology. Rats were anaesthetized with ether, and a midline laparotomy was 
performed to visualize the bowel for the electrophysiologic measurement. This method is 
a modification of the technique developed by Meijssen et al to monitor function of the SB 
in dogs (12). A well-defined jejuna! and ileal segment was chosen as measure-area in 
which a continuous flow of test solution was maintained using canulas. Several iso-
osmolar test solutions were flushed through the segment to determine intraluminal 
transepithelial PD in reference to a subcutaneous Ag/AgCl, electrode (37'C, 8 mlIntin). 
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The standard solution consisted of (in mM): Mannitol 50; NaCi 110; HEPES 5; KCl 4; 
Na,S04 10. In the theophylline and glucose containing solutions part of the mannitol was 
iso-osmotically replaced by 5 mM Theophylline or 30 mM a-D-Glucose respectively. 
Before starting the measurement preperfusion was perfonned (6 minutes) to equilibrate 
luminal content with the standard perfusion solution. Subsequently the following solutions 
were infused for 5 minutes each: Stanciard-Theophylline-Standard-Glucose-Stanclard. The 
standard solution was used to assess the basal potential differences wlrich reflect 
physiologic active ion transport. Infusion of Theophylline-solution (5mM) evoked chloride 
secretion, predominantly a crypt function, resulting in an intraluminal negative PD cPD-
theo). A Glucose-solution (30mM) evoked sodium-coupled glucose absorption, reflecting 
villus function. also resulting in an intraluminal negative PD cPD-glu). An overview of 
the technique is depicted in Figure L 
Fig.1. Overwew of the set up for electrophysiologic measurements. 
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Histology. Full thickness biopsies were collected just before the electrophysiologic 
measurements and immediately fixed in 3.6% buffered formalin. then dehydrated and 
embedded in paraffin. Sections of 4-5 p;m were stained with hematoxylin-azophloxin-
safran. By standardized projection of sections on a screen through a light microscope, 
crypt and villus length could easily be measuted. Villus height was measuted by 
subtracting crypth length, i.e the shortest distance between the bottom of intestinal villi 
and the lamina muscularis mucosae, from mucosa height. For each rat, a total of 10 
measurements was performed. and the average was considered representative in the 
comparative study. 
Metabolic parameters. During the sixth postoperative week, rats were kept for 4 days in 
metabolic cages provided with a system to collect faeces and urine, and to measure food 
and water consumption. 
Statistical analysis 
Statistical analysis of data between experimental groups was performed using the 
Student's t-test. We preferred to express our data as the difference between SH and SBr 
at each time point, because there was a tendency in the sham-operated group to a 
decreased PD response, apparently as a consequence of the operation. Differences with p-
values lower than 0.05 were considered to be significant. 
Results 
Mean weight change curves during the postoperative period for resected and sham-
operated animals are shown in Figure 2. 
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All electrophysiologic data obtained in SH and SBr rats are summarized in Figures 3 and 
4. 
3 weeks after surgery 
Electrophysiology 
VIllus length 
Crypt length 
1 I) weeks after surgery 
Electrophysiology 
llHoTl1EO SKo(lJJJ 1I8-THCO 380GUI 
"THeO-~GW_~ 
VIllus length 
Crypt length 
Fig.3. Jejunum: cfcctrophysioJogic and histolOgic findings. SH, shamoperated; sa, Short b~/;PD, potential difference: 
Gfu, glucose; THEO, theophylline; values in mean (SO). 
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3 weeks after surgery 
Electrophysiology 
Villus length 
Crypt length 
10 weeks after surgery 
Electrcphysiology 
Villus length 
Crypt length 
Fig.4. Ifeum: etectrophysiofogk; and histologic findings. Abbreviations as for Fig.S. 
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Weight 
Sbam-operated animals exhibited a small postoperative weight loss followed by weight 
gain to 110% of the preoperative weight. In the short bowel group the follow-up revealed 
postoperative weight loss to 70-80% followed by a gradual recovery to 90% of the 
preoperative weight. None of these rats gaiued preoperative body weight within 10 weeks. 
Two SBr, rats died duriug the experimental period due to clinical short bowel syudrome. 
Electrophysiology 
JeiunaJ electrophysiologic measurements. At 3 weeks, the glucose and theophylline 
stimulated PD responses in SBrl rats were significantly djminished compared to SH I rats 
(p<0.02 and p< 0.05 respectively). At 10 weeks the stimulated PD responses in SBr, 
rats were significantly lower in the jejunal segment as compared to SH, rats (pD-glu: p < 
0.01; PD-theo: p<0.05). In IS rats, no response was found to either of the test solutions 
(results not shown). 
neal electrophysiologic measurements. At 3 weeks, stimulated PD responses in rats from 
the SBr, group were significantly diminished for both glucose (p<0.01) and theophylline 
(p<0.05) compared to those in group SH,. At 10 weeks no significant differences in PD 
responses were found in either of the groups. In IS rats, again, no response was found to 
either of the test solutions (results not shown). 
Histology 
Histologic data are depicted in Figures 3 aod 4 respectively. 
Jejunal findings. At 3 weeks postoperatively, villus length was significantly enlarged in 
SBr, rats compared to SH, rats. Also 10 weeks postoperatively, jejunal villus length was 
significantly enlarged in SBr, rats compared to SR, rats. In addition, no differences in 
crypt length were found in either of the animals. 
neal findings. Three weeks postoperatively, villus length was significantly increased in 
SBr, animals compared to SR, animals (p< 0.05). Ten weeks postoperatively, no 
significant difference was found in ileal villus length between the experimental groups. 
Agaiu, no differences in crypth length were found in either of the groups. 
Metabolic parameters 
Figure 5 shows that 6 weeks postoperatively there were nO significant differences between 
SR aod SBr operated animals for food intake, water consumption, and uriue and faeces 
production. 
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Discussion 
In our experiments we perfonned near total SB resection to obtain a sublethal SBS model. 
In our view the occurrence of malnutrition, which is a characteristic of our sublethal 
model~ may be a major trigger for intestinal adaptation. We set out to evaluate the 
inIerrelationship between active electrolyte transport mechanisms and mucosal growth in 
jejunal as well as ileal segments in the follow-up of intestinal adaptation. The metabolic 
studies, perfonned six weeks postoperatively, demonstrated that at that time differences 
between sham-operated and resected animals were not caused by major metabolic 
cbanges. E1ectropbysiology, a reliable tool for functional assesstnent of active electrolyte 
transport mechanisms (12), might be useful to monitor the functional adaptation process. 
The electrophysiologic results show that the methodology developed is technically feasible 
in rats. It has been demonstrated that clamping the superior mesenteric artery for two 
hours results in ischemic intestinal injury in which active electrolyte transport mechanisms 
have been damaged (13). As expected, ischemic colllIol animals did not develop a 
transepithelial PD in response to any of the solutions. In contrast, transepithelial PD 
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values obtained in sham-operated and resected animals show that active transepithelial 
transport of electrolytes by an isolated bowel segment can be evaluated quantitatively by 
in situ electrophysiologic monitotiug. Previous studies have already shown that in vitro 
preparations of intestine can be used to study electrogenic Na+ absorption and 
electrogenic Cl' secretion (14). From both in vitro and in vivo studies, it is generally 
assumed that villus epithelial cells are responsible for electrolyte coupled absorptive 
processes (14,15). Crypt cells, on the contrarY, are thought to be mainly responsible for 
secretion of ions and water (14,16). Barry et aI demonstrated (17) that electrical potential 
differences are fundamentally similar comparing in vivo and in vitro results. The in vivo 
technique should be preferred to avoid ischemia, disruption of neural, lymphatic and blood 
supply and to have better sources of endogenous metabolites. However, the technique 
described in this study should be refined to develop a non-invasive measutiug system, as 
recently developed for large anirnaIs (U). Such a refinement would have great value in 
the investigation of adaptation mechanisms by determining the effect of diet composition 
(18), hormonal supplementation (19,20), or manipulating the polyantine metabolism (21). 
Previous experiments shOWed that reported tinting of functional adaptation varies. These 
variations may be related to the amount of riasue resected, postoperative time points 
studied, the specific region of the enteric remnant explored and the nature of the transport 
activities tested. For example, Urban et aI (10) found decreased duodenal and ileal 
transport of sodium, chloride, water and galactose in rats 2 weeks after a 70% SB 
resection. By 4 weeks postresection, increased duodenal sodinro, chloride and water, and 
ileal galactose transport were found. There was increased morphologic growth both 2 and 
4 weeks after resection. Another study (22) evaluated carbohydrate absorption 2, 6 and 12 
weeks after an 80 % resection. Both in jejunal and ileal remnants, a progressive rise, first 
seen by 6 weeks, was evident. 
The present experiments show that 3 weeks after resection, both the glucose-induced 
(reflecting Na +-couple glucose transport by the villus epithelium) and the theophylline 
provoked PD response (reflecting active CI- secretion by the crypt epithelium) in ileum 
were significantly diminished as compared to sham operation. At that rime, a considerable 
increase in villus length was found in resected rats but no enlargement of the crypts was 
found. In jejunum, 3 weeks after resection, similar results were found. We assume that 3 
weeks after resection the enteric remnant exhibits functional immaturity as a consequence 
of increased cell turnover. Such innnaturity has already been postulated (5,6,7,10) and 
may readily explain the reduction in Na +-glucose cotransport, a characteristic feature of 
mature villus cells. However, the parallel reduction in the theophylline-induced PD is 
more difficult to interpret, considetiug the prominent role of innnature intestinal crypt 
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cells in active CI- secretion. This chromologous rmding cannot be explained by • 
hyperactivation of the CI- secretory poars by endogenous secretagogues in the SB grouP. 
because the basal PD was not significandy different between SH and SBr rats. An 
potential factor expected to result in impairment of the electrieal response to both glucose 
and theophylline in the early adaptive phase after SB resection might be the absence. or a 
functional alteration, of intercellular tight junctions during this hyperplastic period (23). 
In ilenm, a different picture emerges 10 weeks after resection. Deal PD measurements in 
resected rats were then no longer different from those in sham-operated rats. Besides, 
villus length was no more significantly increased in resected animals. In contrast, by 10 
weeks after resection, evoked jejunal PD responses remained decreased as compared to 
values obtained 10 weeks after sham operation. This finding, conpled with still 
significantly enlarged jejunal villus length after resection, implies that, for the specific 
transport capacities tested, functional adaptation of ilenm precedes functional adaptation of 
jejunum after a 90% SB resection in rats. 
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THE EFFECT OF DffiTS WITH INTACT OR PARTIAL HYDROLYZED 
PROTEIN ON FUNCTIONAL ADAPTATION AFTER MASSIVE SMALL-BOWEL 
RESECTION IN THE GROWING RAT 
Abstract 
The aim of this study was to examine the relative importance of protein complexity and 
protein composition in promoting adaptation after extensive small-bowel resection. 
Ninety rats subjected to near-total smaJI-bowel resection received either normal rat chow, 
a diet with partial hydrolyzed proteins, an identical diet but with intact proteins or a non-
identical diet with intact proteins. During the experimental period survival was scored and 
weight was measnred regularly. 
Either 2 or 10 weeks after resection the adaptive state was evaluated by determining the 
metabolic Slatns, serum enzyme activities, postheparin diantine oxidase activity, villus and 
crypt lengths, as well as' cell proliferative activity. Tbe results show that the diet with 
partial hydrolyzed protein is as effective as the diet with intact proteins in initiating and 
supporting adaptation. In the first two weeks, the non-identical diet with intact proteins 
was superior to these diets as evidenced by a lower short tertn mortality rate, increased 
postheparin diamine oxidase activity, increased crypt lengths and crypt cell proliferative 
activity. No long tertn differences were found among the experimental groups. 
These results suggest that the role of protein composition is more important than the role 
of protein complexity in the early adaptive phase following smaJI-bowel resection. 
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Introductiou 
Intestinal adaptation, the ability of the residual small bowel to compensate for the loss of 
iutestinaI mucosa which may occur after surgety, is critical to the succesful recovery of 
patients with short bowel syndrome (SBS). The management of SBS requires a period of 
TPN, at least 1llltiI some bowel regeneration occurs, allowing the introduction of enteral 
nutrition. With respect to the well-established TPN, the importance of oral intake as a 
positive stinmlus to the adaptive Stage of the remaining bowel has been recognized. Lack 
of luminal content leads to absence of the hyperplastic response, occurring in the residual 
intestine (1). In segments exposed to enteral nutrients following resection there is an 
increase in both epithelial cell proliferation rate in the crypts and ntigration rate of the 
cells onto the villi, resulting in enlarged villi (2,3). The villus hyperplasia is characterized 
by an increase in mucosal cell mass and in DNA, RNA and protein content (4). 
Functionally, these segments exhibit increased abscrptive capacity per unit length (4). 
Other factors stimulating iutestinaI adaptation to SB resection include bile and pancreatic 
secretions (5), circulating honnones (6), and polyamines (7). 
Several findings indicate that complexity and composition of the proteins within the diet 
may play a role in the adaptation process of the bowel (8-14). Experimentally, the effect 
of complex versus chemically defined diets as well as the effect of individual nutrients on 
iutestinaI adaptation have been studied. Although not based on experimental justification, 
elemental diet became the Standard treatment of choice when Starting oral refeeding (15). 
The few data obtained from rat studies revealed no benefit from elemental diets over 
nonelementa1 food regimens and even suggest that a polymeric composition is better 
(16,17,18). In these studies, the inferiority of elemental diets could reflect differences in 
protein composition instead of complexity. However, a semi-elementa1 diet nonnally 
consists of partial hydrolyzed proteins, but with the same amino acid composition as the 
intact protein. 
The present study, therefore, was designed to compare a diet with partial hydrolyzed 
proteins with an identical diet containing intact proteins. The diet with partial hydrolyzed 
proteins is used in children suffering from SBS in the age of 10 -16 year. 
In addition. a macromolecular diet differing in composition from the diet with partial 
protein, was tested. In the clinical situation, this diet is prescribed to children of that age 
when there is no indication for a hydrolyzed diet and may reveal the relative importance 
of diet composition in comparison to diet complexity. Adaptation, after near-total small 
bowel resection, was evaluated by means of the following parameters: survival, weight, 
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serum parameters indicating the nutritional status, postheparin DAO assessment, histology 
and crypt cell proliferation, 
Materials and methods 
Animals 
Ninety male WAG rats (Harlan CPB, Zeist, The Netherlands) weighing 200-225 gram 
(10-12 weeks: young adults) were used. Animals were housed in a wire-nelling cage (to 
avoid saw-dust eating) and maintained. under conventional conditions with 12-hour light 
and dark cycles in accordance with the guidelines of the National Research Council. The 
animals were given the specific diet and water ad libitum. 
Operative procedure 
The rat was anesthetized with ether. The abdomen was shaved and desinfected with 
alcohol 70%. Laparotomy was performed through a ntidline incision, whereafter the small 
intestine was exteriorized from the ligament of Treitz to the ileocecal valve. Ninety 
percent of the small intestine was then resected, from 2 em distal to the ligament of Treitz 
to 2 em proximal to the ileocecal valve. Intestinal conthntity was restored in an end-to-
end fashion with continuous suturing using nticro sutures (7-0 silk, B. Braun-SSC AG, 
Switzerland). The abdomen was closed in two steps, first the muscle layer was closed and 
subsequently the skin layer using sutures (2-D silk, B. Braun Melsungen, Germany). 
Diet protocol 
Before resection all rats were fed the standard laboratory diet (AM2, Hope Farms, 
Woerden, The Netherlands, normal rat chow). After resection, the rats were randomly 
assigned to one of the four experimental groups, differing in diet composition. All diets 
were given enterally in solid form. Group 1 (n=20) received AM2. Group 2 (n=21) was 
given a polymeric diet, based on casein protein (Nuttison, Nutricia-Zoetermeer, The 
Netherlands; non-identical polymeric diet). Group 3 (n=26) received a diet with partial 
hydrolyzed protein, based on whey protein (Pepti-2000, Nutricia-Zoetermeer, The 
Netherlands). Group 4 (n=23) was fed the same diet as group 3, but with intact protein 
(Pepti 2000 N.H., produced for experimental purposes, Nutricia-Zoetermeer, The 
Netherlands). The nutrient compositions of Nuttison, Pepti 2000 and Pepti 2000 N.H 
were optimalized for use as rat food, according to Table I. All used diets were isocaloric. 
AM2 contained. more nitrogen in contrast to the other isonitrogenous diets. 
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Table 1 Composition of experimental diets 
(values given per gram of the specific diet) 
GrouP"""' 2 3 4 
product name- AM2 Nutrison Pepti 2000 Pepti 2000 N.H 
-l component 
Protein (g) 0.24 0.19 0.18 0.18 
'" protein hydrolysate 0.19 0.18 
.. casein 
'" whey protein 0.18 
Fat (g) 0.06 0.18 0.15 0.15 
'" vegetable oil 0.18 0.08 0.08 
- linoleic acid 0.02 0.08 0.04 0.04 
- alpha-linolenic acid 0.002 0.001 0.001 
'MCT 0.08 0.08 
Carbohydru .. (g) 0.51 0.58 0.51 0.51 
• glucose 0.02 0.01 0.01 
'" maltose 0.14 
'" polysaccharides 0.42 0.04 0.04 
'" MD/glucose syrup 0.60 0.60 
Fiber (g) 0.05 
'" dicacell 2 +4 10.05 
Minerals (mg) 
'" sodium 2.70 4.76 2.03 2.03 
'" potassium 7.91 6.30 6.19 6.19 
'" chloride 3.16 5.85 3.42 3.42 
'" calcium'" 7.58 5.62 5.32 5.32 
'" phosphorus '" 5.21 4.52 4.28 4.28 
'" magnesium 2.09 0.94 0.67 0.67 
'" iron 0.17 0.05 0.04 0.04 
• zinc 0.01 0.04 0.03 0.03 
• copper" 0.01 0.006 0.006 0.006 
'" manganese '" 0.06 0.06 0.06 0.06 
'" iodine 0.0003 0.0003 0.0003 0.0003 
Vitamins (mg) 
'" vitamin A (IU) 15.75 11.65 10.99 10.99 
'" vitamin D3 (IU)* 1.80 1.13 1.07 1.07 
'" vitamin C 0.21 0.25 0.25 
'" vitamin E (IU) 0.10 0.07 0.04 0.04 
* vitamin K 0.007 0.0001 0.0003 0.0003 
'" thiamin (B 1)* 0.Q2 0.004 0.004 0.004 
* n1>ollavin (B2) 0.02 0.004 0.004 0.004 
* niacin 0.08 0.05 0.04 0.04 
'" pyridoxine (B6)* 0.02 0.007 0.006 0.006 
'" vitamin BIZ'" 0.05 0.06 0.05 0.05 
'" folic acid'" 0.004 0.001 0.001 0.001 
'" panthotbenic acid 0.03 0.02 0.02 0.02 
'" biotin 0.003 0.007 0.007 0.007 
'" choline* 1.87 1.13 2.00* 2.00 
'" meso-inositol** 1.06 1.06 1.06 
Energetic value(Cal) 4.65 4.51 4.76 4.51 
'" EN% protein 28.7 16 16 16 
*EN%fat 7.6 35 29 29 
'" EN% carbohydrate 59.6 49 55 55 
* EN% fiber 4.1 
'" = nutrients in original diets were in shanage compared to values given by the National Research Council 
and therefore supplemented to given amounts. ** = meso-inositol is not indicated in the NRC-table and 
therefore the amount in Nutrison has been adjusted to the amOunt available in Pepti diets. 
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In Table 2, the major differences in composition between the experimental diets are 
summ.arized. 
Table 2 :Major differences in diet composition 
Group- I 2 3 4 
Product name-+ AM2 
• Components 
Nutrison Pepti 2000 Pepti 2000 N.H 
Fme.- + 
Protein casein whey·hydrolysate whey-intact protein 
Fat vegetable oil 100% MCT50% MCT50% 
vegetable oil 50% vegetable oil 50% 
Carbohydrates polysaccharides 73 % polysaccharides 91.8% polysaccharides 91.8% 
glucose 2.6% glucose 2% glucose 2% 
maltose 24% maltose 6% maltose 24% 
ExperimenJ:al design 
, 
Each experimental grouP, was divided into two sub-groups, "A animals" (Follow-up 14 
days before sacrifice; grouP 1: n=7, grouP 2: n=8, group 3: n=8 and grouP 4: n=lO) 
and "B animals" (Follow-up 70 days before sacrifice; group 1: n=13, group 2: n=13, 
group 3: n=18 and group 4: n=13) 
Parameters obtained during lifetime: 
Survival 
Anintals were sacrificed if they bad a deteriorating condition or if weight decline was 
more than 30 % of the preoperative weight. 
WeighI 
Throughout the experimental period, the animals (A & B) were weighed three times a 
week, at 8.30 a.m. 
Metabolic status 
On postoperative days 10-14 (A), and 66-70 (B) respectively, anintals were housed in 
separate metabolic cages to measure food and water consumption and urine and feces 
production. 
Serum analysis 
On the 14th (A) and 70th (B) postoperative day, blood was obtained by tail bleeding, 
under ether anesthesia, for determination of sennn levels of alkaline phosphatase; (AP, 
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Unitsll at 31'C), alanine aminotrallSferase; CALT, Units at 31'C), aspartate aminotransfe-
rase; CAST, Unitsll at 37'C), albumin; CALB, gil), cholesterol; (CHOL, mmol/l), 
triglyceride; (TRIG, mmol/l), total protein; (fP, gil) and blood urea nitrogen; (BUN, 
mmol). Serum levels of AF, ALT and AST were detennined by photometric methods 
using special pack kits (Merck Diagnostica, Germany) for a multi-test analyser system 
(ELAN). Using the ELAN, serum Alb levels were determined by means of the 
bromcresolgreen method, Cbollevels using the enzymatic CHOD-PAP method, serum TP 
conceDtration by means of the biuret method and BUN using the GIDH method (special 
pack kits from Merck Diagnostica, Germany). 
Postheparin DAO assessment 
On the 14th CAl; 21th, 42th and 70th (B) postoperative day, 100 international units (IU) 
of heparin. was injected into the penile vein. Fifteen minutes after injection blood was 
obtained by tail bleeding to determine postbeparin. diamine oxidase activity in serum. 
Diamine oxidase (DAO) activity, as a possible measure for the adaptive state of the 
remaining smaI1 intestine, was measured using a radioactivity- based modification of the 
method of OkYama and Kobayashi (19,20). The method is based on the principle that 
DAO converts "C-putrescine to''C-,:l'-pyrroline. In a fuJaI concentration of 2.5 mI, the 
assay mixture consisted of Ca) 200 1'1 test-sample solution; (b) 2100 !'1 0.1 M sodium 
phosphate buffer, pH 7.0; (c) 100 1'1 chlotal hydrate; 41.4 gil and Cd) 100 !'1 of substrate 
solution ( a mixture of 1.25 mmolJl putrescine diliydrochloride including 0.11'1 Ci "c put-
rescine diliydrochloride). The samples were incubated for 120 minutes at 31'C. The 
reaction was stopped by adding 200 1'1 of an aminoguanidine-containing solution (10mM 
aminoguanidine in 2% sodium carbonate). Thereafter, the labeled product, "C-,:l'-
pyrroline, was extracted into 4 mI of a toluene-based scinta1lation mixture (Packard 
Instrument Company Inc, reorder no 6013089, Downers Grove, USA) by centritilgation. 
The radioactivity present was measured using a liquid scintil1ation analyzer (packard, Tri-
carb 2500 TR, Downers Grove, USA). Assay blanks consisted of 2300 1'1 sodium 
phosphate buffer, 100 1'1 chloral hydrate and 100 1'1 substrate solution. 
DAO activity was expressed as Units/mI (1 Unit= DInol of putrescine diliydrochloride 
oxidated in 1 hr at 37'C, pH 7.0) 
Parameters obtoined after sacrifice: 
Histology 
Specintens of intestine just distal to the Jigatnent of Treitz and just proximal to the 
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ileocecal valve were obtained for histology. The collected tissues were dehydrated and 
embedded in paraffin. Longitudinally cut sections of 4-5 fLID. were stained with 
hematoxylin-azophloxin-safum. Quantitative morphometric analysis of crypts and villi was 
performed on sections projected on a screen through a light nticroscope. In each section 
10 villi and crypts were measured with the mean value representing one animal. The 
mean of all rats (data given in fLID. ± SD) was considered representative for an 
experimental group. 
Cell proliferative activity 
Cellular proliferation was assessed by means of an immunohistochentical method using 5-
bromo-2'-deoxy-uridine (BrdU, Boehringer Mannheim, Germany), a thyntidine analogue 
incorporated during the S phase of the cell cycle into reduplicating DNA (21). Animals 
were injected intravenously with 10 mg BrdUlkg bodyweight two hours before sacrifice. 
After death, paraffin sections were prepared and sections of 4-5 fLID. were stained using a 
ErdU monoclonal (Becton Dickinson Innnunocytometry Systems, San Jose USA). 
Identification of stained €Oils was by projecting a section on a screen through a light 
nticroscope. Labeled cells were present in a definable crypt area, consisting of the first 
twenty crypt cells from the bottom towards the top at each side, and therefore calculated 
as percentage positive cells in this area. In this way, differences in crypt length were 
excluded and absolute proliferative activity was assessed. 
Statistical analysis 
Differences in survival rate were analyzed using the chi-square test. For other test results, 
one way analysis of variance was used, followed by the Student-Newman-Keuls test. A P 
value ,;; 0.05 was considered statistically significant. 
Results 
Survival 
Survival data are shown in Table 3. Statistical analysis showed that the short-term 
mortality rate in animals fed the non-identical polymeric diet (group 2) was significantly 
lower than in anintaIs fed either the diet with partial hydrolyzed proteins (gronp 3) or the 
identical diet with intact proteins (group 4). Rats fed normal rat chow (group 1) had an 
intermediate position with no statistic significant mortality rate compared to the other diet 
groups. No differences were found in long term mortality and overall mortality. 
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Table 3 
Short term mortality « 14 days) 
AmmaIs A+B A B 
Group 1(n=20) 3 0 3 
Group 2(n=26) 5 2 3 
Group 3(n=21) 1 0 1 
Group 4(n=23) 8 4 4 
Long teon mortality (> 14 days) 
B 
3 
4 
2 
Statistical differences; - = in comparison to. Short term A+B. 3-4. 3-2 
Weight 
Cbapter4 
The mean p=ntual weight changes (weight/preoperative weight) of all experimental 
animals (subgroups A & B) are shown in Figure 1. Initially lb.e animals showed a weight 
decline of 20-25% of lb.e preoperative weight, but regained !heir preopetative weight at 
10 weeks postopetatively. Weights differed significantly on day 7 (p<0.05; group 1 > 
any othet group). 
% We lon"T; 
0 
8 o~ 
""' 
5 0 
0 
2 0 
0 
o 7 28 os 42 S5 5' 70 
postoperative days 
-- AM2 -+- Pept, 1 2000"* Nu"tr 1 zon --- Pept [ 2000 NH 
Fig.1. Weight changes in the adaptive phase following 90% small bowel resection. AM2, normal rat chow (gror.;p 1); 
Nutriscn, non-identical diet (group 21; Peptj 2000, diet with partial hydrolyzed proteins (group 3); Pepti 2000 N.H., 
identical diet with intact proteins (group 4). 
On day 10 less diffetenees Wete found (p<O.05; group 3 < group 1 and group 3). 
From day 14 on, lb.ete Wete no longet any differences. 
Results of subgroup A; visualized in Figure 2 and Table 4A 
Metabolic status 
Metabolic results showed a significantly higher food intake and fecal output in group 1 
corupared to group 4 values. In addition, group 2 had significantly more fecal oUlpUt 
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compared to group 4. 
Serum analysis 
Serum analysis demonstrated significant decreases in cholesterol and protein 
concentrations in group 1 compared to the other groups. Iu this group, the blood urea 
level was significantly higher. 
Postheparin DAO assessment 
Postheparin DAO levels in animals fed the non-identical polymeric diet (group 2) were 
significantly higher than in the other groups. 
Histology 
Jejunal findings. With regard to villus length there were no differences among groups. 
Crypth depth, however, was significantly increased in group 1 and group 2 compared to 
group 3 and group 4. 
neal findings. Villus length in group 3 was significantly enlarged compared to any other 
group. Crypt depth was significantly greater in group 1 compared to any other group and 
crypth depth in group 2 was significantly increased compared to group 3 and group 4. 
Cell proliferative activity 
Jejunal findings. The percentage labeled cells was significantly increased in group 2 
compared to any other group. 
neal findings. The percentage labeled cells was significantly increased in group 1 and 
group 2 compared to group 3 and group 4. 
Table4A Serum analysis of A ammaJs 
Group 2 3 4 P<0.05 
AF (Unitsll)* 185.9±1!9.5 227.0± 86.6 281,4±168.9 233.6± 53.6 NS 
ALT (UnitsJI)* 93.3± 45,4 53.0± 16.3 7S.1± 48.5 179.7±23S.4 NS 
AST (UnitsJI)* IS1.3± 97.5 129.1± 63.6 132.7± 52.5 308.0±319.7 NS 
ALB (gil) 21.5± 5.2 23.2± 3.3 21.4± 2.0 20.3± 2.5 NS 
CHOL (mm01ll) 0.19± O.OS 0.94± 0.25 0.71± 0.31 0.91± 0.33 2-1.4-1.3-1 
TRIG (mm01ll) 0.16± 0.09 0.30± 0.17 0.37± 0.20 0.23± 0.12 NS 
TP (gil) 36.1± 8.5 48.0± 6.2 5O.8± 5.6 44.3± 5.1 3-1. 2-1. 4-1 
BUN (romol) 16.5+ 0.09 8.8+ 2.1 10.3+ 3.8 8.5+ 3.1 1~. 1-2. 1-3 
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METABOUC srATUS POSTIlEPARIN DAO activity 
msroLOGY JEJUNUM Cell proliferative activity 
mSTOLOGY ILEUM Cell prollferalive~~~L_ 
Fig.2. Experimental findings 14 days after 90% smoU bowel resection. Abbreviations as for Fig. 1. 
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Results of B animals; visualized in Figure 3 + Table 4B 
Metabolic stazus 
Rats fed rat chow (group 1) had significantly increased food and water intake and faeces 
and urine output compared to rats fed either the non-identical polymeric diet (group 2), 
the diet with hydrolyzed proteins (group 3), or the identical diet with intact proteins 
(group 4). 
Serum analysis 
Serum alanine aminotransferase concentration in group 2 was significantly increased 
compared to the other groups. In group 1, serum urea level was still significantly elevated 
compared to the other groups. 
Postheparin DAO assessmem 
At 3 weeks after the resection, posllieparin DAO activity was still significantly increased 
in aIrimaIs fed the non-identical polymeric diet (group 2) compared to the other aIrimaIs. 
At 6 and 10 weeks after the resection, no significant differences were found among each 
group. 
Histology 
In jejunum as well as ileum there were no significant differences in villus length and 
crypth depth between the experimental groups. 
Cell proliferative activity 
The percentage labeled cells in jejunum nor ileum did not differ among each groups. 
Table 4B Serum analysis of B animals 
Group 1 2 3 4 P<O.05 
AF (UnitsJI)* 135.3± 28.1 95.1± 35.3 99.8± 27.6 93.3±30.0 NS 
ALT (UnitslJ)* 7L8± 63.3 63.6± 45.3 94.9± 88.4 16.7± 4.5 3-< 
AST (UnitsJI)* 175.6±110 204.9±105.9 322.4±251 120.S±96 NS 
ALB (gil) 24.1± 3.6 24.7± 1.9 25.0± 2.0 24.2± 2.5 NS 
CHOL (mmolll) 0.89± 0.30 0.64± 0.34 0.73± 0.40 0.53±0.20 NS 
TRIG (mmolll) 0.43± 0.28 0.37± 0.30 0.32± 0.16 O.25±O.l1 NS 
TP (gil) 49.6± 10.1 55.S± 6.2 56.1± 3.5 56.0± 4.4 NS 
BUN (mmol) 9.6+ I.S 7.5± 1.9 7.8± 1.1 7.3+0.8 1-4.1-2.1-3 
* = assayed at 37"C 
- = in comparison to 
68 Chapter 4 
METABOLIC STATUS POSTHEPARIN DAO activity 
• 
• 
mSTOLOGY JEJUNUM Cell proliferative activity 
mSTOLOGY ILEUM Cell proliferative activity 
,,-
Fig.S. Experimental findings 10 weeks after 90% small bowel resection. Abbreviations as for Rg.1. 
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Discussion 
Awareness of the importanee of diet composlnon andIor complexity on imestinal 
adaptation after small bowel resection arose from a variety of studies (8-14). To exclude 
influences of non-isocaloric feeding, we studied diets containing similar isocaloric 
amounts per 1000 Kca! Bruto Energy. With respect to the nitrogenous composition, rat 
chow can be considered as a relative high-protein diet compared to the other tesred diets, 
which itself can result in growth differences (22). 
This study demonstrates that rat chow (group 1) is superior to other diets in enhancing the 
onset of the adaptive phase after near-total small bowel resection. Rats fed rat chow 
already had significantly less weight loss on the 7th postoperative day. The relatively high 
protein content in the nonna] rat chow may be responsible for the observed weight loss. 
Besides, !his formula was the only diet containing dicacel, a partly soluble fiber. Non-
fermentable fiber is known as a major regulator of bowel function, increasing stool 
weight and bowel frequency, and decreasing transit time. The importance of fermentable 
fiber is most probably the enhancement of colonic adaptation by fermentating fiber to 
short chain fany acids (23). In a study of enterectomized rats, infusion of Triglycerides 
has been shown to improve jejnnal and colonic adaptive growth (24). Because of !he 
possible role of the non-isonitrogenous composition of rat chow andlor colonic adaptation 
in the rat chow group emphasis will be put on the differences betWeen !he diet with 
partial hydrolyzed proteins (group 3), the identical diet with intact proteins (gronp 4) and 
!he non-identical polymeric diet (group 2) to facilitate imerpretating the test parameters of 
the different groups. 
The early adaptive response of animals fed the non-identical polymeric diet, as evidenced 
by mortality, poslheparin DAO activity and histology, was superior to both the the diet 
with partial hydrolyzed proteins and the identical diet with intact proteins. The short term 
mortality rale in animals fed the non-identical polymeric diet was significantly lower !han 
in animals fed either the partial hydrolyzed or identical nonhydrolyzed diet. In the SBS 
model used, the occurrence of malnutrition was a major trigger for imestinal adaptation. 
The additive effect of, for exaruple non-identical polymeric feeding, may overcome the 
lethality of the massive resection. Our weight data indicate thaI the resecred amount is 
indeed near total because some rats were unable to thrive and the rentaining animals, 
although reaching their preoperative weight 10 weeks after resection, did not show further 
weighl gain. This observation implies thaI in !his model, manipulation with dietary 
components like glutarnine(25,26), aminoguanidine treatment (7) and growth factors (27) 
should be evaluated in order to establish whether they are able to enhance adaptation. 
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The metabolic results show that animals fed the non-identical polymeric diet bad more 
fecal output in the short term compared to animals fed the identical nonhydrolyzed diet. 
However, the illtake/output percentage was similar among groups. These data, obtained at 
week 2 and 10 respectively indicate that influences of non-pair feeding are probably 
negligible. 
Two weeks after resection, serum analysis revealed a similar results among animals fed 
partial hydrolyzed, identical nonhydrolyzed or non-identical polymeric diet. After 10 
weeks, the activity of ALT in rats fed the identical nonhydrolyzed diet was significantly 
decreased for nnknown reasons, compared to rats fed the non-identical polymeric diet. 
However, no differences in serum protein and albumin levels, sensitive parameters of the 
nntritive status, were found. 
The activity of DAO, an enzyme primarily found in the villus tip cells of the small 
intestine has been shown to increase at least five fold after intestinal resection (7). 
Previous studies suggest, that DAO acts as a negative feedback modulator in adaptive 
intestinal proliferation bey producing undefined active metabolites and suppressing 
pntrescine content (7,28,29,30). Therefore, one may reason that the DAO activity 
correlates with the adaptive state of the intestine after resection. Two weeks after 
resection., non-identical polymeric diet fed animals bad significantly increased Postheparin 
DAO activity compared to partial hydrolyzed or identical nonhydrolyzed diet fed animals 
and they also showed increased jejunal and ileal crypt cell proliferation in this group. 
Thompson measured DAO activity throughout the gastrointestinal tract and demonstrated 
a decreasing proxiroodistal gradient (31). This may explain why no significant elevations 
in DAO activity were found in rat chow fed animals. These results suggest that colonic 
adaptation in some way takes over the role of DAO in regulating proliferative activity in 
the small intestine. Three weeks after resection., animals fed the non-identicai polymeric 
diet still bad significantly increased Postheparin DAO activity. However, 6 and 10 weeks 
after the resection, no more differences were revealed between the groups. Long-term 
analysis showed that DAO activity remains significantly elevated compared to non-
resected rats (previous unpublished studies; control values 0.09 ± 0.06, n=9). This 
observation led us to speculate that massive resection leads to a state in which the 
remaining intestine is continuously triggered to nonfunctional hyperplasia, which is 
prevented by diamine oxidase. Previous work performed in the same rat model (32), bad 
already shown that in the hyperplastic period three weeks after resection, impairment of 
the electrical response to both glncose and theophylline is present. 
Two weeks after resection., histologic analysis showed markedly increased ileal villus 
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length in animals fed the partial hydrolyzed diet compared to the other groups. These 
findings support the hypothesis propounded by Touloukian (20) that compensatory 
changes found after feeding an elemental diet are the effect of a systemic stimulus, rather 
than the result of increased load of nutrient. 
In the early adaptive phase the non-idemical polymeric diet is superior to the partial 
hydrolyzed diet and the identical nonhydrolyzed diet in enhancing intestinal adaptation. 
No differences were found between the partial hydrolyzed diet and the identical 
nonhydrolyzed diet, which provides an experimental base for a clinical trial in SBS 
patients in which hydrolyzed are compared with nonhydrolyzed diets. Nonhydrolyzed 
diets lead to less complications compared to hydrolyzed diets. In addition, these results 
indicate that the role of diet composition is snperior to the role of diet complexity on the 
adaptive process after small-bowel resection. More research is necessary to unravel which 
components in the non-idemical polymeric diet that differ from the ones in the partial 
hydrolyzed and identical nonhydrolyzed diet (Table 2), are effective in promoting 
intestinal adaptation after ,resection. 
In future stndies it is important to address the question whether after near-total small 
bowel resection the observed adaptive capacity has already reached its limits or may even 
be further enhanced. In summary, the common belief that feeding an elemental diet is 
better than a complex diet seems a fairy tale that tends to underestimate the effect of diet-
composition. 
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PART B. 
SMALL-BOWEL TRANSPLANTATION 

CHAPTERS 
Technical and functional analysis of total 
small-bowel autotransplantation 
5.1 One-step total orthotopic small-bowel autotransplantation in growing dogs: one 
step too far ? 
5.2 Long-term analysis of the functional, morphologic, and bacteriologic staWS of the 
small intestine following autotransplantation in growing dogs. 
This cbapter has been published as abstract in Acta Cbirurgica Austriaca supplement 
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1. ONE-STEP TOTAL ORTHOTOPIC SMALL-BOWEL 
AUTOTRANSPLANTATION IN GROWING DOGS: ONE STEP TOO FAR ? 
Perioperative events and functional evaluation 
Abstract 
Transplantation of a functioning small intestine might be the treatment of choice for 
children suffering from the short bowel syndrome. It is uncleat, however, whether bowel 
graft function is sufficiently preserved to maintain growth and development. This study 
was undertaken to evaluate the role of total orthotopic small·bowel autotransplantation in 
the treatment of the short bowel syndrome in elllereCtomized Beagle puppies (16 weeks; 
5-6 kg). Short bowel control animals (n=3) bad a fast and dramatic weight loss and there 
was no adaptation of the' remaining bowel. Sbam-operated anintals (n=3) grew normally, 
and in animals that tmderwent small·bowel autotransplantation (n = 10) only a minor and 
tempOrary weight loss was observed. Unfortunately, the mortality rate in this group was 
extremely high (80%), so only two anintals could be evaluated functionally. Studies on 
fecal fat excretion, in vivo electrophysiologic responses, D-xylose absorption and brush 
border enzyme activities were performed at several time points during three months 
postoperatively. In short bowel control animals, fecal fat excretion was severely 
increased, while transplanted animals bad fecal fat excretion similar to that of sbam· 
operated animals. Deterntination of D-xylose absorption, in vivo electrophysiologic 
responses and brush border enzyme activities confirmed physiologic functioning of the 
graft. These results suggest that the function of an autotransplanted bowel is not intpaired 
on the short term. 
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Introduction 
Intestinal adaptation occurs after massive small bowel loss from disease or surgery. 
Gradually, varying from a few months to over one year, the remaining intestine adapts to 
the loss of bowel and oral intake is gradually increased until intravenous alimentation can 
be stopped. Unfortunately, some of these patients never reach this stage and remain 
torally dependent on total parenteral nutrition (TPN) (1). Although long-term TPN 
provided the first satisfactory treatment for the shon bowel syndrome (SBS) (2), its 
complications including metabolic, infectious and psychological aspects, form the main 
reason to envision this therapy as a temporary solution (3,4). Non-adapting children 
would be candidates for a SB graft. Although small-bowel rransplantation (SB1) is now 
technically possible in man (5,6), physiologic analysis of the posttransplan! gut is a 
neglected area. This lack of knowledge is even more obvious in view of the many 
immunobiologic studies performed, and therefore the intPortance of physiologic Studies 
should be stressed (7). The inttinsic and extrinsic denervation and the lymphatic drainage 
disruption alter the bowel's functional capacity at least temporarily after rransplantation. It 
is of utmost importance 'to assess whether the effects of the transplantation procedure 
itself bear a temporarily character or whether rransplanted gut has definitive altered 
functional capacity, e.g. specific rranspon abnormalities. Our previous Studies showed 
that adult dogs can survive long-term after a two-stage segmental allorransplantation. In 
these experiments MHC-matched segmental ileal allografts were ttsed, to determioe 
whether for living-related rransplantation it has a potential role (8). The present study was 
initiated to investigate whether total orthotopic intestinal autografts are able to maintain 
growth and development in puppies with surgically created SBS. Several tools were used 
to assess the physiologic function of the graft. In vivo electrophysiologic measurements 
were performed to determioe cAMP-mediated cbloride secretion and sodium-dependent 
active transpon of carbohydrates and amino acids. Furthermore, absOIption of D-xylose 
and fat was monitored and brush border enzyme activities were determined. 
Materials and Methods 
Animals 
Sixteen Beagle puppies, weighing about five kilogram, were used (Harlan CPB, Zeist, 
The Netherlands). To exclude differences in terms of growth only female dogs were ttsed. 
The bitches were divided into three groups: group 1, shon bowel controls (n=3); group 
2, sham-operated animals (n=3); and group 3, autorransplan!ed animals (n=10). During 
the experimental petiod the animals were housed in separate cages. 
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Operative procedure 
The premedication consisted of 2 mI tbalamonal (0.05 mg fentanyl + 2.5 mg droperidol) 
and 0.5 mg atropine, given intramuscularly. Thereafter, general endotracheal anesthesia 
was introduced using nesdonal (2Omg/kg) and a nrixture of N,O, 0, and ethrane was used 
as intubation gas. During the operation, a Ringer-lactate infusion (30 mIfhr) and 0.1 mg 
fentanyl were administered. In case of autotransplantation, 25 mI rheomacrodex was given 
at the end of the ischemic time, simultaneously with 2 mI calcintu and 15 mI bicarbonate 
solution. While furisbing the operation, 0.04 mg narcan was administered and if necessary 
another 5 mI bicarbonate was given. After the operation, extubation took place and the 
dog awoke under a heating lamp. 
TecJud.que 
Short bowel control group. Following midline incision, short bowel control animals were 
created by resection of the total SB i.e. from the ligament of Treitz to 5 em proximally 
from the ileocecal valve. Thereafter the proximal jejunum was reamstomosed end-to-<md 
to the distal terminal ileum (Figure 1). 
Sbam-operated groun. A sbam operation was defined as a control operation without 
interrupting vascular, neural and lymphatic supply. In these animals an antiperistaltic 
Roux-Y loop was created about 20 em proximally to the ileocecal valve. In detail, a 
bowel part was heterotopically placed from approxintately 20 to 45 em from the ileocecal 
valve. The proximally transected part was exteriorized as a cutaneous ileostomy. 
Gastrointestinal cominuity was restored in an end-ta-side fashion (Figure IB). the loop 
was created in order to collect biopsy specimens and to perform functional mouitoring. 
Autotransplant groUD. The small intestine was totally harvested from the ligament of 
Treitz to 5 em proximally from the ileocecal valve. After removal, the graft was perfused 
with 40 cc heparinized saline (5 IU heparin!m1 0.9% saline) at 20°C until the venous 
effluent became clear and the graft white. We developed a transplantation technique to 
guaraotee maximal bllod in- and au-flow as well as sufficient tightness to prevent kinking 
and torsion at the anastomosis site. This technique consisted of anastomosing the superior 
mesenteric artery and vein in an end-ta-side fashion to the abdominal aorta and caval vein 
respectively, and of fixation of nervous tissue and the lymphatic vessels to the periaortal 
and pericaval tissue. Mean warm ischemic time was about 40 minutes. In this group a 
distally situated Roux-Y loop was constructed as desctibed above. Therafter, the graft was 
proximally anastomosed with the host's duodenum and distally with distal 5 em of the 
remaining terminal ileum (Figure IC). 
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B 
Fig_'. Schematic design of the separate groups; A, Short bowel control group; 8, Shamoperation; C, 
AutOtransplantation. 
Perioperative care 
The perioperative care consisted of standard care given after all major abdominal surgeI)'. 
All animals received 250 mg neomycin twice daily on days -2 and -1 preoperatively. The 
first five postoperative days 1.5 ml depomycin was given subcutanecusly. In addition, 2 
X 500 IU heparin was given subcutanecusly from day -2 until day 5 after the operation. 
The animals were supported with parenteral fluids for 2 days postoperatively and 
gradually restored to norma! kennel diet (Puppipap, Hopefartns BV, Woerden, The 
Netherlands). Urinary sodium and potassium values were determined repeatedly during 
the first several weeks after operation to detect severe electrOlyte loss that might be 
caused by the Roux-Y loop. 
Evaluation 
The general condition of the animals was observed daily. 
SurviVal. After enterectomy animals were sacrificed if they lost more than 30% weight or 
had a deteriorating physical condition. 
Weight. Measured twice a week, always at 8.00 a.m. 
Blood analvsis. Routine laboratory blood chemistry data (hemoglobin, leucocytes and 
serum toral protein, albumin, cholesterol, and triglyceride) were recorded at days -8, 10, 
34, 62 and 97 postoperatively. Between 5 and 7 months postoperatively, serum levels of 
NH" vitamin B12, folic acid, vitamin A, vitamin E, calcium, and iron were determined. 
Short-term. evaluation 83 
The D-xylose absorption test. The dogs were fasted overnight prior to the xylose 
challenge. D-xylose (0.5 gram/kg Body Weight) was dissolved in water and given orally 
at days 57 and 92. Blood samples (in heparinized tubes) were collected before, and half-
an-hour, 1 and 2 hours after the ingestion of xylose. A simplified xylose assay procedure 
developed by Eberts et al (9) was used to obtain a xylose blood level time curve. 
Fecal fat analysis. The method used, described in detail by Van de Kamer et al (10), 
gives the amount of fat in feces and the relative proportion of fatty acids. Fecal fat 
excretion was determined at dsy -8, 10, 34, 62 and 97 respectively. 
Electrophvsiologic measurements. The Roux-Y loop was used for electrophysiologic 
measurements in vivo on postoperative dsys 34, 62 and 97. The electrophysiologic teSt 
for intestinal trausplant monitoring was carried out as descnlled earlier (11). Briefly, a 
triple-Iumen-double-balloon catheter was used to isolate a SB segment of 2.5 em. A 
peristaltic roller pump (Gilson, minipuls 3) secured continuous flow of test solution. The 
segment was perfused with several iso-osmotic test solutions ([theophylline] = 5 roM, 
[glucose] = 30mM, [phenylalanine] = 30 mM) to determine transepitheliaI potential 
differences (PD) relative to a standard solution. The electrophysiologic responses to 
theophylline (evokes cAMP mediated cbloride secretion), glucose (evokes sodimn-coupled 
active carbohydrate absorption) and phenylalanine (evokes sodium coupled active autino 
acid absorption) are commonly accepted parameters to monitor SB function (12,13). The 
test was performed under general endotracheal anesthesia and atropin was added to obtain 
reproducible, accurate measurements. 
Disaccharidase activities. The activity of lactase and maltase was determined during 
operation by open biopsy and at fixed moments postoperatively (days 10, 34, 62 and 97) 
by blind biopsies. The mucosal biopsies were snap-frozen in liquid nitrogen and stored 
at -70·C. The method used is a modification of the assay introduced by Dahlquist (14). 
Briefly, the mucosal biopsy was weighed and homogenized using 0.2% Triton X-IOO (0.2 
m1fmg mucosal weight) and see sand. The utixture was incubated for 30 minuteS at 4°C 
and centrifuged at 10.000 g for 3 utinuteS. Thereafter, 16.7 ILl homogenate (5 or 10 times 
diluted with 0.2% Triton for maltase activity) was added to 25 !'1 of a 0.025 M maltose 
solution or a 0.05 M lactose solution (substrate dissolved in 0.15 M citrate bnffer pH 5.6) 
and incubated in a water bath at 3T C for different periods. The reaction was interrupted 
by adding 1 mI (1 :20) glucose reagent (containing Tris, Merck 19700) and incubating for 
additional 10 minuteS at room temperature. Reading was performed at 25' C in a 
spectrophotometer (Gilford 3500 computer directed analyzer, Oberlin, Ohio USA) at 340 
nm. The protein content of the homogenate was measured, using the method described by 
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Watanabe et al (15). The disaccharidase activity was expressed in U/mg protein, in which 
a Unit was defined as the activity hydrolyzing 1 !'IDol of disaccharide per minute under 
conditions used. 
Histology. Biopsies from the Roux-Y loop were taken at approximately 5 em from the 
cutaneous stomas on days 0, 10, 34, 62 and 97 postoperatively. Tissue Wete fixed in 
3.6% fonnaldehyde, dehydrated and embedded in paraffin. Subsequently, 4-5 !'ID sections 
Wete stained with hematoxylin-azophloxin-safran. 
Sta1istics 
Results ate given as mean ± SD. Xylose absorption test data were calculated using area 
under curve analysis. For statistical analysis, the study population was too small. 
Results 
Survival 
The survival times of all experimental dogs ate listed in Table 1. 
The mean survival after enterectomy (group 1) was 11.3 days. Animals with a sham 
opetation (group 2) survived indefinitely. Dogs undergoing a one-step orthotopic SB 
autotransplantation in combination with a Roux-Y loop (group 3) showed a high mortality 
rate. The technical failure due to vascular thromboses was 20% (2110). These dogs died 
from axteria! thrombosis within 48 hours postoperatively. Two dogs Wete excluded from 
ovetail analysis because of an ovetdose heparin. These dogs did not coJJJ:ribute to the 
vascular-related failure rate as they survived beyond two days. The failure rate due to 
other causes was 50% (418). One dog in group 3 died from peritonitis of uncertain origin 
on day 2, another from invagination on day 5, a third from unknown causes on day 5 and 
a fourth on day 14 due to cachexia and pneumonia. 
WeigJa 
The weight data of the experimental animals ate illustrated in Figures 2A and 2B. The 
animals of group 1 (SBS control) showed a fast and dramatic weight loss as a result of the 
near-total SB resection. The animals of group 2 (sham operation) grew normally and 
recovered uneventful when these animals ate compared with none-opetated historical 
controls (data supplied by Harlan CPB, Zeist). Surviving animals of group 3 (SBS + SB 
antotransplantation) initially lost little weight., but subsequendy manifested a catch up 
growth. 
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Table 1 Postoperative survival time 
Group 
I. Short bowel control 
II. Sham operation 
m. Autotransplantation 
'" 
, 
, 
". 
• 
Survival in days 
10 
10 
14 
>150 
>150 
>150 
2 
2 
2 
3 
4 
5 
5 
14 
>150 
>150 
~ 
"'-----=-
Cause of death 
SBS 
SBS 
SBS 
Alive and well 
Alive and well 
Alive and well 
Peritonitis 
Arterial thrombosis 
Aneri.al thrombosis 
Hemorrhage (Overdose heparin) 
Hemorrhage (Overdose heparin) 
U-.wn 
Invagination 
CachexiaJPneumonia 
Alive and well 
Alive and well 
----
........-
••• ,,' ___ n_Mn ___ M_ 
po$~O~4~Tve days 
F"19.2A. Weight Changes after performing enterectomy. sflamoperation or autotransplantation on day O .
... ,gIrt C>:O) ,.~-C ____________________________ -, 
~.C~~~,,~~~~,~o~~~~~~~~,,~~~,~,~~" 
<>~N>tJ_ ~rj_ 
<>Q(> In_s 
F"19.2B. Weight curves after performing Shamoperation or autotransplantation. 
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Blood analysis 
Biochemical parameters shown in Table 2A indicate that the general condition of the 
animals in group 2 is similar to that in group 3. Table 2B shows that serum ammonia 
levels differed: 53.0 ± 5.4 in the sham-operated animals, 78.2 ± 3.2 in the 
autotransplanted animals. Other serum values revealed no differences. 
D-xylose absorption 
Area-under-curve calculations revealed that total D-xylose absOl:ption after sham operation 
was not remarkably different from D-xylose absorption after autotranspiantation at 57 and 
92 days posttransplant (Figure 3A). Also, no differences were found between the 57 and 
92 days posttransplant values within each group. 
Table 2 Blood ana1ysis, nutritional status (Mean values ± 8») 
2A: Values o~ed. at several time points 
• Group Day- -8 0 34 62 97 
2 Hemoglobin 6.9±O.4 7.I±O.5 7.S±O.1 7.4±O.5 S.7±1.I 
3 (mmo1ll) 6.7±0.2 S.I±O.3 7.9±O.4 7.7±O.3 9.0±O.6 
2 Leucocytes 11.9±1.7 S.S±1.8 7.1±O.2 6.0±O.8 6.0±O.8 
3 (%) 7.6±2.4 6.4±1.2 7.6±2.3 8.1±O.2 6.0±0.5 
2 Total protein S4.3±2.1 53.0±1.4 54.9±3.4 53.S±1.2 57.S±2.9 
3 (gil) 56.2±2.0 56.2±1.3 54.9±O.4 54.4±3.5 53.4±3.0 
2 Albumin 28.J±O.6 27.0±I.O 27.0±1.4 25.8±O.7 29.4±1.I 
3 (gil) 28.3±O.5 29.2±0.4 26.3±O.& 24.0±3.5 25.S±0.3 
2 Cholesterol 3.23±O.O9 3.13±0.57 3.76±0.84 3.61±0.93 4.02±O.7 
3 (mmo1ll) 3.26±0.i3 4.07±0.20 3.34±o.o6 4.0l±O.2S 3.60±0.1 
2 Triglyceride 0.28±0.15 0.29±0.!O 0.44±O.16 031±029 0.31±O.06 
3 (mmo1ll) 0.37±O.01 O.43±0.OS 0.35±0.OI O.44±0.03 O.26±O.02 
2B: Values obtained between 5 and 7 months 
Group NH3 VitBU Folic acid VrtA VitE Ca Fe 
• (Jano1ll) (pmolll) (um01ll) (JanoI) (Janol) (mmo1ll) (Janolll) 
2 53.0±S.4 241±137 21.3±0.6 3.20±O.73 30.43±2.93 2.82±O.OS 25.13±6.01 
3 7S.2+3.2 223+50 23.2±2.6 2.23+0.71 32.15±S.30 2.94+0.03 24.9±&.49 
Fecal fOJ; analysis 
Fecal fat excretion appeared to be a sensitive indicator of malabsorption as it was severely 
increased in short bowel control animals (Figure 3B). Following sham operation or auto-
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Fig.3. Func/iOnal evaluation after perforrmng ShamoperatiOn or autotransplantation. Data are expressed as mean:!:: SD. 
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tr.msplantation no decreased fat absorption was found at the typical time poims. 
However, one of the long-term surviving autotransplanted dogs developed several 
episodes of enteritis, attended with weigbt loss and impaited fat absorption. 
Electrophysiology 
The results of the electrophysiologic measurements are depicted in Figure 3C. No 
differences were found in stimulated PD responses (Glucose-evoked, Theophylline-evoked 
and Phenylalanine-evoked) througbout the test period for group 2 and group 3. The 
baseline PD measurements in group 2 were comparable at the several time poims. 
Compared to this group the baseline PD response in group 3 were lower at 34 and 62 
days postoperatively but were not different anymore at 97 days. 
Disaccharidase activities 
Brush border enzyme activities are shown in Figure 3D. In the sham.-operated animals, 
activities of both maltase and lactase remained constant througbout the test period. In the 
autotransplant group, stable enzyme activities were found as well. Comparing enzyme 
activities between the groups showed no clear differences between group 2 and group 3. 
Histology 
The biopsies of both the sham-operated and autotransplanted animals showed intact villi 
with no evidence of inflammation in the mucosa and submucosa at the regular time poims 
after grafting. Besides no signs of atrophy could be seen. 
J);scussion 
For infants with SBS who are totally dependent on TPN, transplantation of a functioning 
small imestine ntigbt be the best treatment (16). There is little experimental proof that 
orthotopic bowel tr.mspIants may improve the morbidity and mortality rates of infants 
suffering from the SBS (17-20). It is suggested that after bowel transplantation sufficient 
functional capacity will remain after SBT to perntit normal growth. However, until now, 
all experimental research concerning SBT physiology in large animals has been performed 
in adult recipients. These results cannot simply be translated to immature recipients and 
therefore supplementary research is necessary. The present sOldy was undertaken to 
evaluate the technical and functional feasibility of a one-step total orthotopic 
tr.msplantation in the treatment of the SBS in young animals. 
It has been learned from clinical and expetimental experience that the adaptation capacity 
following major bowel resection is enormous (21,22). To exclude the possibility that a 
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puppy after near total enterectomy thrives on its remaining bowel, we included a short 
bowel control group. Such a control group is often omitted [19]. From the results of 
group 1 (SBS control). it can be concluded that the model used was suitable for the aim 
of the study, as the animals bad irreversible weight loss and persistent diarrhea, despite 
adequate intake of food and water. Group 2 (sbam operation) was included to monitor the 
effect of creating a Roux-Y loop without interrupting the vascular, neural and lympbatic 
supply. The two suxviving dogs in group 3 (SBS + SB autotransplantation) demonstrate 
that the SBS in a growing animal can be succesfully treated with a total orthotopic SB 
autotransplant. 
Weight~ being a "sensitive" marker of the nutritive status, was gained normally after 
autotransplantation. 
Compating blood parameters between group 2 and 3, only ammonia levels were markedly 
increased in autotransplanted animals. Sevetai rat studies (23) and a piglet study (24) bave 
already shown that venous drainage into the systemic circulation produces abnormalities 
in ammonia and antino aeid levels. Our study underlines that ammonia levels will rise 
after altering the anatomy of the portal vascular system. However, no major argument to 
avoid systemic drainage can be given as dietary manipulations are likely able to correct 
metabolic disturbances found. 
The D-xylose absorption test has been widely used as a pivotal test to evaluate small 
intestinal function in both adults and children (25). Although the pathway of D-xylose 
uptake has not yet been elucidated, it is clear that the assessment of D-xylose absorption 
reflects jejunal mucosal integrity. Our results showed unaltered D-xylose absorption after 
autotransplantation, indicating that the transplantation procedure itself did not influence its 
absorption, suggesting a normal jejunal function. 
Another functional test, mainly challenging the ileum, is the determination of fat 
absorption. Scbraut and colleagues reported that a high level of fecal fat excretion is 
generally found in adult recipients of allografts or isografts (19). This impaired fat 
absorption was assumed to be caused by denervation and interruption of the Iympbatic 
system. Raju et al (26), using adult dogs, evaluated long-term nutritional function of 
orthotopic SB autotransplantation and found depressed D-xylose and fat absorption as late 
as 12 months after surgery. We also detected impaired fat absorption in the short bowel 
control group. Surprisingly, no impaired fat absorption was found in the puppies after 
autotransplantation duting periods of clinical health. The fact that one of the long-term 
suxviving autotransplanted dogs developed sevetai episodes of enteriris, during which 
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increased fecal fat excretion was found, might pose a serious problem, This finding may 
suggest lIlat, although the recipient can nutritionally be supported entirely by its intestinal 
graft, recurring periods of infection and dysfunction in the long-run cannot be exclnded, 
The electrophysiologic responses after autografting were comparable to those after sham 
operation at any time point. This finding suggests that the autotransplantation procedure 
did not disturb specific sodium-coupled active transport of carbohydrates aud amino acids 
and cAMP mediated chloride secretion. Thus, the SB capacity of both absOIption aud 
secretion of fluid aud electrolytes, which facilitates the solubilization aud absorption of 
ingested macro- aud micronutrients, remained unaffected. The lowered base-line PD 
values after autografting during the first three months may be relared to the effects of 
denervation. Lear et aI (27) demonstrated enhanced chloride secretion in both isografts 
and allografts, which was identified as active secretion of chloride from the crypt as a 
result of lost autonomic control. In our study, the redoced base-line PD values also may 
have been due to increased secretory activity of the crypts. In addition, theophylline-
evoked responses were not any different following denervation. Therefore, it can be 
postulated lIlat the chloride secretion caused by denervation is non cAMP linked. 
Malmfors aud associates (28) showed lIlat peptidergic nerves, storing substance P, VIP, 
enkephalin aud somatostatin, are intrinsic in a piglet model of jejunal autotransplantation, 
whereas adrenergic nerves were extrinsic. Other results indicate that denervation has no 
effect on serotouin secreting cells (29). We propose lIlat the increased secretory flux 
found in the early postoperative period may be the resultant of an intbalsnce between 
endogenous secretagognes (e.g., acetylcholine, serotouin, substance P) and ami-
secretagognes (e.g., somatostatin, eDkephalin). 
Our electrophysiologic results suggest lIlat the functional condition of the heterotopically 
placed Roux-Y loop is not considerably dintinished in the recorded time period aud thus 
atrophy is unlikely. This finding was confirmed by determination of brush border enzyme 
activities and histologic mouitoring of the graft. 
The reasons for perfortuing a one-stage total orthotopic autotransplantation were to 
evaluate whether this procedure was technically feasible and, if so, whether near normal 
growth and development could be establisbed. Our results show that a one-step total 
orthotopic SB autotransplantation in puppies is technically feasible, although the early 
postoperative mortality rate is unacceptably high. Most cauine studies report a high 
incidence of thrombotic complications, most probably caused by low blood flow due to 
graft edema (30-32). We found a vascular failure rate of 20% (2110), which is acceptable. 
In young anin!als, disturbance of the water aud electrolyte homeostasis, enhanced by 
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denervation, greatly contributes to the outcome. Othet contributing factors include 
bacterial translocatiou, which results in sepsis, paralysis, invagination and intestioa! 
obstruction. In our model, the mortality rate due to other causes is 50% (4/8). Therefore, 
we postulate that a one-step transplantation procedure, as described above, is fraught with 
an inordinate mortality of 75% (6/8) for a growing dog. In the near future, we will 
investigate the role of a two-stage segmental allotransplantation in achieving lower 
morbidity and mortality rates of enterectomized puppies. 
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Long-term evaluation 
5.2 LONG-TERM ANALYSIS OF THE FUNCTIONAL, MORPHOLOGIC, 
AND BACTERIOLOGIC STATUS OF THE SMALL INTESTINE 
FOLLOWING AUTOTRANSPLANTATION IN GROWING DOGS 
Abstract 
93 
Many candidates for small-bowel transplantation are children, who need enough 
functional intestine to grow and develop normally. Our aim, therefore, was to evaluate 
the long-term non-immunologic effects of the small intestine on function, morphology and 
quantitative bacterial counts in subsets of the gastrointestinal tract after one-step small-
bowel autotransplantation (n=IO, only 2 dogs survived long-term due to technical- and 
management related complications) or sham operation (n=3) in a growing animal. To 
monitor graft function animals were weighed and serum parameters were determined.; we 
also performed D-xy!ose absorption testing, fecal fat analysis and intestinal transit time 
studies. After sacrifice, (1 year after the operation) disaccharidase activities were 
determined. Morphologic and bacterial studies were also performed after death. 
Comparing data of sham-operated and autotransplanted animals, increased maltase activity 
in both jejunum and terminal ileum and increased villus height in both duodenum and 
ileum was found following autotransplantation. The bacterial counts (log" CFU/gram 
tissue ± SD) showed aerobic overgrowth following autotransplantation in terminal ileum 
(7.oo±Loo vs 6.00 ±O.13) and ascendiog colon (7.72±O.66 vs 5.33 ±O.04) compared 
to sham operation. These results suggest that autotransplantation, in a growing animal, 
leads to adaptive functional and morphologic changes, and to elevated aerobic bacteria 
counts in distally situated parts. This overgrowth did not lead to secondary impaired 
function in these growing animals. 
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Introduction 
Small-bowel transplantation (SBn is considered an exciting new field in transplant 
surgery and innnunology and the worldwide interest is still increasing. The current 
clinical experience demonstrates the inherent feasibility and practibility of SBT in humans 
(1,2,3). Among the functions of the intestinal graft that has to be preserved in the long-
term after SBT are motor-, hOIDlonal-, innnunologic- and nutritional- components. 
Several studies have been perfOIDled to evaluate the long-term consequences of SBT on 
various aspects of graft physiology. Thompson et al reported long-term evaluation after 
SBT up to 20 months in adult dogs that had received an autotransplant (4). They showed 
that the effects of total exttinsic denervation are permanent and resulted in bacterial 
overgrowth and eventual disturbance of stool fat excretion. In addition, no intrinsic 
dependent gut functions were disturbed. Raju et al performed similar studies in adult 
autografted dogs (5). They found persistently increased fat excretion and D-xylose 
absotption for 12 months. This study learned that systemic venous drainage of the graft 
shows more severe functional abnomtalities than physiologir portal venous drainage. In 
other investigations the 'transplantation procedure itself resulted in impaired motility, 
which may explain the bacterial overgrowth (6,7). 
Although many studies have addressed the effect of SBT on gastrointestinal function, little 
work has been done to evaluate the effect on intestinal motphology. In adult dogs normal 
villus height was found in both jejunum and ileum 12 to 18 months after 
autotransplantation (4). Whether intestinal motphology is unaltered along the entire 
gastrointestinal tract is unknown. This issue is important because quantitative 
motphomemc analysis may parallel the functional condition of the graft. Moreover, 
segmental allotransplantation most likely involves adaptive changes in both function and 
motphology to overcome the "shortened" gut. 
Many candidates for SBT are children having irreversible small intestinal failure. SBT is 
widely considered as the best method to treat the short bowel syndrome. In our opinion it 
must be demonstrated that these grafts are functionally as well as histologically preserved 
before SBT can be proposed as a practical option. Our aim, therefore, was to evaluate the 
long-term effects on intestinal function as well as on motphology and quantitative 
bacterial counts in well-defined parts of the gastrointestinal tract in a growing animal after 
autotransplantation. 
To establish graft function in the long run growth and serum parameters were studied; 
and we also performed in vivo D-xylose absotption testing, fecal fat analysis, and 
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intestinal transit time studies. One year after the operation the animals were sacrificed and 
disaccharidase activities were determined. 
Materials and Methods 
Animals 
Female Beagle puppies, weighing 5-6 kilogram, were purchased from Harlan CPB, the 
Netherlands. They were maintained in separate cages under conventional conditions in 
accordance with the guidelines on care of laboratory animals. 
Experimemal. design 
Two groups of animals were studied: dogs that underwent a sham operation (Group 1; 
n=3) and dogs that underwent a one-step orthotopic small-bowel (SB) autotransplantation 
(Group 2; n=lO). The surgical technique bas been descnbed in detail in paragraph 5.l. 
Enteritis during the experimemal period could be successfully treated with 2.5 ml 
Depomycin subcutaneously for 5 days. 
In group 2, only two animals survived the major operation and could be evaluated in the 
long run. During lifetime the following functional parameters were used to determine 
graft function: blood analysis, D-xylose absOIption testing, fecal fat analysis and intestinal 
transit time. 
The dogs were sacrificed one year after surgery with an overdose barbiturate. Just before 
sacrifice, the animals were heparinized with 5000 IV heparin for enabling blood 
collection. After death, samples for functional-, histologic-, and bacteriologic studies were 
collected. 
Functional evciluotion 
Weight. Measured twice a week during the expetimental period. 
Between 11-12 months after the operation the following parameters were studied: 
Blood analvsis. The following routine laboratory blood chemistry data were determined: 
hemoglobin, leukocytes, serum total protein, albumin, cholesterol, triglyceride, alkaline 
phosphatase; AF, alanine aminotransferase; ALT, aspartate aminotransferase; AST, blood 
urea nitrogen; BUN, Creatinine; Crea and total bilirubin; TBll... Additionally, serum 
levels of vitamin Bu, ammonia, folic acid, vitamin A, vitamin E, calcium, iron were 
determined. 
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D-xvlose absorption test. Food was withheld 12 hours before performing the test. D-
xylose (0.5 gramlkg body weight) dissolved in water was prepared as test solution. Blood 
samples (in heparinized tubes) were collected before, and 0.5, I and 2 hours after oral 
administration. A D-xylose blood level titue curve was obrained using the method 
desenDed by Eberts et al (8). 
Fecal fat analysis. The method used has been described in detail by Van de Kamer et al 
(9). 
Small-intestinal transit titue studv. Dogs were fasted overnight. Orogastric intubation was 
performed using a sterile 18CH levin stomach tube (Atgyle, SherwoodlIreland). After 
confitt!ring that the trachea had not been intubated, using transillumination, 120 cc 
barium-sulfate containing solution (Micrppaque mixed with water; 1: 1.5) was brought 
into the stomach. Lateral radiographs were then taken every fifteen minutes using a 
Sirescop 3 (Siemens), and the intestinal transit titue was determined. 
Harvesting for histologic, 'bacteriologic, and disaccharidase activily studies; 
The exact sites of collection are schematically given in Figure IA and Figure lB. 
In Figure lA the sites of the gastrointestinal tract from which specimens were taken are 
defined: from the duodenum (25 em proximal to the ligament of Treitz)l, the jejunum (8 
em distal to the ligsment of Treitz)', the ntiddle small-bowel (50 em distal to the ligsment 
of Treitz)', the ileum (50 em proximal to the ileocecal valve)', the terminal ileum (3 em 
proximal to the ileocecal valve)' and the ascending colon (25 em distal to the ileocecal 
valve)-. In Figure 1B the sites of the Roux-Y from which material was collected (R-Y 1 to 
R-Y 4) are defined. 
Harvesting for disaccharidase activity assessment. After death, material for disaccharidase 
activity determination was collected from sites 2, 4 and 5 of the gastrointestinal tract and 
from R-Y 1 to R-Y 4. 
Harvesting for histologic assessment. For histologic purposes specintens of hean, lung, 
spleen, liver and mesenteric lymph node were harvested. From the gastrointestinal tract 
specintens were taken from sites 2, 3, 4, 5 and 6. From the Roux-Y specimens were 
taken from sites R-Y 1 to R-Y 4. 
Harvesting for quantitative bacteriologic studies. After death, the thoracic cavity was 
opened to obtain 2.5 ml of blood by cardiac puncture and to harvest a piece of lung 
tissue. Subsequemly, the abdontinal cavity was opened and 2.5 ml of portal and inferior 
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caval vein blood was collected. Moreover, pieces of liver, spleen and mesenteric lymph 
node Were harvested. From the gastrointestinal tract specimens were taken from sites 2, 
3,4,5 and 6. From the Roux-Y a specimen was taken from R-Y 3. 
A 
7.5 ern 7.5 ern 7.5 em 1 ern 
Stoma 
R-Y 4 R-Y 3 R-Y 2 R-Y 1 
Fig.1. Specimen collection for assessing functional, morphologic and bacterial status (defined in text): A sires of 
gastrointestinal tract; 8, sites of Raux-Y. 
Specimen processing 
Disaccharidase activitv. Disaccharidase activity was detennined as described in detail in 
paragraph 5.1 (10). 
Histoio"". The specimens that were collected for histology were fixed in 3.6% buffered 
formalin, dehydrated, and embedded in paraffin. Longitudinally cut sections of 4-5 p;m 
were then stained with hematoxy\in-azopbloxin-safum. They were examined by 
standardized projection on a screen through a light microscope. 
Bacteriolo"". Blood samples (1 mI) were cultured in Thioglycolate-Broth (10 mI) and 
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Brain-Hean Infusion Broth respectively. After an incubation time of 24-48 hr, 100 1'1 of 
broth was plated on blood agar, chocolate agar and fastidious anaerobe agar. The plares 
were examined after 24 and 48 h of incubation at 37°C. A blood sample was considered 
positive if any growth was found. Fecal samples (1 gram) were suspended in sterilized 
saline (9 mJ), and subsequemJy diluted by a factor of 10, 10', 10', 10" and 10'. Hundred 
JLl was plated on blood agar and McConkey agar. Plares were inspected after 18-24 hr of 
incubation at 37°C and the CFUs were counted. Data were reported as CFU/gm feces ± 
standard deviation (SD). 
Tissue specimens were weigbed and diluted 10 times with sterilized saline. The 
suspension was thoroughly homogenized, whereafter 100 1'1 of the homogenate was plated 
on blood agar and McConkey agar. Following an incubation time of 18-24 h, the number 
of bacteria per tissue specimen was calculated after counting the number of viable 
colonies. 
Selected colonies, obtained from blood-, fecal- and tissue samples, were subsequently 
identified using standard 'aerobic (BBL gaspak Co,-, AP"E-, Titerte!< Non-Fermenter-
and Titertek-Enterobacteriaceae automated system) and anaerobic (BEL gaspak anaerobic 
system) identification methods. 
Statistical analysis 
Statistical analysis was not performed as the study population was too stnall. 
Results 
WeighJ: 
"r--------------------------------, 
o~~~~~~~~~~~~~~~~~ 
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age in weekS 
Fi9.2. Weight Cl.Irves after performing shamoperarion or autotransplantation. 
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Figure 2 shows that dogs that underwent a sham operation grew notmally during the 
observation period when compared with non-operated historic controls (data not shown). 
In the first postoperative weeks, dogs that underwent a one-step total otthotopic SB 
autotransplantation showed a minor and temporarily weight loss. Subsequently a catch up 
growth approachlng the weight curve of sham operated animals was observed. In the first 
postoperative months, however, autotransplaIJted dogs developed several enteritis-like 
episodes attended by diarrhea and weight loss. Such episodes were no longer observed 
from six months postoperatively and in the long run the weights of autotransplaIlted 
animals were equal to data of sham-operated anintals. Apart from the first postoperative 
weeks and the infectious periods, stool consistency was normal. 
Blood analysis 
Blood parameters are shown in Table 1. The nutritional parameters indicate that the 
general condition of the animals after sham operation is comparable to the condition of 
animals after autotransplantation. In autotransplaIJted animals serum ammonia levels were 
increased compared to sham-operated animals (75.8 ± 8.1 vs 37.9 ± 16.9) 12 months 
postoperatively. 
Table 1 Blood analysis, nutrit:ional status (Mean values ± SD) 
Values obtained one year posttransplant 
Hemoglobin (mmolll.) 
Leukocytes (10911) 
Total Protein (gil) 
Albumin (gil) 
Cholesterol (mmol/l) 
Triglyceride (mmol/l) 
AF (Unitsll. 37"C) 
ALT (UnitsII. 37"C) 
ASf (UnitsII, 37"C) 
BUN (mmol) 
CREA (}<mol/l) 
TBIL (p.mol/l) 
Vit BIZ (pmolll.) 
NH3 (p.mol/l) 
Folic acid (nmol/l) 
Vi, A ( ,,",01) 
Vit E ULmol) 
Ca (mmol/l) 
Fe (p.mol/l) 
D-xylose absorption test 
Group 1 
10.3 ± 0.3 
6.1 ± 1.4 
57.4 ± 2.7 
28.2 ± 2.6 
4.5 ± 0.7 
0.24 ± 0.03 
31.7 ± 7.4 
34.5 ±11.4 
14.4 ± 2.7 
4.1 ± 0.7 
72.0 ± 2.0 
3.2 ± 0.5 
233 ± 88 
37.9 ± 16.9 
24.3 ± 2.1 
2.80 ± 0.74 
39.3 ± 4.22 
2.77 ± 0.06 
27.12 ± 4.02 
Group 2 
10.3 ± 0.2 
7.4 ± 1.3 
63.8 ± 1.0 
29.5 ± 0.5 
5.6 ± 1.4 
0.33 ± 0.01 
25.1 ± 2.0 
55.2 ± 41.6 
18.5 ± 1.3 
5.1 ± 1.0 
75.0 ± 4.0 
3.9 ± 0.8 
246 ± 135 
75.8 ± 8.1 
26.2 ± 2.4 
2.60 ± 0.73 
47.5 ± 17.5 
2.85 ± 0.04 
30.1 ± 12.0 
The D-xylose absorption test results, obtained one year posttransplant, are shown in 
Figure 3A. Area-nnder-<:UIVe calculations indicated that total D-xylose absorption after 
sham operation (350.6 ± 95.0) is similar to that after autotransplantation (394.3 ± 
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146.2). Moreover, comparing these results with values obtained on the shon term (data 
given in paragraph 5.1), no alterations were found. 
3A D-Xylose test 
1 Year postoperative 
4 . _ _ _ . - . . -. _ _ _ - - • • :f/T?:l I . - _." --- _ •• - _ ... - -' _ .. 
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Maltase activities 
Histology 
Villus height 
,,,,,~O------r--------------~ 
3B Fat absorption 
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Fig.3. Functional evallPJrion after performing shamoperation or autotransplantation. Data are expressed as mean ± SD. 
Long-term evaluation 101 
Fecal fat analysis 
The results of fecal fat excretion are depicted in Figure 3B. One year after the operation 
no elevated fat excretion could be detected in either group. 
SmLZll-in1estinal transit time study 
The intestinal transit time was similar in both groups (visualized in Figure 4). 
A B 
c D 
Mg.4. IntesDnal transit time study: 4A, before Barium-sulfate solution was brought into stomach; 48, stomach filled 
with Barium-sulfate solvtion (t= 0 hours); 4C, barium-sulfate solution present In the SInaI/Intestine ft= 15 minutes); 40, 
Barium-sulfate solution present In colon (t= 2 hours). 
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Disaccharidase activities (Maltase and Lactase) 
Data of maltase and lactase activities are shown in Figure 3C. In well-defined pans of the 
gastroinlestina! tract lactase enzyme activities of autotransplanted animals were 
compatable to those in sbam-opetated animals. Maltase activities of autotransplanted 
animals were increased as compared to sham-opetated animals, both in jejunum and 
tenninal ileum. 
Histology 
At the macroscopic level, nO obvious differences between dogs in group 1 and group 2 
could be demonstrated. In autotransplanted animals, bowel-lengths measured from the 
ileocecal valve to the transection point and from the ligament of Treilz to the transection 
point were markedly increased as compared to preopetative lengths (from 5.0 ± 0 to 17 
± 4 and from 1.0 ± 0 to 19 ± 2 centimeters). 
Microscopic analysis is depicted in Figure 3D. After autotransplantation obvious increases 
in villus size were seen in the duodenum as well as the ileum one year after the operation 
compared to sham operntion. No other major changes in inlestina! morphology were seen. 
QZIIl1ttitative bacteriologic studies 
The bacteriologic data are shown in Table 2. The numbers of aerobic bacteria found in 
the ascending colon and the tenninal ileum were markedly elevated. The bacteria most 
frequently identified were Micrococcus- , Pasteurella-, and hemolytic and other E coli 
species. 
Table 2 
Tissue 
lung 
liver 
spleen 
MLN 
portal blood 
caval blood 
c:an!iac blood 
jejunum 
ileum 
mid jejunumrlleum 
terminal ileum 
Roux-Y 
colon 
Diseussion 
Bacterial counts; results given in log16 CFU/gram tissue + SD 
Group 1 Group 2 
none none 
none none 
none none 
none none 
none Done 
none none 
none none 
5.25 ± 2.33 6.24 ± 0.72 
6.12 ± 0.71 5.59 ± 0.16 
5.30 ± 2.26 5.90 ± 0.23 
6.00 ± 0.13 7.00 ± 1.00 
none 6.49 ±0.65 
5.33 ± 0.04 7.72 ±0.66 
Although it is becoming increasingly clear thet transplanting of the small intestine has 
shown its inherent feasibility the postoperative course is extremely difficult. It is often 
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complicated by problems such as graft-versus-host disease, rejection and sepsis (11). In 
the present animal model we circumvented rejection by perfomring a one-step total 
orthotopic SB autotnmsplantation and were thus able to study the long-term non-
immunologic effects of SBT on function, morphology and bacteriology of the intestine in 
a growing animal. 
Weight analysis, sensitively reflecting the overall nutritional status, showed that no 
significant effect on weight could be found in autotnmsplanted animals compared to sham-
operated anintals. This observation was supported by analysis of nutritional parameters 
one year postoperatively. Again, no significant alterations were demonstrated, irulicating 
that a normal nutritional balance is maintained after autotransplantation. 
In agreement with other studies elevated ammonia levels were present following systemic 
venous drainage of an intestinal graft (12,13). This physiologic consequence, already 
occurring within three months (Chapter 2), may have implications for the diet after 
transplantation. 
We found that growing autotnmsplanted animals had normal D-xylose and fat absorption 
one year after the operation despite the presence of bacterial overgrowth. Others (4,S) 
have reported depressed D-xylose and fat absorption for the 12-month period after 
transplantation. A major difference with our study is their use of adult anintals. The 
adaptive functional reserve of the intestine of a growing animal may well prevent the 
development of functional abnormalities following extrinsic denervation. This statement is 
supported by our data on morphology and disaccharidase activities of autotransplanted 
intestine. One year after autotnmsplantation, increased duodenal as well as ileal villus 
height was observed and the overall bowel length was markedly increased. In addition, 
increased maltase activity in jejunum as well as terminal ileum was detected. 
One explanation is that denervation itself is able to exert trophic influences on the 
morphology and specific functional characteristics of the intestine. There is evidence that 
the myenteric plexus regulates cell proliferation and cell growth in the rat jejunum (14). 
Furthermore, the segments contained higher levels of sucrase activity (U/mg protein). 
Another explanation for the morphologic and functional adaptive changes, at least in the 
distal part of the gastrointestinal tract, may be that it compensates for malabsorption 
related to bacterial overgrowth. This is in agreement with the results of Thompson et aI 
(4), who found unaltered morphology in association with impaired absorptive function of 
the intestine in adult animals. 
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Moreover, an altered ecologic balance of the gut flora following SBT is one of the factors 
that migbt promote sepsis. The alteration in microflora may be caused by ischemic injury, 
lymphatic and neural disruption, systemic venous drainage, immunologic components, and 
use of antibiotics (15). Browne et al found that even SBT alone leads to Gram-negative 
aerobic overgrowth in the distal small-bowel as well as in the ascending colon in a rat 
model three weeks posttransplant (16). Moreover, it was found that addition of 
cyclosporine in isografts facilitated translocation of bacteria from the gnt to the mesenteric 
lymph nodes. So, the addition of cyclosporine therapy may be the critical factor which 
predisposes patients to sepsis following SBT, even in the absence of rejection. 
This study shows that infectious complications after SBT can be documented in the first 
postoperative months. Determining the nnmber of fecal bacteria during such infectious 
episodes revealed "abnormal flora", which was defined as >10' organ.isms!gram feces. 
This phenomenon is most probably caused by alterations in bacterial gnt homeostasis as a 
result of the surgical procedure itself. From six months on, there were no more clinical 
signs of bacterial OVergt0wth. At autopsy, however, we found elevated aerobic bacteria 
counts in the terminal ileum and ascending colon after autorraosplantation. The hypothesis 
that the detected bacterial overgrowth was due to a rraosplant with discoiirdinated motor 
complexes is unlikely because a normal intestinal transit time was found. Our findings 
suggest that althougb bacterial overgrowth is present in the distal part of the 
gastrointestinal tract one year after autorraosplanlation in a growing anitnal, this has no 
clinical itnportance in the long run. 
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ULTRASONOGRAPHY; A USEFUL TOOL IN TIlE FOLLOW-UP OF 
SMALL-BOWEL TRANSPLANTATION 
Abstract 
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This study was undertaken to determine whether ultrasonography is a valuable tool for 
monitoring the postoperative course after performing small-bowel transplantation in 
growing dogs. 
FiIst. we report u1trasonographic features of normal canine bowel using a 7.5 MHz 
transducer. Secondly, in dogs that received an isoperistaltic Roux-Y loop, after sham 
operation or autotransplantation, ultrasound was used to assess signs of atrophy one year 
postoperatively. And thirdly, we performed sonography in seven growing dogs after twO-
stage segmental small-bowel allotransplantation to evaluate the postoperative course. 
In normal canine bowel, it appeared technically feasible to distingnish mucosa and 
muscularis by ultrasound. Long-term ultrasound studies of a Roux-Y loop demonstrated 
mild to moderate atrophy in segments close to the intestinal continuity, but not in 
segments close to the ileostomy. Monitoring the postoperative course of two-stage 
segmental small-bowel allotransplantation, early complications, including intussusception, 
thrombosis, and postoperative ileus, were noted. Moreover, in one case rejection-related 
mucosal atrophy was clearly demonstrated by ultrasound. 
We conclude that ultrasonography is useful in monitoring early complications of smaII-
bowel transplantation and therefore we propagate using ultrasound as part of the 
multidisciplinary support. 
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:lntroductiou 
In patients with extensive smaJl-bowel (SB) reseetion, transplantation of the smaJl 
intestine would be the best treatment modality and is the only alternative to permanent 
Total Paremetal Nutrition (TPN) (1,2,3). 
Teclmically, smaJl-bowel transplantation (SET) in human is now feasible (4,5), but 
rejection, graft-versus-host.<Jisease (GVHD) and infectious complications are key 
problems that should be overcome in the postoperative period (4-7). In this rather stormy 
postoperative period, intensive muitidisciplimIy support and monitoring is necessary to 
identify and resolve postoperative complications. Bach recently descnl>ed the radiologic 
findings in five patients after orthotopic SBT (8). He concluded that radiology had limited 
value in monitoring rejection, but helped to detect or exclude teclmical complications such 
as perforations and anastomotic leaks. 
In this study, we investigated the value of ultrasonography in the follow-up of SB grafting 
in Beagle puppies. 
Materials and methods 
Animals and experimen1al groups 
In total twenty healthy Beagle puppies (Harlan CPB, Zeist, The Netherlands), weighing 5-
A sham operation was performed in 3 anintals and a one-step orthotopic SB 
autotraosplantation in 10 anintals as described in detail in paragraph 5.1. 
A two-stage segmemal SB allotransplantation was performed in another 7 animals. In the 
first stage, a heterotopic SBT was performed in which the recipient's own bowel was still 
intact. The transplant (1 meter) was harvested on a vasculax pedicle, consisting of both 
superior mesemeric artery (with aortic cuff) and vein, from a fully Major 
Histocompatibility Complex (MHC)-matched donor. The graft was revascularized by 
anastomosis of the mesenteric vessels to the abdominal aorta and caval vein in an end-to-
side fashion. The distal end of the graft was constructed as an isoperistaltic Roux-Y loop 
in continuity with the recipient's terminal ileum about 5 em proximally to the ileocecal 
valve, and the proximal end was exteriorized as open ileostomy. After seveta! weeks 
enterectomy took place and the transplant was placed in continuity in an end-to-end 
fashion (Figure 1). These animals received CycJosporine (10 mg/kg/d i.m. at day -1 tim 
+7 and 20 mg/kg/d orally afterwards) UD!i! the end of the experimental period. 
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Fig.1. Schematic design of rwo-sra.ge segmental allotransplanra'ti()ll, 
Monitoring 
For llistologic and, or ultrasonograpllic evaluation the following material was collected: 
- normal SB segments from dogs prior to autotransplantation to minimjze number of used 
animals. 
- at sacrifice, a defined segment of a Roux-Y loop, 16 centimeters distally from the 
enterostomy loop one year after its performance during sbamoperation or one-step 
orthotopic SB autotransplantation (see paragraph 5.2, Figure IB: R-Y 3). 
- pieces of lung, liver, mesenterial lymph node, kidney, transplant and host bowel were 
obtained at sacrifice from animals that underwent a two-stage segmental SB 
allotransplantation. 
Histology 
The material was fixed in 3.6% buffered formaldehyde, and embedded in paraffin. 
Hematoxylin-azophioxin-safran staining was performed on 4-5 p;m sections. 
Ultrasound 
All ultrasound examinations were performed by an experienced pediatric radiologist using 
a commercially available ultrasound unit (Aloka Model SSD-630, Aloka Co., Ltd) 
equipped with a 7.5 MHz linear transducer for in vivo studies. In sham-operated and 
autotransplanted animals, ultrasound was used to evaluate the condition of the constructed 
Roux-Y loop one year posttransplant. The loop was identified through water-filling using 
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an urinary catheter, inserted into the loop about 15 em from the enterostomy, Optimal 
visualization of the loop was accomplished in all cases. Real-time images were obtained 
in both transverse and longitudinally planes in the supine position after sedation with 5 
mg droperidol, injected intramuscularly. In this way diameter, muscle- and mucosal 
thickness could be measured. After segmental allotransplantation ultrasonogtaphic studies 
were frequently performed, without any sedation or premedication, to evaluate the 
postoperative course. 
In vitro ultrasound studies were performed with a commercially available 7.0 MHz linear 
array transdocer (Acuson, Mountain View, CA). A sntaIl segment of bowel submerged in 
either saline or 3.6% buffered formaldehyde was used for in vitro examination. 
Results 
Survival 
The 3 sbam-operated dogs survived indefinitely. Unfortunately, 8 of 10 autotransplanted 
animals died due to complications related to maoagement and technique in the first several 
weeks (9, paragraph 5.1). Thus, ouly in 2 autotransplanted dogs the condition of the 
Roux-Y loop could be evaluated in the long run. 
The postoperative course after a two-stage segmental SB allotransplantation in 7 dogs is 
summarized in Table 1. 
Table 1 The posttransplantation course; after a two-stage segmental allotransplantation 
Dog Stages Postoperative complications Survival and cause of death 
1 I venous thrombosis 1 day> venous thrombosis 
2 1 recipient intussusception (day 1 and 7). ileus 53 days, pneumonia 
3 1 1I3nSplant intussusception (day 10) 14 days. hemorrhagic transplant 
4 1&2 none 48/19 days. functional bile congestion 
5 1 none 24 days, rejection 
6 I heart fuilure 11 days, multiorgan failure 
7 1&2 transient gastroenteritis and anemia > > 100/50 days 
Notes: 
* AlB days; A is number of days after first stage! B is number of days after second stage. 
* Dogs 2. 3, 4, 5 and 7 developed transient thrombopenia accompanied by a transient anemia. 
Histologic- versus ultrasound appearance of normal canine intestine 
In Figure 2A, the schematic characteristics of canine sntaIl intestine are given as 
anatomically identified. 
Ultrasonography 113 
Fig.2.A. Generalized cross section of vertebl8le small bowel, consisting of four layers: an outermost layer of serosa and 
mesothelial (s), the mClSClJlaris Imu) composed of longitudinal and circular fibers, a relative thick. layer of submucosa 
Ism) and the innermost mucosa (m). 
Figure 2B is a cross section of normal canine SB after histological preparation. The 
principal four layers; mucosa, submucosa, muscularis, and serosa, are easily identified on 
histologic sections. 
Fig.2.B. HistologiC cross section of normal canine bowel. The layers visualized represent serosa and mesothelial Is}, 
mlJScularis Imu}, submucosa Ism} and mucosa fm). 
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Using 7.5 MHz trallSducers in vitro with fresh tissue immersed in saline, mucosa and 
muscularis can easily be distinguished as separate hypoechoie bands. The hyperechoie 
rings represent strong reflections from interfaces between mucosa and muscularis and 
between serosa and surrounding fluid (Figure 2C). 
The submucosa and serosa are located at this position but do not cause these reflections. 
The thickness of these layers is overestimated on sonography by abnormally strong 
reflections. Therefore, the muscularis appears small compared to histologic prepared 
material. In vivo imaging of the canine bowel by ultrllSonogtaphy is represented in Figure 
2D. 
Fig.2.C. Transverse ultrasound scan of canine bowel in 
vitro surrounded by saline; hypoechoic bands represent 
mucosa fm) and muscularis fmuJ. 
Fig.2.D . Transverse ultrasound scan of canine 
bowel in vivo surrounded by formaldehyde; 
hypoechoic bands represent mucosa fm) and 
muscularis (muJ. 
Comparing Figure 2C with 2D, it appears that the echogemc band between mucosa and 
muscularis is thicker in vitro. Simultaneous reduction of the muscularis band suggests that 
the echogenie band is pan of the muscularis. Moreover, an echogemc band reflecting the 
outer layer is clearly visible in vitro but this layer can hardly be distinguished in vivo 
because the individual loops are packed closely together. 
Histologic versus uftrasound appearance of Roux-Y loop, one year crjier its perjomumce 
The Roux-Y loop was constructed for indirect functional monitoring of the graft (in vivo 
electrophysiologic responses and disaccbaridsse activity; exact data given previously (9». 
Figure 3A shows the histologic appearance of a Roux-Y loop one year after the 
performance. The histologic section showed altered mucosal arcbiteclllre characterired by 
reduced crypt depth and dintinished villus height. Additionally, in vivo ultrasonogtapltic 
examination of the Roux-Y loop demonstrated reduced mucosal thickness as well (Figure 
3B). No other deviations could be found. 
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Ag.3.A. Histologic cross section of 
Roux-Y loop (corresponding to R-Y 3, 
Fig 1. paragraph 5.21, showing reduced 
mucosal architecture. 
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Fig..3.B. Longitudinal sonogram of Roux-Y loop demonstrating 
reduction of mucosa! layer (corresponding to Figure 1, Chapter 5, R-
Y3). 
Ml = mucosal layer of normal loop. 
M2 = mucosal layer of Roux-Y loop. 
Postoperative complications following segmental allotransplantation, visualized by 
ultrasound 
Venous thrombosis. Figure 4A shows the histologic appearance of intestine following 
venous thrombosis. The mucosal architecture was intact but villi and crypts were 
completely desquamated. 
Rg.4.A. Hi::;tologic section of inte::;tine following venous thrombosis. The layer::; repre::;ent sero:>a (s), mu::;cularis (mu), 
submucoSa (sm) and destroyed mUCO:>a (m). 
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Figure 4B shows u1=onographlc features of intestine in saline following venous 
thrombosis. 
In venous thrombosis, ultrasound studies showed wall thickening, resulting in distention 
of the bowel. In the bowel wall intramuml air was seen. Moreover, the mucosa showed 
increased echogenicity compared to normal bowel. 
Fig.4.B. Longitudinal in vivo ultf'aiSound image of canine SInaI! intestine following venous thrombosis; arrows indicate 
mucosa 1m) and fTllJScuIaris (mu} layer respectively (surrounded by saline) Arrowhead: mucosal air. 
Inrussusception. Intussusception was diagnosed twice in one dog and one titue in another 
dog using ultrasound (Figure 5). One developed jejuna-jejunal intussusception of host 
bowel, and the other ilea-ileal intussusception of donor bowel. Only the dog that 
developed intussusception of the host bowel showed clinical signs (vomiting, abdominal 
mass, colickY pain). Sonographically, no differentiation could be made between 
intussusception in transplant or host bowel. The intussusceptions did not reduce 
spollWleously, therefore, successful surgical reduction was performed after 24 hours. 
Fig.S. Cross-sectional ultrasound image through the intussusception, demonstrating alternating hyperechoic and 
hypoechoic rings {arrowsJ. 
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Mesenterial lvmph node enlargement. All dogs that received an ailotransplant developed 
enlarged mesenterial lymph nodes. varying from 1.5-5 centimeters. Histologicaily. sinus 
histiocytosis and erythrophagocytosis were revealed. Moreover, lymphoid depletion was 
clearly demonstrated in tile sections but lymph nodes still contained a few germinal 
centers. Sonographicaily, mesenterial lymph nodes had a homogenous hyperechoic 
appearance (Figure 6). In srudies performed in autotransplanted animals, no such 
enlargement was detected. 
Fig.G. Enlarged mesenten"a"ymph node (MLNI in transverse ultrasound section. 
Rejection. The histologic appearance of rejected transplant-intestine is shown in Figure 
7 A. There was a strongly altered intestinal architecrure due to massive infiltration witll 
inflammatory cells in tile intestinal wail. In vitro ultrasound srudy of a rejected bowel 
showed slightly increased echogemcity and mucosal atrophy, reflected by a tI:lin mucosal 
layer and thickening of muscularis with loss of strong reflections between muscularis and 
mucosa (Figure 7B). 
Miscellaneous abnormalities. In the early postoperative period intraperitoneal effusions 
were identified that usually disappeared spontaneously. Inspissated bile in gallbladder was 
demonstrated in some dogs. 
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Fig.7.A. Histologic cross section of acutely rejected 
small intestine, demonstrating serosa (s) and 
muscularis (mul and edema of mucosa fm) and 
submucosa (sm). 
Discussion 
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Fig. 7 .S. In vitro ultrasound image jf) farm/Hin of acutely 
rejected small intestine; bands represent sloughing 
mucosa (arrowhead) and a thickened museumr (mu) 
layer. Section demonstratcs decreased echogenicity of 
interface between mucosa and ml.lScularis. 
The present findings demonstrate that using a 7.5 MHz transducer, exploratory research 
of canine bowel is feasible, as mucosa and muscularis can clearly be identified. It is 
known from the literature that, to distinguish. all four layers of bowel, at least a non-
commercially 20 MHz transducer should be used (10). 
The histologic- and sonographic studies, performed in sham-operated and autotransplanted 
animals, showed that Roux-Y grafting resulted in mild mucosal atrophy depending on the 
posmon relative to the gastrointestinal tract. Comparing sham-operated and 
autotransplanted animals, no differences were found in the presence of atrophy, 
histologically or sonographically of the Roux-Y loop. 
Seven dogs that underwent a two-stage segmental allotransplantation demonstrated 
postoperative complications including intussusception and infectious episodes. Previously, 
we performed the same transplantation procedure in adult dogs (11). In these experiments 
no such complications were encountered suggesting that young recipients of a bowel 
transplant are more susceptible to infectious complications and intussusception. In fumre 
experiments, we will try to circumvent these complications by introducing selective 
decontamination of the digestive tract (SDD) and early gastrostomy feeding (12,13). 
We observed the sonographic abnormalities found after venous thrombosis. Clinically, 
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ultrasonography has already been demonstrated to be quite valuable in the area of 
vascular abnormalities (14). Therefore. ultrasound can be of help to detect or exclude 
suspected vascular complications after SET. On ultrasound, thrombosis of the superior 
mesenteric vein appears as echogenic material filling a dilated structure (15). The 
described dilatation of the intestinal wall is a reflection of the presence of edema which is 
found after ischemic injury. EvelllS that follow bowel ischemia include paralysis of the 
small intestine and SUbsequent formation of intramural air in the intestinal wall cansed by 
bacterial entrance, which in its tum is caused by breakdown of mucosal integrity. These 
features are clearly detectable using ultrasonography. 
lntrasound is generally applied to diagnose quickly and accurately cases of human 
intussusception (16,17). It was shown that intussusception in dogs is quite similar to 
human intussusception. The appearance can be described as "bowel within bowel" and 
consist of alternating hypo- and hyperechogenic rings. Our study again demonstrated that 
intussusception is a postoperative complication occurring after SET in large anhnaIs. This 
was already seen by Pritchard who found 22 % intussusception in a one-step orthotopic 
allogeneic SET model in young pigs (18). 
The presence of eularged mesenterial lymph nodes, as detected, may be the leading point 
for transplanted bowel to be trapped into intussusception. Other contributing factors may 
be neural nonregulation or episodes of bacteraemia (19), and it is even described as a 
complication of Roux-en-Y anastomosis (20). Enlargement of mesenterial lymph nodes 
following allogeneic SET in rats has already been described by Grant et al (21). 
Mesenteric lymph nodes contain the main part of lymphoid components of intestine, so 
enlargement probably reflects an immunological process after allogeneic transplantation. 
We even speculate that, in our experiments, it is a subclinical feature of GVHD. 
Histologic exantination of the lymph nodes several weeks after transplantation revealed 
lymphoid depletion, which may underline this hypothesis (22-24). In these dogs we found 
anemia, but no other evidence for GVHD could be revealed. The design of our 
experiments suggests that MHC-matcmng would not guarantee protection from GVHD 
(25). The suspected subclinical GVHD may occur because of minor histucompatibility 
antigen differences between graft and host (26). 
Fmally, in vitro ultrasonography could readily identify villous slonghing associated with 
rejection (27). This finding suggests that ultrasound may even be able to identify signs of 
rejection by regular quantitative ultrasound analysis of mucosal thickness of transplanted 
bowel. Recently, Cheung found that in vitro ultrasound studies can potentially 
differentiate, normal versus abnormal bowel wall after porcine SET (28). We speculate 
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that ultrasound may be of great value in assessing relationships of mucosa and muscularis 
thickness. 
In conclusion, ultrasound is a valuable tool to monitor the postoperative course of SBT. 
Routine investigations emble early detection of postoperative complications seen after 
SBT. In vitro sonography detects interesting fmdings of the bowel wall, including venous 
thrombosis and acute rejection, and therefore in vivo application seems promising. 
Ultrasound may also have some value in assessing GVHD and chronic rejection after SBT 
because altered bowel architecture is present in these situations. 
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MHC-MATCHED SEGMENTAL SMALL-BOWEL ALLOTRANSPLANTATION 
IN ENTERECTOMIZED GROWING DOGS: AN ADEQUATE THERAPEUTIC 
MODALITY 
Abstract 
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The present study was undertaken to investigate wbether a two-stage segmental smaIl-
bowel allotransplantation can promote normal growth and development of young dogs (16 
weeks, 5-6 kg) with a surgically created abort bowel syndrome. 
After near-total small-bowel resection (group 1, n=3) an irreversible weight loss was 
seen. After sham operation (group 2, n=3), no growth disturbances were found. Major 
histocompatibility-matched small-bowel transplantation with cyclosporine A as 
immunosuppressant was performed in two-stages; during the first stage one meter 
jejunoileum from an adult donor was placed beterotopically. Four weeks later, the native 
gut was removed whereafter the graft was placed orthotopically (group 3, n=7). In this 
group only one dog survived long-term, all other dogs died due to infectious 
complications. Addition of selective decontamination of the gut and early gastrostomy 
feeding resulted in long-term survival in 66% of the dogs (group 4, n=IO). Follow-up (4 
months) leamed that growth of a young dog after transplantation of a major 
histocompatibility-matched segmental small-bowel allograft is compromised about 20% 
compared to sham-operated animals. Functional analysis abowed normal D-xylose 
absorption, normal values of serum parameters, but increased Iactuloselmannitol ratio, 
fecal fat excretion and postheparin DAO release. These results show that under these 
conditions a segmental small-bowel transplant functions sufficiently to treat the abort 
bowel sYUdrome but functions suboptimally to maintain a normal growth pattern. Thus the 
value of segmental small-bowel allotransplantation under cyclosporine treatment in 
maintaining the normal growth and development in young dogs without specific 
nutritional interference is questionable. 
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Introduction 
Small-bowel transplantation (SBT) will probably become the ultimate therapeutic modality 
for a variety of life-threatening gur-related ruseases in early chilclhood. 
In transplant medicine, matching donor and recipient for major histocompatibility (MHC) 
antigens is a successful modality to achieve prolonged graft survival (1,2). With respect 
to this, living relatives could donate segments of bowel if a segmental small-bowel (SB) 
transplant shows to be a reasonable alternative to total parenteral nutrition (fPN). It is 
still not clear, however, whether a segmental SB transplaut functions sufficiently to 
maintajn growth and development of a child. 
In a previous study we showed that adult dogs are able to survive long-term after 
receiving a segmental MHC-matched SB graft (3). The present study was undertaken to 
investigate the value of a MHC-matched two-stage segmental SB allotransplantation in the 
treatment of the short bowel syndrome (SBS) in en!erectomized puppies. We evaluated the 
functional capacity of a segmental graft, derived from an adult donor, by assessing the 
general condition of the animal (growth, serum parameters), absorptive capacity of the 
intestine (D-xylose absorption and fecal fat excretion), mucosal integrity 
(lactulose/mannitol excretion ratio), and the adaptive response (postheparin DAO release). 
Materials and methods 
AJzimals 
Donors. In total 17 adult male and female Beagles, weighing 10 to 20 kg were used 
(Harlau CPB, Zeist, The Netherlauds). Their ages ranged from one to three years. 
Recipients. In total 23 healthy female Beagle puppies, 16 weeks of age, weighing 5 to 6 
kg were used (Harlan CPB, Zeist, The Netherlands). 
MHCl1U1tc!zing 
Matching for antigens of the canine MHC complex, DLA, consisted of typing for both 
class I and class II antigens, as described previously (4,5). Direct and indirect 
nticrocytotoxicity tests, based on a battery of about 60 alIoantisera, were used to define 
the class I, serologically defined, antigens belonging either to DLA-A, DLA-B or DLA-
e. Typing for class II antigens (DLA-D) was done by means of the unilateral mixed 
Iytnphocyte reaction using a culture period of 6 days. The selection of donor-recipient 
pairs was based on a two haplotype sintilarity. 
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Experimemal groups 
The dogs were subdivided into four experimental groups: group 1 (n=3), short bowel 
controls; group 2 (n=3), sham operated animals: group 3 (n=7), MHC matcbed 
segmental jejunoileal allografts and group 4 (n=10), MHC matched segmental jejunoileal 
allografts + selective decontamination of the digestive tract (SDD) + early gastrostomy 
feeding. 1n group 3 and 4 immunosuppression consisted of cyclosporine A (CsA). 
Operative procedure 
The anesthesia and the operative techniques of enterectomy and of the sham operation are 
descn1led in detail in chapter 5. 1n chapter 6 this has been done for the two-stage 
segmental SB allotransplantation. 
Perioperative treatmeTl1 
The perioperative care of group 1,2, and 3 consisted of "standard" care descnbed in 
detail in chapter 5. Animals in group 3 and group 4 received 10 mg/kgJday CsA in olive 
oil (Sandintmune, Sandoz, Basel, Switzerland) intramuscularly from one day prior to 
surgery up to and including the seventh postoperative day. From then on, CsA was given 
oraliy, in capsules, at a dose of 20 mg/kgJday. 1n addition, group 4 animals received 
SDD-treatment starting 1 week prior to surgery and continuing throughout the 
eJcperintental period. After bowel engraftment in group 3, early posttransplant infections, 
associated with bacterial translocation into the blood, were caused by Enterobacteriaceae 
and staphylococcus areus species. This detennined the chief ingredient of our daily SDD 
regimen in group 4: 6.5 mglkg/d ciprofloxacin (Bayer Nederland BV, Mijdrecht, The 
Netherlands) to prevent bacteremia due to Enterobacteriaceae and sensitive 
Staphylococcus arens strains. Polymyxin B (10 mg/kg/d; Pfizer Chemicals, New York, 
USA) was included for providing cover against a wide range of potentially pathogenic 
Gram-negative aerobic bacteria, with multiresistant Protens as a major candidate. The 
mixture of ciprofloxacin and Polymyxin B can give yeast, such as Candida, overgrowth 
and therefore Nystatin (2 X 60.000 Units/d; Labaz Sanofi-Winthrop, Maassillis, The 
Netherlands) was included. After food was withheld for 36 hours prior to surgery, an 
energy-eontaining solution was daily supplemented oraliy (Extran, Nutricia, Zoetenneer, 
The Netherlanda). Group 4 anintals were also supported with force feeding via the 
gastrostomy (Nutrison Pediatrics, Nutricia, Zoetenneer, The Netherlands) in the first 
postoperative week after both the first-stage and the second-stage operation in group 4 
(6). Thereafter irradiated (0.9 megaRad) dog food (Pnppap, Hope Fanns, Woerden, The 
Netherlands) was given and water was freely available. 
128 Chapter 7 
Evaluation 
The general condition and the enterostomy outlook, if present, were observed daily, 
SurvivaL AIrimals were sacrificed if their general condition deteriorated or if they lost 
more than 30% of their preoperative body weight, 
Weight: measured twice a week, always at 8,00 a.m, 
Detailed technical informa1ion about blood chemistry, D-xylose absorption testing and 
fecalfat analysis is given in paragraph 5.1 and 5.2, 
Blood analysis. In long-term surviving animals of group 4 blood analysis was performed 
regularly after the first-stage and second-stage operation, In animals receiving CsA, 
plasma trough levels were determined using a radioimmunoassay for CsA (Cycle-Trac 
SP-Serum/Plasma; Incstar Corporation-Stillwater, Minnesota, USA). 
Assessment of the absorptive capacity, the integrity, and the adaptive status of the small-
intestine was performed in animals of group 2 and in long-term surviving animals in 
group 4, always at the same time interval during five months after surgery. (See Table 1 
for a schematic overview of the expetimenta1 design), 
Table 1 Experimental design of functional assessment of the graft 
Weeks after 
OK 2 Test related to specific functional component of the small intestine 
-6 
-5 
-4 OK 1'" 
-2 
o OK2** 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
Absorption 
Fecal fat excretion 
Fecal fat excretion 
Fecal fat excretion 
Fecal fat excretion 
Fecal fat excretion 
D-xylose absorption 
Fecal fat excretion 
Fecal fat excretion 
D-xylose absorption 
Permeability 
LactuJ.oseImannitol ratio 
LactuJ.ose/mannitol ratio 
Lactuloselmamlitol ratio 
* = sham operationlheterotopic placement of allograft 
** = orthotopic placement of allograft 
Adaptation 
Postheparin DAO release 
Postheparin DAO release 
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D-xylose absorption test. The D-xylose absoIption test was performed 4 and 12 weeks 
after orthotopic grafting. 
Fecal fat excretion. Fat excretion in faeces was determined at 5 (preoperative) and 2 
weeks before and 1, 2, 3, 8 and 11 weeks after orthotopic placement of the graft. 
Lactulose/mannitol excretion test. The lactulose/mannitol excretion ratio assessment was 
performed preoperatively, and 5 and 13 weeks after the orthotopic placement of the graft. 
Dogs were fasted overnight and a specimen of urine (for background sugar 
concentrations) was taken immediately before starting the test. Per kg body weight, 400 
mg D-lactulose and 100 mg D-mannitol were dissolved in 2 ml of water. Following oral 
administration, urine was collected for five hours. After two hours the dogs were allowed 
to drink water freely. The urine samples were stored at -20·C until analysis. Samples 
were analyzed for lacmlose and mannitol content using a gas liquid chromatographic 
method (7). The test results were expressed as the lactulose: mannitol concentration ratio 
measnred in the urine pool five hours after sugar ingestion. 
Postheparin DAO assessment. Food was withheld 12 hours. before performing the test. An 
aroount of 1500 IU Heparin (Thromholiquine, Organon Technica B.V., Boxtel, The 
Netherlands) was dissolved in 5 ml sterile saline, and injected intravenously. Blood 
samples were collected at 0, 15, 30, 60 and 120 minntes after the injection. The DAO 
concentration in plasma was determined as described in detail in chapter 4. The test was 
performed 6 and 14 weeks after orthotopic placement of the graft. 
StaIistics 
All data are expressed as means ± standsrd deviation (SD). Differences of the tested 
pararoeters between groups (weight, fecal fat excretion and area-under-curve calculated 
data of D-xylose absoIption, poS!heparin DAO release, and lactulose/mannitol excretion 
ratios) were anaIyred using Student's t test for two means. Comparisons within a group 
were performed using the paired Student's t test. Signllicance is defined as a p value < 
0.05. 
Resn1ts 
Survival 
Survival data of all animals are given in Table 2. The enterectomized dogs (group 1) had 
a mean survival time of 11.3 days. The sham-operated animals (group 2) survived the 
experimental period without complications. In Table 3, the postoperative course and cause 
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Table 2 Postoperative survival time 
Group 
I. Short bowel control 
II, Sham operation 
ill, SBS + segmental 
allotransplantation 
+ CsA 
IV, SBS + segmental 
allotransplantation 
+ CsA + SDD + early 
gastrostomy feeding 
Survival in days 
10 
10 
14 
throughout experimental period 
throughout experimental period 
throughout experimental period 
1 
53 
14 
48 
24 
11 
throughOUt experimental period 
3 
21 
51 
62 
throughout experimental period 
throughout experimental period 
throughout experimental period 
throughout experimental period 
throughout experimental period 
throughOut experimental period 
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Abbreviations: SSS: short bowel syndrome; CsA: Cyclosporine A 
SDD: selective decoDtamination of the digestive tract 
Table3 The posttransplantation course 
After a twO=Stage segmental allotransplantation without SDD (Group 3) 
Dog Stages Postoperative compli.catU;ns Survival and cause of deP1h 
1 1 venous thrombosis 1 day. venous thrombosis 
2 1 recipient intussusception (day I and 7), ileus 53 days pneumonia 
3 1 transplant intussusception (day 10) 14 days, hemorrltagic o:ansplant 
4 1&2 none 48 days. functional bile congestion 
5 1 none 24 days, rejection 
6 1 heart failure 11 days, multiorgan failure 
7 1&2 transient gastroenteritis and anemia throughout experimental period 
After a two-stage segmental allotransplantation with SDD (Group 4) 
Dog Stages Postoperative complications Survival and cause of death 
I 1 arterial thromho,;,; 3 days, arterial thromho,;,; 
2 1 hypoalb1lIlliIlemia 21 days, pulmonary thromho,;,; 
3 1&2 none 51 days, rejection 
4 1&2 intussusception (autopsy) 62 days, acute peritonitis 
5 1&2 none throughout experimental period 
6 1&2 none throughout experimental period 
7 1&2 none throughout experimental period 
8 1&2 none throughout experimental period 
9 1&2 none throughout experimental period 
10 1&2 none throughout experimental period 
Notes: 
* The survival data given in days after the first-stage operaIion, with the second-stage performed at day 28 
* Dogs 2,3,4,5 and 7 in group 3 developed transient thrombopenia accompanied by a transient anemia 
* Dogs 2.4 and 7 in group 4 developed transient thrombopenia accompanied by a severe anemia 
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of death in group 3 and group 4 (two-stage segruenta! allotransplantation without or with 
SDD) is given. 
In group 3 only one of the seven dogs survived the experimental period. One dog died of 
venous thtombosis (technical complication; 14%). Five of the remaining six dogs had to 
be sacrificed as a resnlt of the postoperative complications (67%). All these dogs bad 
positive blood cnltures, containing gut-derived bacteria like Hemolytic E Coli and 
Staphylococcus aureus, in the early postoperative period. One dog died of pneumonia at 
day 53, one due to transplant intussusception at day 14, one developed a deteriorating 
condition due to functional bile congestion and bad to be sacrificed at day 48, and another 
dog developed mnltiorgan failure at day 10. In only one dog rejection was the causal 
factor of death at day 24. 
In group 4, one dog bad to be sacrificed due to arterial thtombosis (technical 
complication; 10%). The failure rate due to transplantation-related factors was 30%. In 
this group no episodes of bacteraemia were encountered. One dog was sacrificed at the 
21th day due to a deteriorating condition. AUtopsy revealed thrombus formation at the 
pulmonary artet)'. Only one of eight died of rejection 23 days after the otthotopic 
placement of the graft. A third died from acute peritonitis caused by intussusception at 
day 34 after OK2. The remaining six dogs bad no postoperative complications and 
survived the experimental period. 
WeighI 
Group 1 anintals (SBS control) had a dramatic, irreversible weight loss. The animals in 
group 2 (sham operation) showed a nomtal growth pattern compated with non-operated 
historical controls (data supplied by Harlan CPB, Zeist). In Figure lA, the mean weight 
curves and ages of the animals from group 2 and group 4 is given. Throughout the 
experimental period the growth pattern of group 4 anintals was significantly compromised 
(-20%) compated to group 2 animals. 
In Figure 1B the weightcurves of group 4 anintals after CsA treatment was stopped, 200 
days after OK2, are shown. At that time, the dogs did not show significant growth. 
However, after stopping CsA treatment a surprisingly catch up growth was found before 
rejection took place. 
Blood analysis 
The follow-up of blood parameters of group 4 is given in Table 4. Only ammonia levels 
were significantly increased in the long term compated to the preoperative values. 
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Compared to group 2 ammonia levels were also significantly increased in the long term 
(exact data given in chapter 5). Figure 2 gives the CsA plasma trough levels of group 4. 
The levels showed a considerable variation. However, compared to week 2, mean CsA 
levels were significantly increased at week 8 and week 12. 
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Fig.1 A. Weight curves after performing shamoperation In =. 3/ or two-stage segmenral allotransplantation (1'1 = 6). 
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Fig.1 B. Weight curves after CsA trearmenr was stopped if1 group 4 animals. Dog 2 and 6 did not Show rejection before 
sacrifice. 
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Table 4 Blood anal~ nutritional status (mean values ± 50) 
4A: values obtained following heterotopic placement of intestinal graft 
days- -7 0 28 -7 28 
Hb(mmolJl) 7.7±0.5 8.6±1.0 7.6±2.3 Vit B 12(p1D01JI) 274±122 316±83 
1.(10'11) 7.3±1.2 5.7±1.5 9.3±1.7 Folic acid(nmol/l) 29.1±2.1 29.2±3.3 
Na(mOsmolJl) 143.5±1.5 140.8±2.9 141.3±0.7 vit A{Jnnol) 3.45±0.65 3.0l±0.63 
K(mOsmolJl) 4.3±0.6 3.3±0.3 3.8±0.7 vit E{Jnnol) 42.9±8.2 44.6±7.6 
Chol(mmolJl) 4.7±0.9 4.6±O.6 4.7±O.7 Ca(mmolJl) 2.81±0.34 2.78±0.11 
TG(mlIIDlJI) 0.43±0.1l 0.50±0.28 O.43±0.08 Fe{JnnolJl) 15.3±4.5 19.8±17.8 
TP(g/l) 55.2±4.1 51.3±4.1 55.6±4.0 NH,{JnnolJl) 37.5±25.3 43.2±7.8 
A1b(g/l) 27.6±1.5 27.0±4.3 25.4±1.3 
ALAT(Unitsll)* 33.9±13.6 49.6±23.3 52.6±50.5 
ASAT(Units/l)* 26.7±7.1 36.0±9.8 29.5±6.8 
AF(Units/l)* 118.2±10.6 118.9±36.2 79.5±19.4 
Creat{JnnolJl) 55±12 55±9 59±7 
BUN(mmol) 5.5±1.6 3.0±0.6 4.2±1.6 
TBlL{janolJl) 2.2±1.l 1.3±1.3 2.0±1.5 
NAG (lUll) 3.6+0.7 3.5±2.4 5.6±5.3 
4:8: values obtained following orthotopic placement of intestinal graft: 
days- 6 34 69 HZ 112 
Hb(mmolJl) 7.6±1.l 7.9±1.2 8.8±0.6 8.9±1.0 vit B 12(p1D01JI) 233±33 
1.(10'11) IO.7±IO.O 7.4±3.1 6.6±2.9 3.9±O.3 Folic 3cid(mnolJl) 28.7±3.8 
Na(mOsmolJl) 141.3±1.9 143.3±2.2 142.9±2.1 143.4±1.2 vit A{Jnnol) 3.19±0.39 
K(mOsmolll) 3.95±O.26 4.20±O.19 4.22±0.18 4.21±O.22 vit E{Jnnol) 52.6±lO.2 
Chol(mmolJl) 4.55±O.66 4.73±0.56 4.75±0.96 5.13±O.96 Ca(=IJI) 2.76±O.07 
TG(mmolJl) O.46±O.06 O.48±O.14 O.44±0.15 O.44±O.O7 Fe{JonolJl) 13.8±3.7 
TP(gIl) 54.8±7.9 61.4±3.9 61.5±3.7 61.1±3.0 NH,{JnnolJl) 123±19.1** 
A1b(GIL) 22.3±2.4 25.7±2.7 25.7±3.2 25.3±2.7 
ALAT(Units/l)* 30.5±lO.1 31.8±13.2 37.3±12.4 32.1±3.7 
ASAT(Unitsll)* 24.5±8.2 30.7±5.9 31.3±10.7 28.8±5.8 
AF(unitsll)* 68.4±16.8 61.7±10.3 54.1±12.7 51.5±9.5 
Creat{Jnnolll) 51±8 6O±8 77±10 70±1l 
BUN(mmol) 4.4±0.8 5.7±O.9 6.6±O.6 S.9±O.7 
TBlL{janolJl) 1.8±1.2 3.0±2.4 2.9±1.l 2.6±1.l 
NAG (lUll) 6.7±4.5 7.7±8.2 13.9+5.7 !3.6±4.9 
* assayed at 37"C 
** p<O.OS versus preoperative values in the same group 
Abbreviations used: Rh. hemoglobin; L. leukocyteS; Na. sodium; K. potassium.; Chol. cholesterol; TG. 
triglyceride; TP. total protein; Alb. albumm; ALAT, alanine aminotransferase; ASAT. aspartate 
aminotransferase; AF, alkaline phosphatase; Creal. creatinine; BUN. blood urea nitrogen; -mIT.. total 
bilinoin; NAG. N-Acetyl Hexosaminidase 
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Fig.2- CycJospodne bloodleveJs following two-stage segmental aHotranspJantation 
D-xy/ose absorption testing 
D-xylose absorption test results of group 2 and group 4 are depicted in Figure 3A. Area-
1lllder-curve calculations revealed that D-xylose absorption is similar for both test groups 
at 4 and 12 weeks. 
Fecalfat analysis 
Fecal fat excretion was significantly higher in group 4 compared to group 2 from week 3 
after the orthotopic positioning of the segmental graft (Figure 3B). 
Lactu1ase!mannitol absorption testing 
In the alIotransplanted grouP. the mean lactulose/mannitol excretion ratio Increased 
significantly from O.04±O.03 preoperatively up to O.08±O.06 and O.1l±O.07 at week 5 
and 13 after the orthotopic placemem of the graft (Figure 3C). 
Postheparin DAO assessment 
Postbeparin DAO release was significantly increased at week 6 after orthotopic 
positioning of the segmental graft compared with sbam-operated dogs of the same age 
(Figure 3D). Fonrteen weeks after orthotopic placement, postbeparin DAO release did not 
differ significantly between the groups. 
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Fig_3. Functional evaluation after performing shamoperation (n=3J or two-stage segmenralallorransplanration (n= 6). 
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Discussion 
The postoperative course of human SBT is often complicated by infectious episodes, 
which are associated with fungal andlor bacterial translocation (8). In 
immunocomprontised patients, disturbance of the ecologic equilibrium in the 
gastrointestinal tract can lead to bacterial overgrowth, which in tum results in septicentia, 
a major postoperative complication (9,10). When performing intestinal transplantation, 
susceptibility to sepsis increases due to surgery-related changes in the small intestine, i.e. 
ischentic injury, Iymphatic- and neural disruption, altered motility and systentic venous 
drainage (11,12). Compared to adults, children have an increased risk of developing 
infectious complications because they have still an innnature immune system and often 
lack previous exposure to antigen. 
Previous work in adult dogs showed that DLA-matched segmental allotransplantation 
resulted in long-term survivors without the need of SDD (3). In the present study, we 
found that young recipients have indeed increased susceptibility to develop posttransplant 
infections that were associated with bacterial translocation into the blood of 
enterobacteriaceae and staphylococcus aureus, species that translocate more easily through 
a leaky intestine. The institution of enteral feeding may iDfIuence the postoperative course 
positively since immediate postoperative enteral feeding is known to decrease the translo-
cation of bacteria, to reduce the hypermetabolic response to stress, and to enhance the 
immunocompetence (13,14). 
A comparison of the survival data of group 3 and group 4 revealed that SDD together 
with early institution of enteral nutrition led to a lower mortality rate without infectious 
complications and bacterial translocation. The low rejection rate is a surprising finding as 
it has been suggested that younger transplant-recipients are at higher risk for graft 
rejection (2), and it thus implicates that MHC-matching is also a promising avenue in 
young recipients of a SB graft. In group 3 as well as in group 4 transient thrombopenia 
was encountered in a number of dogs. We have speculated already (chapter 6) that the 
transient thrombopenia is a subelinical feature of GVHD, which may imply that MHC-
matching does not protect from GVHD. 
This study demonstrates that near-total SB resection in growing dogs leads to the short 
bowel syndrome, which becomes lethal after 10-14 days. Emerectomised dogs who had a 
segmental jejunal allograft were able to get away from the symptoms of the surgically 
created syndrome. Although others (15) had already demonstrated that weight gain after 
segmental allografting is possible, no comparison with sham-operated control animals has 
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been made so far. In our study, long-term surviving dogs increased in weigbt but their 
growth was compromised during the entire experimental period compared to sbarn-
operated animals. 
The weight curve shows that, following segmental aIIografting, the weigbt gain was only 
compromised in the early postoperative phase whereafter the growth remained srunted 
thougbout the experimental period as no catch up growth was found. In our opinion, the 
dogs were probably stiU suffering from under-nourishment in the early postoperative 
phase. This finding may imply that if TPN is administeted in the critical postoperative 
phase, normal growth after segmental aIIografting under esA is possible. 
The weigbtdata after esA treannent was stopped indicate that the esA regimen is a major 
factor in the absence of catch up growth following segmental grafting. 
Blood analysis showed that serum parameters of group 4 animals were comparable to 
group 2 animals, which indicates that a segmental SB graft is able to maintain an adequate 
conditional status of the host. The elevated serum ammonia levels in group 4 animals are 
most probably due to the caval shunting of the mesenteric vessels, a phenomenon already 
found in autotransplanted'dogs (chapter 5). 
Fujiwara et aI (16) studied esA absorption in chronically surviving aIIotransplanted 
mongrel dogs. They found that during the early postoperative period esA absorption was 
unpredictable and highly variable. To assure adequate plasma esA levels, the animals 
were given esA imramuscn!arly during the first postoperative week. We found that an 
oral dose of 30 mg/kg/day CsA was sufficient to prevent rejection in adnlt DLA-matched 
dogs (3). However, most dogs suffeted from commonly known esA side-effects (17,18). 
This study shows that 20 mgikg BW esA given orally, resnlting in relative low plasma 
esA levels, in combination with DLA-matching was sufficient to prevent graft rejection 
without encountering esA-related. side-effects. 
No impaired D-xylose absorption was noted in the aIIotransplanted dogs. A1thougb the 
xylose absorption test has been widely used to study the absorptive capacity of the small 
intestine (19), it may have limited value owing to variation in renal function and 
gsstroiotestinal transit time, parameters that affect excretion of oral xylose (20,21). 
Moreover, snbtle changes in intestinal permeability are not detected with D-xylose, as it 
is actively absorbed (22). Nevertheless, we included this test as a reference point of the 
literature with respect to functional evaluation of a SB graft. 
Analysis of fecal fat excretion revealed that excretion of animals that had received an 
orthotopic allotransplant was significantly increased from day 21 on. These values, 
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however are still within the normal fat excretion range. Because our control dogs did not 
receive CsA, a drug that can induce decreased fat absorption by itself (23), we conclude 
that the transplanted segment of ileum functions sufficiently to majntain at least near 
normal fat absorption. 
In addition, we included the Iactulose-mannitol absorption test, a test being independent of 
the amount of urinary excretion. Lactulose. a disaccharide, is absorbed via the 
paracellular route and the amount excreted is a reliable index of mucosal leakiness. On 
the contrary, mannitol, a monosaccharide, is absorbed by the transcellular route and thus 
reflectS mucosal surface area. The increased lactulose/mannitol ratio found in the 
alIotransplanted dogs shows that subtle changes in intestinal permeability, not apparent 
with D-xylose, are present at both 29 and 85 days after orthotopic transplantation. Andre 
et al (24) made a direct comparison between the lactulose-mannitol ratio and SlCr EDTA 
test, another permeability test, in inflammatoty bowel diseases. They concluded that the 
combination of these tests provides increased sensitivity and might therefore be useful to 
monitor SB transplant recipients on alterations in mucosal architecture. 
DAO is an enzyme, being unique in that its blood levels correlate positively with the 
imegrity of the intestinal mucosa (25). The intestinal content is known to be released into 
the blood upon stimulation by intravenously injected heparin (26). In case of intestinal 
mucosal damage, like SB atrophy, a lower plasma release of DAO was found (25,27). 
Rose et al (28) have shown that postheparin serum DAO is not significantly affected by 
autotransplantation and systemic drainage, suggesting that it may serve as a potential 
indicator of the condition of the transplanted intestine. In the present study, the area-
under-curve values of the heparin stimulation curve of alIotransplanted animals is 
significantly increased at 43 days following orthotopiC grafting compared to sham-
operated control animals. No such elevated value was found 99 days after orthotopic 
grafting. The temporary rise in intestinal DAO activity can be explained by hypothesizing 
that the segmental graft demonstrates an adaptive response to overcome the effectS of 
shorteniug its length. This hypothesis is supported by results of Rokkas et al (29), 
suggesting that DAO is an important regulator of intestinal mucosal growth. 
In conclusion, this study shows that a two-stage segmental allotransplantation in 
combination with SDD and early gastrostomy feeding is able to prevent the symptoms of 
the surgically created shon bowel syndrome. However. although it is able to maintajn an 
adequate nutritional status, a segmental graft under CsA regimen is unable to maintajn the 
normal growth panem without specific nutritional interference in the critical postoperative 
phase. 
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INTRODUCTION 
Diamine oxidase (DAO), catabolizing a variety of substrates including histamine and 
diamines, is the degradative enzyme of the catabolic pathway of polyamines. To 
understand the relevance of DAO it is necessaty to have knowledge of polyamine 
metabolism and the physiologic functions in which polyamines ate implicated. Until 
recently, polyamines were considered as metabolic end products, having no physiologic 
significance. Tbe first account indicating that polyamine reputation should be changed 
dates back to some pioneering studies in the early sixties (1,2). By then, it was proposed 
that polyamines are a prerequisite for vita! processes of cell proliferation. Consequently, 
intetest in polyamine research increased and considerable progress has now been made in 
studying the mechanisms underlying the physiologic implications of polyamines. 
Catabolism of polyamines is due to reactivity with or' -dependent amine oxidases, of 
which only diamine oxidase has been well defined. Altered DAO levels have been found 
in some pathologic states suggesting a role in either etiology or symptomatology. 
1 FUNCTIONAL IMPLICATIONS OF POLYAMINE METABOLISM 
1.1 Pathways of polyamine metaholism 
Polyamines, such as putrescine, spermidine, spermine and homologues or analogues of 
these derivates tend to be conserved during the evolution from prokaryotes to vertebrates. 
Such conservation implies an importaot physiologic function, which is confirmed by a 
variety of recent reports (3,4,5). By now, the polyamine metabolism, $lepicted in Figure 
1, has been elucidated and this has led to an accepted set of theories descnbing how this 
metabolic pathway is directly related to physiology (3,4,5), clinical medicine (6,7) and 
pharmacology. in vertebrates, polyamines ate metabolized along two major pathways; the 
imerconversion pathway and the scrcalled terminal polyamine catabolism. Arginine, an 
essential amino acid~ is converted into ornithine, which in tum is converted into the 
polyamine putrescine by ornithine decarboxylase (ODC; EC 4.1.1.17). Polyamine 
turnover is sensitively regnlated by the imerconversion pathway; spermidine symhase 
forms spermidine from putrescine and spermine is synthesized from spermidine by 
spermine synthase. These reactions involve the donation of aminopropyl residues from 
decarboxy-S-adenosylmethionine, which is formed by a potential rate limiting enzyme S-
adenosylmethionine decarboxylase (SAM-DC; EC 4.1.1.50), to the appropriate 
polyamines. Reversely, according to physiologic requirements, spermidine can be formed 
from spermine and putrescine from spermidine by an acetylation in the N' position, 
completed by acetyl eoA: spermidine/spermine N'-acetyl transferase (cytosolic; 
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Fig.1. Schematic view of polyamine metabolism and lhe way of which polyamines are implicated in cell division and 
growth. 
Enzymes: (1) arginase; (2) ornithine decarboxylase (ODC); (3) 5-adenosylmethionine decarboxylase (SAM·DC): (4) 
spermidine synthase; (5) spermine synthase; (6) 5'.methylthioadenosine (MTA) phosphorylase; (7) acetyl CoA:polyamine 
N'-acetyltransferase (Cytosolic; cSAT); (8) acetyl CoA:spermidine N8·acetyltransferase (nuclear; nSAT); 19} polyamine 
oxidase (FAD·dependent); (10) diamine oxidase (DAO}. 
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cSAl) and subsequent oxidative splitting performed by FAD-dependent polyamIDe 
oxidases. Re-utilization of spermidine and putrescine makes this a cyclic process, which is 
controlled by enzymes that provide sensitive metabolic regulation. Two basic 
requirements of the key enzymes, ODC, SAM-DC and cSAT are higb inducibility and a 
short half-life time. Mechanisms that may improve sensitivity of an enzyme are known as 
multiplicity of regulators, co-operativity, substrate cycles and interCOnversion cycles (8). 
In general, ODC is usually the rate lintiting enzyme (9), having the shortest in vivo half-
life of any enzyme yet studied, but under certain circumstances SAM-DC and cSAT may 
also become rate lintiting. Each imennediate of the interconversion cycle is degraded into 
an aldehyde, if serving as substrate of a copper-containing amine oxidase, like serum 
amine oxidase and diamine oxidase (DAO; EC 1.4.3.6). 
1.2 The role of polyamines in perireplicative events 
Polyamines may play an essential role in a variety of biological processes. 
Growth processes are mainly controlled by polyamine concentrations (10,11), as one of 
the prerequisites for cell proliferation is the enhanced syothesls of polyamines when 
entering the Gl phase, at the time of initiation of DNA syothesis and prior to cell 
division. This phase-specific rise in polyamine demand is reflected by an increase of ODC 
activity, usually the rate lintiting enzyme in polyamine syothesis. More specific, it is 
evident from studies in cells partially depleted of polyamine (12,13) that DNA, RNA and 
protein syothesis are the prereplicative events regulated, at least in part. by these cations. 
Many investigators have attempted to elucidate involvement of the polyamines in these 
processes. In severa! studies using polyamIDe depleted cells, it was found that the 
interference with DNA synthesis was the result of a decrease in DNA chain initiation 
rather than reduoed DNA chain elongation (14,15). The results of Geiger and Morris 
(16,17), however, suggest that polyamine deficiency results in markedly reduced rate of 
DNA replication fork movement and not in a decreased initiation frequency. The relative 
importance of polyamines for RNA syothesis remains elusive a1thougb in vitro data 
suggest a role in the regulation of almost every step of the synthesis and degradation of 
RNA (18). Moreover, polyamines have been implicated in the stimulation of mRNA 
transcription and translation, some molecular events of protein syothesis (19). In genera!, 
DNA syothesis is the cell event mostly affected by polyamine deprivation. In cell 
division, the posrreplicative event, physiologic concentrations of polYamIDes interact with 
polymerization and transformation of actin tIlaments (20). 
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1.3 The degradative enzyme of the polyamine metabolism 
It is clear that rapidly proliferating cells, including bone marrow-~ intestinal mucosal- and 
tumor cells have a high requirement for polyamines. 
Nonnally, terminal polyamine catabolism does not participate in the regulation of cellular 
polyamine levels, although copper-containing amine oxidases are present in a wide variety 
of tissues. DAO starts functioning in a regulating manner in rapidly proliferating tissues~ 
as it is produced in particularly high amounts. Moreover, under certain pathophysiologic 
circumstances elevated DAO levels are found, which cae be either a causal factor or a 
disease-related effect. Apart from its role in the polyamine pathway, DAO also catalyzes 
the deamination of histamine and even plays a major role in histamine degradation in 
some anintal species (21). 
2 HISTORl:CAL BACKGROUND 
Since its discovety in 1929 the histamine-inactivating capacity of diamine oxidase, by then 
called histaminase by Best (21), was known. It was renamed by Zeller in 1938 (22), 
because the enzyme also deaminated several diamines, including putrescine, cadaverine 
and agmatine. These two names were used synonymOUSly, until the enzyme was proposed 
to be called DAO, as it was shown that putrescine and cadaverine are preferentially 
deaminated by the enzyme. So far, DAO has been purified and characterized from 
various sources (Table 1). 
Table 1 Purification and characterization of DAO 
Tissue 
Kidney 
P1at:ema 
Amniotic fluid 
Pregnancy plasma 
Socrce 
horse 
pig 
human 
h= 
human 
human 
Molecular mass (M) 
not determined 
185,000 
not determined 
90,000-120,000 
245,000 (DAO-A; dimer) 
485,000 (DAO-B; tetramer) 
245,000 (DAO-A; dimer) 
485,000 (DAO-B; tetr:mler) 
References 
23 
24 
25 
26,27 
28,29 
26,29 
Several studies have been performed on the biochemical properties of DAO from different 
species. It appeared that multiple forms of DAO exist (29), probably varying in stability 
and in kinetic properties. The differences observed are probably species-dependem but 
storage and experimental conditions may also differently influence the biochemical 
properties of DAO obtained from various sources (30), 
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3 BIOCHEMIC ASPECTS 
3.1 DAO assays 
There is a variety of methods to detect DAO activity due to the multiplicity of substrates 
and reaction products. Table 2 gives a summation of used substrates and reaction 
products. The numerous assays described differ in specificity, sensitivity, rapidity and 
simplicity. As normal DAO activity in plasma is in the low detecting range, a method 
with a high sensitivity and simplicity is preferred. The most commonly used method for 
in virro measurement of DAO activity is the 14C-putrescine assay. This isotope assay is 
based on spontaneous nonenzymatic cyclization of 'Y-antinobutyraldehyde, the product of 
DAO catalyzed degradation, to "'l-Pyrroline or its polymers. 
TableZ DAO detection methods 
Substrate Assay Determination of References 
Histamine biolopcal residual ileal histamine 31.32 
blood pressure changes 21 
fluorometric 33 
polarographic 33 
spectrophotometric DNFB-residual histamine 34 
manometric O2 consumption 35 
spectrophotometric O2 consumption 36 
Cadaverine spectrophotometric :aldehyde formation 37 
vacuum distill.ation ammonia formation 22 
diffusion analysis ammonia formation 38 
colorimetric decolorization time 39 
colorimetric residual dye 40 
titration colorization KMn04 41 
spectrophotometric O-dianisicline complex 42 
spectrophotometric ammonia h"berated 43 
Putrescine spectrophotometric aldehyde formation 37 
vacuum distillation ammonia formation 22 
diffusion analysis ammonia formation 38 
colorimetric decolorization time 39 
colorimetric residual dye 40 
titration colorization KMn04 41 
spectrophotometric O-dianisidine complex 42 
spectrophotometric .ammonia liberated 43 
Hexamethylenedi.amiD.e spectrophotometric aldehyde formation 37 
vacuum. distillation ammonia formation 22 
diffusion analysis ammonia formation 38 
colorimetric decolorization time 39 
colorimetric residual dye 40 
titration colorization KMn04 41 
spectrophotometric O-dianisidine complex 42 
spectrOphotometric ammonia hlx:rated 43 
14C Putrescine radiochemical ""l-Pynoline formation 44 
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Since putrescine and ~cpyrroline have a differential solubility, DAO actIVity can be 
measured by counting radioactivity of A,-pyrroline extracted from the aqueous into the 
organic phase. 
3.2 DAO inhlbitors 
Some attention has been paid to the inhibition of diantine oxidase activity by several 
specific blockers. Sattler et al (45) tested over 300 drugs on inhibitory potencies with 
human and canine DAO in vitrO. The underlying thougbt was that in intensive care units, 
in patients producing elevated bistantine levels (e.g. in case of shock, polytrauma), 
unwanted clinical side-effects could be elicited by drugs inhibiting DAO. It was 
previously believed that blocking intestinal DAO would be swamped by the immense 
enzyme amounts present (46). However, recent studies showed that inhibition with 
antinoguanidine reduces the intestinal DAO activity to unmeasurable levels (47). 
4 FUNCTIONAL ASPECTS 
4.1 Role of DAO in mucosal growth regulation 
Proliferation of cells in the gastrOintestinal tract is controlled by multiple substances 
including hormones (glucocorticoids, thyroxine, insulin) and growth factors (epidermal 
growth factor). Additionally, it has been proposed that cell proliferation in gut mucosa 
depends on the supply of polyantines reaching the progenitor cells, regardless of the 
original trophic stimulus (48). It has been documented in several :;tudies that ODC 
probably plays a key role in regulating mucosal growth by regulating polyamine levels. 
To study the relative role of ODe and DAO in regulating mucosal growth, their activities 
were measured in epithelial cells after small bowel resection in rats. Dowling described 
that it was suspected that during the adaptive response the mucosal DAO activity would 
drop to permit andlor facilitate intestinal growth (49). However, results from several 
studies demonstrated that not ouly ODe activity rises during adaptive hyperplasia, but 
that DAO activity as well rises parallel to ODe (50). The speculative actions of ODe and 
DAO in the mucosal-growth-regulation process is outlined in Figure 2. 
ODe reacts to a variety of trophic stimuli' (for the gut mucosa) with immediately 
increased activity. The increased enzyme activity causes an increase in polyamine content 
and a subsequent increased cell proliferation activity. Proliferation-associated increases in 
DAO activity, mainly found in the villus tip of the mucosa, suggest that DAO acts as a 
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Fig.2. Schematic outline of speculative role of ODe and DAD in mucosal growth regulation. 
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brake inlnl>iting crypt cell production by regulating putrescine content or by the 
production of undefined active metabolites. Moreover, in resected rats treatment with 
aminoguanidine not only abolished DAO activity but in rum stimulated adaptive intestinal 
mucosal growth. This observation suggests that following extensive resection the 
structural and functional adaptive response of the remaining intestine may be enhanced by 
blocking of DAO activity. The stimulated response may lead to sigoificant reduction of 
the resultant malabsorption seen in patients after massive sutall-bowel resection. The basic 
questions that remain to be answered are: is aminoguanidine induced intestinal adaptation 
transient or sustained ?; does the adaptive response after tempoIaty aminoguanidine 
treatment revert to its non-enhanced state ?; is the effect of aminoguanidine dose-
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dependent ? No clinical consequences have been described in healthy controls ar",r 
administration of strong inhibitors of DAO no clinical consequences have been described 
(51). So the clinical use of efforts to block DAO in patients after massive bowel loss 
might become reality although negative side effects in unhealthy Slate should not be 
underestimated. 
4.2 Postheparin DAO release 
In healthy Slate very low basal values of plasma DAO are detected (52). The enzyme is 
unique in that its plasma levels appear to correlate positively with the maturity and 
integrity of the inrestinal mucosa. For example, lowered enzymatic activity is found in 
plasma of patients with inresti:naI mucosal atrophy, indicating that normal plasma DAO is 
primarily inrestinal-derived (53). At present, the potential value of DAO as an index of 
intestinal disease is widely investigated. Some recent studies suggest that measuring serum. 
DAO activity is more suitable in the follow-up of enteropathies than as a screening test, 
due to the large biological variations in serum values obtained (54). DAO is maillly 
synthesized by mature villus cells, with about 60% preseD! in the organelles and the rest 
free in the cyrosolic compartment. In the majority of studies it has been hypothesized that 
after synthesis DAO is translocated to heparin-sensitive binding sites in the capillaries of 
the lantina propria (55). Such location may involve the prevention of polyantine crossing 
from the intestine into the clrculation. Recent immunofluorescence studies revealed that 
the base of the villus cells, and not the endothelial binding sires, represents the primary 
storage compartment in the intestine (56). DAO is most probably released through the 
secretory pathway at the basolateral membrane, induced by heparin or other highly 
negatively charged molecules. DAO linked to organelles is released only when the 
cytosolic compartment has been depleted. Upon its release, DAO is translocated to 
endothelial binding sires, already depleted by heparin stimulation, and subsequently 
released into the circulation. It is generally assumed that, following heparin stimulation. 
plasma DAO levels rise markedly and that the intestine is the major (or sole) source of 
such increase (57). It is thought that this provocative plasma postbeparin DAO 
measurement enhances the sensitivity of using DAO to monitor mucosal maturation and 
integrity. Further studies on the application of such a Don-invasive rest for deterntining its 
usefulness are now warranted. 
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4.3 Relevance of DAO in pathologic states 
The association of DAO activity with a number of pathophysiologic states is often 
hypothesized upon. Although altered DAO activities bave been found in a number of 
pathologic situations (Table 3), the precise role retuains speculative. Continued 
exploration on the metabolic role of DAO might provide clues to the functioning of the 
enzyme in normal and diseased states. Moreover, the investigations on the diagnostic 
value of DAO in clinical evalustion of certain diseases may provide a sensitive tool for 
monitoring. 
The placenta is proposed to be the source of elevated DAO activity in serum during 
pregnancy. Normally, DAO is thought to bave a barrier function in the placenta by 
preventing harmful histamine/polyamine crossing into the maternal cin:ulation. 
Experimental findings suggest a positive correlation between placental DAO and the 
vitamin B6 status in pregnant women. In addition, the value of measuring serum DAO 
activity in cases of pregnancy toxemia and threatened abortion, being markedly reduced 
by then, is identified by an increasing number of reports (58,59). 
Elevated DAO activity in neoplastic disorders has been observed in cases of endometrial 
adenocarcinoma, granulosa cell carcinoma, myosarcoma of the uterus, medullary 
carcinoma of the thyroid gland, in smaIl-ce1l carcinoma of the lung, and in stomach and 
colon carcinoma (60). Immunohistochemical studies bave COnflIIIled that some cell types 
in these nnnors are the source of the DAO in the cin:ulation. However, several studies 
bave shown that circulating DAO activity is no reliable diagnostic marker, probably due 
to variability of its release from the tumor. Whether the increased' DAO activity in 
neoplastic cells has a link to tumor cell development retuains to be determined. 
Lumina! histamine-induced histaminosis is a general name for allergic-like reactions that 
may occur after fond induced histaminosis under DAO blockade. DAO inhibition is 
known to accentuate allergic responses, suggesting a regulating role of DAO in the 
pathophysiologic reactions involving histamine release (61). 
Consistendy elevated polyamine levels have been described in cystic fibrosis. No 
abnormalities in polyamine catabolism bave been revealed in this disease, although 
abnormally bigh circulating DAO activity is found in about 30% of the patients. More 
investigations are needed to resolve the role of DAO in some of the clinical 
manifestations seen in this disease (62). 
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Table 3 Pathopbysiologic states associated with altered DAO activity 
State Alteration postulated role in healthy References 
Pregnancy toxemia .j. serum DAO levels barrier function; 58,59 
Abortion preventing histamine/polyamine 
crossing 
Neoplasia t inttacarcinoma DAO level unclarified 60 
subsequent f circulating DAO 
Allergic response DAO-blockade regulaIor of histamine 61 
release 
Cystic fibrosis f t serum DAO activity unclarified 62 
Infertility f t DAO activity in semen uncl3rified 63 
Uremia .j. .j. Kidney & Urine DAO protecting from 63 
t plasma DAO nephrotoxicity 
Bowel ischemia , plasma DAO levels protecting the bowel 60,64 
following decreased from toxic effects 
tissue activity 
Recent studies have shown a negative correlation between DAO aC1lvlty and sperm 
motility, and thus fertility, Adding aminoguanidine to the ejaculate might offer new 
therapeutic modalities to improve fertility is some cases of male infertility (63), 
In uremia, polyamines are retained and may play a role in certain secondary 
complications, including infection and anemia, In uremic patients elevated serum DAO 
levels have been detected in combination with decreased urinary and }<idney DAO, Such 
DAO levels may implicate removal of toxic polyamines in plasma and inhibition of toxic 
aldehyde formation in the kidneys (63), 
Several investigators have described imeraction of DAO with ischentic states of the 
bowel, Mucosal DAO activity, being the major source of tissue DAO (>90%), shows an 
increasing proximal-to-distal gradient, decreasing to low levels in the colon. The enzyme 
is primarily synthesized and located in the villus absorptive cells of the gastrointestinal 
tract. Since villus tip cells are most sensitive to ischemia, decreased tissue DAO activity 
and subsequent increased circulating plasma levels of DAO have been found due to its 
luminal release aod uptake in the blood, Measuriog DAO activity could therefore provide 
a marker of intestinal injury, Moreover, it has been postulated that DAO has a role in 
protecting the bowel from toxic effects following increased histamine concentrations 
observed in intestinal ischemia (64), 
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8.2 SERUM DIAMINE OXIDASE HAS NO PROGNOSTIC VALUE IN ACUTE 
SMALL-BOWEL REJECTION IN RATS 
Abstract 
Rejection of imesti.naI allografts is still a major problem lrindering clinical transplantation. 
A serum marker that could detect rejection at an early stage would be of great help in 
adjusting immunosuppressive protocols. The enzyme diantine oxidase is mainly produced 
by mature enterocyteS and a correlation exist between imesti.naI and serum diantine 
oxidase activity. 
To study the value of diantine oxidase as marker of acute rejection fully allogeneic total 
orthotopic small-bowel transplantation was perfOIllled in rats using the W AG-to-BN donor 
host combination (group 2; daily serum diantine oxidase deteIl!lination until rejection, 
n=9). Syngeneically transplanted WAG rats served as control (group I; daily serum 
diantine oxidase deteIl!lination until day 16, n=6). AnintaIs in group I survived 
indefinitely and anintals in group 2 ilied of rejection between 10 and 18 days. In both 
group 1 and 2 a fluctuating serum diantine oxidase pattern with time was found. Basal 
serum diantine oxidase level was significandy decreased' in allogeneic animals corupared 
to syngeneic controls at day 13, 14 and 16. At that time, however extensive mucosal 
slouglring had already taken place. Studying aIlotransplanted animals inilividually, no 
prognostic diantine oxidase change, inilicating onset of rejection, could be revealed. 
These data inilicate that the small-bowel transplantation procedure itself is responsible for 
fluctuating serum diantine oxidase levels in the first two weeks postoperatively and that 
monitoring serum diamine oxidase has no value in early detection of acute small-bowel 
rejection. Whether the prognostic character of diantine oxidase is suppressed by early 
transplantation-related factors should be investigated in a chronic rejection model 
following small-bowel transplantation. 
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Introduction 
A maior obstacle to clinical small-bowel transplantation (SBT) is the vigorous rejection 
elicited by the graft (1-3). In order to treat this rejection optimally, monitoring of this 
process is of utmost importance. An early and reliable index of rejection would allow for 
institution of anti-rejection therapy before the graft is irreversibly damaged. 
Histologic analysis is the "gold standard" for reliable detection of small-bowel (SB) 
allograft rejection. This method, however, has several shortcomings: biopsies require the 
presence of an enterostomy; full-thickness slides, which bear the risk of graft perforation, 
are mandatory to accurately predict early onset of rejection; and multiple biopsies must be 
taken to avoid sampling error because of the patchy distribution of the rejection process in 
the graft (4,5). 
Another approach of monitoring of rejection is to study functional absorption of agentS 
like cyclosporin anti maltose (6,7}. These methods suffer from considerable variability 
and have proven unreliable. With time more sensitive tests, based on absorption or 
permeability, have been developed. The use of such methods is still cumbersome in that 
they require oral administration of the test-solution and/or blood sampling at several time 
points (8,9). Recently, Meijssen el aI developed a non-invasive method to assess 
electrophysiologic parameters in an enterostomy (10). It was found that electrophysiologic 
parameters correlate with histologic alterations of acute rejection but dismiss the 
disadvantages of histologic monitoring. 
Contrary to some other types of organ transplantation (11) a simple serum marker, which 
reflects functional deterioration of the mucosa, is still unavailable. N-
Acety1hexQsam jn ad ase (12,13), procoaguIant activator (14) and nitric oxide (15) have 
recently been shown to have some value as markers of early SB rejection. 
Another potential serum marker for early detection of SBT rejection is the enzyme 
diamine oxidase (DAO), which degrades polyamines (essential substances for cell growth) 
anti is a key regulator of cell proliferation in the intestine (16). About 95% of tissue DAO 
activity is found in the intestine, primarily located in the mature mucosal cells of the 
villus tip (17}. Cell division is a major regulator in up-regulating imestinal DAO activity, 
whereas DAO in turn down-regulates mucosal growth by polyamine degradation and 
suppresses cell division via active metabolites (18). 
A positive correlation exists between DAO activity in mucosal extracts and serum, with 
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decreasing activities found in case of intestinal injury (19). Intestinal rejection is a fonn 
of imestinaI injury, starting with crypt necrosis followed by mucosal sloughing, and could 
conceivably be associated with cbanges in basal DAO activity. The aim of the present 
srudy was therefore to determine the usefulness of monitoting basal serum DAO levels as 
a marker for early detection of acute SB allograft rejection in rats. 
Materials and methods 
Small-bowel transplantation 
SBT was done as described previously (20). In brief, a one-step total otthotopic SBT was 
perfonned. The donor's SB was harvested from the ligament of Treitz to the terminal 
ileunt, along with the attached vascnlar pedicles consisting of the superior mesenteric 
artery and the portal vein. End-te-side anastomoses were perfonned between the recipient 
aorta and donor superior mesenteric artery, and recipient inferior caval vein and donor 
portal vein, respectively, whereafter the recipient's own SB was resected. Gastroimestinal 
continuity was restored by end-to-end anastomosis of the graft, proximally with the host's 
duodenum and distally with the remaining 1-2 em of terminal ileum. 
Experimenzal groups 
Group 1: Syngeneic SBT using WAG rats (n=6). Blood was collected daily from day 0 
(preoperative value) until day 16 postuperatively. 
Group 2: Allogeneic SBT using BN rats as donors and WAG rats as recipients (n=9). 
Blood was collected from the day of transplantation (preoperative value) until the day the 
animals were sacrificed because of their deteriorating condition. Time of rejection was 
defined as the day on which animals were sacrificed after macroscopic confirmation of 
end-stage rejection., which was proved by histologic examination. 
For determination of basal DAO activity 
One mI of blood was collected via the tail vein. Serum was stored at -7rf'C. DAO activity 
was measured as described by Romijn et al (21). In brief, 200 f'I serum was incubated 
with 100 f'I cbloral hydrate, 2100 f'I 0.1 M phosphate buffer (PH 7.0) and 100 ILl of 
substrate solution (''C-Iabeled putrescine) for 2 hours at 37'C. The reaction was stopped 
by addition of 200 f'I of a 10 mM solution of aminoguanidine in 2 % sodium-carbonate. 
The reaction product, ''C-A '-pyrroline was extracted into 4 mI toluene-based scintillation 
f1nid and the radioactivity present was measured using a liquid scimillation analyzer 
(packard, Tricarb 2500 TR, Packard Instrument Company Inc, Downers Grove, USA). 
DAO activity was expressed as Unitslml with one Unit defined as nmol of''C-A'-pyrroline 
fonned per hour. 
160 Chapter 8 
Statistics 
The results are expressed as means ± SD and the significance of differences among the 
groups on postoperative days was tested using Student's nonpaired t test after taking the 
logarithm of the individual data with P ,;; 0.05 considered significant. The prognostic 
value of DAO for SBT rejection was evaluated using a non-parametric graphical 
representation of the relationship between rejection and the occurrence of DAO level 
changes (22) and a Basic computer program developed by Hop et al (23). 
Results 
Survival 
All syngeneic rats survived indefinitely. Rats with allogeneic SB graft in group 2 had a 
mean survival time of 14.3 ± 3.1 days. Two rats (no 1 and 5 see Table IB) showed 
transient grade 1 graft-versus-host disease characterized by light redness of ears, snout 
and paws (24). 
Diamine oxidase activity 
The individual basal DAO levels on postoperative days following syngeneic and 
allogeneic SBT are given in Table IA and IB respectively. Fignre I sbows the mean 
DAO serum level of DAO activity over time following the operation. Basal DAO level 
was significan!ly lowered in alIogeneically transplanted animals compared to syngeneically 
transplanted animals on postoperative days 13, 14 and 16. Fignre 2 shows a graph to 
visualize the possible prognostic character of DAO in rats 1 and 2, in which rejection 
took place on day 13. In both rats, DAO values were markedly lower on postoperative 
day 7 compared to the other rats given in the Fignre, that rejected their grafts later. 
Although such a pattern in basal DAO level was clearly noted 6 days before rejection in 
rats 1, 2, 3, 8 and 9, statistical analysis could not establish a prognostic value of basal 
DAO level for SB rejection. 
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Table lA Serum DAO valnesI after syngeneic small-bowel transplantation. 
WAG-WAG 
animal- 2 3 4 5 6 
~day 
0 0.17 nt 0.17 0.11 0.19 0.11 
1 nt nt nt 0.03 0 nt 
2 0.01 0 0.04 0.06 0.03 0.38 
3 0.04 0.Q3 0.02 0.21 0.26 0.08 
4 0.07 0.10 0.15 0.27 0.52 0.05 
5 0.10 0.12 0.13 0.52 0.08 0.26 
6 0.11 0.18 0.14 0.87 0.77 0.28 
7 0.15 0.15 0.19 0.51 0.36 0.13 
8 0.39 0.19 0.21 0.05 1.02 0 
9 0.24 0.21 0.29 0.76 0.34 0.23 
10 0.34 0.17 0 0.32 0 0.09 
11 0.30 0.23 0.58 0 0.23 0.07 
12 0 0.10 0.30 0.31 0.39 0 
13 0.34 0.22 0.15 0.47 0.43 0.13 
14 0.34 0.24 0.14 0.07 0.34 0.06 
15 0.16 0.55 0.22 
16 0.30 0.71 0.22 
Table III Serum DAO valnest after allogeneic smaIl-bowel.tr.msplantation 
BN-WAG 
animal- 2 3 4 5 6 7 8 9 
~ day 
0 0.15 0.13 0.07 m 0.12 0.20 nt 0.25 nt 
1 0 nt nt nt 0.06 0.14 nt nt 0.09 
2 0.07 0.02 0 nt 0.06 0.06 0.16 0.07 0.14 
3 0.12 0.09 0.03 nt 0.20 0.14 0.29 0.06 0.22 
4 0.30 0.13 0.02 0.12 0.30 0.16 0.06 0.21 0.15 
5 0.36 0.21 0.01 nt nt 0.28 0.20 0.42 0.25 
6 0.22 0.26 0.04 0.64 0.55 0.20 0.22 0.62 0.48 
7 0.04" om 0.07 nt nt 0.09 0.14 0.47 0.25 
8 0.02 0.01 nt 0.02 0.23" 0.26 0.13 0.32 0.20 
9 0 0.Q3 nt 0.73 nt" nt 0.19 0.27 0.17 
10 0 0 1.07 nt 0.03 0.17 0.14 
11 0.14 0 0.19 0.08 0.25 0.15 
12 0.15 0 nt 0.02 0.22 0.05 
13 0.13" 0.04" nt 0.02 0 0.08 
14 0.10 0.01 0.03 
15 nt 0.02 0.18 
16 nt 0.Q3 0.08 
17 nt nt 
18 
1: DAO values are expressed as nmo11ryrroline formedlml serum/hour 
": day of graft rejection 
b: recipient died with functioning graft (ethemarcose) 
nt = not tested 
": GVHD grade 1 
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Fig.2. Basal DAD activity changes following allogeneic transplantation. Graphic presentation of prognostic value. 
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Discussion 
Because acute rejection of the SB is associated with intestinal ischemia, it is valid to 
evaluate the prognostic significance of substances originating from gut during mucosal 
ischemia. In this respect, N-.cetyl hexosantinidase, • lysosomal acid hydtolase whieh is 
known to be elevated in serum in association with intestinal ischemia is a potentially 
interesting candidate. Conflicting data on its usefulness as early marker to detect rejection 
have been reported (12,13), however, and this enzyme needs further study. Serum DAD 
levels are also known to be elevated during acute ischemia of the SB mucosa (25). 
Intestinal DAD is distributed relatively unifonnly from jejunum to ileum, whereas in 
colon a lower activity is present (26,27). Differentiated enterocytes are the printary site of 
storage of DAD in the intestinal compartment. Upon stimulation DAD is secreted through 
the basolatetal membrane, enters the microvasculature and is released into the circulation 
directly or through lymphatics. DAD release from the bowel can also be provoked by 
intravenous heparin administration which is associated with a rapid increase of plasma 
DAD. Postheparin DAD,plasma levels are lowered in SB mucosal damage (28), Crohn's 
disease (29), celiac disease (30) and suspected mucosal atrophy during TPN feeding (29). 
This directly indicates that basal DAD levels may also :eflect integrity of the mucosa. 
Ischemia leads to a decrease in intestinal DAD activity briefly followed by elevated serum 
DAD levels (31,32). It is unknown whether the causal factor of DAD release in isehemia 
is mucosal injuty itself or that circulating factors capable to interact with microvascular 
receptors are responsible. 
Transplaotation of the ama1I intestine is accompanied by neural and lymphatic disruption, 
and isehemia. Rose et al (33), demonstrated that basal serum DAD levels equalled 
preoperative values 1 month after intestinal autotransplaotation in dogs and remained 
stable for more than 18 months. Basal DAD values showed significant rises on day 2 and 
3 postoperative. This increased basal DAD level was interpreted as delayed appearance of 
DAD in serum due to disruption of lymphatics. Whether basal DAD activity remains 
elevated beyond three days has not been tested yet. 
In the present study, decreased basal serum DAD levels were found 1 day following 
either syngeneic or allogeneic intestinal transplantation. We believe that this dectease is 
caused by luminal DAD release during the transplantation procedure, before unclamping. 
Thus, DAD lost during luminal perfusion of the intestinal graft represents ischemic injuty 
of the mucosa. 
In rats that received a syngeneic intestinal graft the DAD serum activity fluctuated with 
time, probably because of a temporary loss of the homeostatic mechanism that norma1ly 
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regulates mucosal growth. The ischemic injury of the transplantation procedure bas a 
damaging effect on intestinal mucosa. In a model of canine SBT nonnal CIypt function. 
assessed by measuring cyclic-AMP-mediated chloride secretion, was already found by day 
3 (34). This may explain the obvious increases in DAO serum levels within the first 
postoperative week found in both syngeneically and aIlogeneically transplanted animals. 
Following intestinal transplantation, the regulatory role of DAO in mucosal growth may 
become of more importance in maintaining mucosal integrity and is accompanied by 
fluctuating DAO levels. 
A similar pattern of fluctuating DAO serum levels was recognized in rats following 
allogeneic intestinal transplantation. In aIlotransplanted animals, mild histologic injury 
including some crypt cell death was present from day 4 onwards (unpublished data). We 
hypothesize that CIypt cell death results in dintinished cell division and is followed by a 
decrease in intestinal DAO activity. Although a decline in DAO activity was found in 
some animals 6 days before rejection, its prognostic value could not be proved 
statistically. However, n~n-rejected related factors present in the first two weeks may 
alter DAO activity following allogeneic SBT and as such overrule a possible prognostic 
character of DAO. It was demonstrated that on day 13, 14, and 16 significant decreases 
in serum DAO activity were found in aIlogeneically transplanted animals compared to 
syngeneically transplanted animals. However, at that time, extensive mucosal sloughing 
had already taken place (unpublished data). 
In summary, the results from this study suggest that changes in basal serum DAO level 
do not have a prognostic value for acute intestinal allograft rejection. 
Further studies are needed to define the role of monitoriog basal serum DAO in cbronic 
rejection and the importance of perfonuing the postheparin DAO test in the assessment of 
graft function. 
On top of that suppression of DAO may be a means of stimulating SB adaptation after 
major resections, and it is hypothesized that this may consequently be used to stimulate 
adaptation of SB grafts. 
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8.3 POSTHEPARIN DIAMINE OXIDASE ACTIVITY AS MONITORING 
TOOL FOR SMALL-BOWEL GRAFT FUNCTION IN RATS 
Abstract 
A biochemic marker that could provide information about the actual condition of an 
intestinal graft is still missing. The enzyme diamine oxidase, mainly found in villi tips, is 
a potential circulating marker of mucosal maturation and integrity. 
The aim of this study was to investigate whether diantine oxidase has any value in 
monitoring the status of an intestinal graft in rats. Therefore we examined, up to 6 
months postoperatively the differences with time in basal as well as postheparin diamine 
oxidase activity in resected WAG rats that had received either a syngeneic total sruaIl-
bowel transplantation or a fully allogeneic sruaIl-bowel transplantation from a BN donor. 
Statistical analysis was performed using the paired Student's t test and the Student's t test 
for two means with a p value less than 0.05 considered significant. 
The results show that the basal diamine oxidase activity measured preoperatively has a 
considerable variation, and that it has no Validity in establishing alterations following 
sruaIl-bowe! transplantation. 
Animals with a syngeneic total sruaIl bowel had a significantly increased postheparin 
diantine oxidase activity during the experimental period compared to preoperative values. 
In animals with an allogeneic total sruaIl bowel, postheparin diamine oxidase was not 
increased up to the fourth month after operation. Postheparin diamine oxidase activity was 
significantly increased in syngeneic animals compared to allogeneic animals during the 
first 4 months postoperatively. Previous work showed that in these rats no differences 
could be found monitoring weight, nutritional serum parameters, and fecal fat excretion. 
Therefore, we conclude that measoring postheparin diantine oxidase activity has potential 
value in establishing the condition of the graft. The increased values in syngeneically 
transplanted animals indicate that the effects of the transplantation procedure induce an 
intestinal adaptive response that is compromized in allogeneically animals. This may have 
intplications for the use of segmental sruaIl-bowel grafts. 
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Introductiou 
Recent clinical experiences in small-bowel transplantation (SBT) are proIIllSlllg and 
strengthen the belief that this will be the ultimate therapeutic treatment for patients with 
irreversible small-intestinal failure (1,2). 
Following SBT, monitoring the graft is of utmost importance to have an indication of the 
momentary graft function (3) and to be able to earJy recognize rejection (4,5). 
The long-term graft function of transplanted intestine can be influenced by both non-
immune as well as immune mediated factors. The non-immune mediated factors are 
primarily caused by the transplantation procedure itself and include denervation, lympha-
tic disruption, and ischemic and reperfusion injury (6,7). 
Conflicting data have been reported on the long-tetm consequences of the procedure on 
gra.ft physiology. Steatorrhea and reduced D-xylose absorption were observed following 
autotransplantation in adult dogs, which was ascnDed to permanent extrinsic denervation 
(8,9). However, in young dogs, recipients of a total autotransplant did not differ in 
growth and fimctional graft indices (Cliapter 5) from sham-operated controls, indicating 
adequate graft function despite the presence of significant bacterial overgrowth. Among 
the immune mediated factors that may influence the long-term fimctioning of the graft are 
infiltrating cells and their products (10,11). Little auention has been paid to the long-tetm 
immune mediated consequences on graft function. Previous work (12) performed in our 
laboratory showed long-term survival in a fully allogeneic total orthotopic SBT model. 
During an immunologically quiescent phase in which no rejection was encountered, the 
fimctional capacity of the graft was studied by monitoring weight, detetmination of serum 
parameters, and fecal fat excretion. Up to one year after transplantation, no differences 
could be detected compared to syngeneically transplanted rats using these parameters. 
Serum activity of the enzyme diantine oxidase (DAO), an enzyme found almost 
eXClusively in the intestinal mucosa, serves as a sensitive circulating marker of mucosal 
maturation and integrity (13,14). Because basal levels of the enzyme are just within the 
detection limits, DAO is often measured after stimulation with heparin, which releases 
intestinal DAO from the gut into the peripheral blood (15). The postheparin DAO activity 
time curve is known to be reduced during intestinal atrophy and enhanced during an 
intestinal adaptive response (16,17). 
We exantined the differences with time in basal as well as postheparin plasma DAO 
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activity in resected rats that received either syngeneic or allogeneic SBT. in order to 
deternrine whether DAO is a more specific tool to monitor the condition of the graft than 
the previously studied tool (12). 
Materials and methods 
Animals 
Male rats of 10 to 14 weeks old (200-250 gram). that were bred under specific pathogen 
free conditions. were obtained from Harlan-CPB (Austerlitz. The Netherlands). Inbred 
Wistat-Agouti (WAG-RtI") and Brown Norway (BN-Rtl'J strains were used. 
Smo./l-bowel transpl.anta1ion 
One-step total orthotopic SBT was performed as described in paragraph 8.2. 
ExperimeTTIal groups 
Gtoup 1: Syngeneic SBT,using adult WAG rats (n=6). 
Gtoup 2: Fully allogeneic SBT using adult BN rats as donors and adult WAG rats as 
recipients (n=6). Rats in both groups received intramuscular CsA (Sandintmun. Sandoz. 
Basel. Switzerland) in a dose of 15 mg/kg at days O. 1. 2. 4 and 6. (Untreated control 
rats reject their grafts in 12.8 ± 1.0 days (18). 
MeasuremenJ: of DAO activity 
Basal and postheparin plasma DAO activity was determined preoperatively and then 
monthly until 6 months. A blood sample. consisting of 1 ml blood obtained from the tail 
vein. was collected in heparinized tubes prior to administration of 100 Unitslkg heparin. 
and 15 minutes afterwards. 
Diamine oxidase activity. expressed in Units/ml. was determined as described in 
paragraph 8.2. 
Statistics 
All data are expressed as means ± standard deviation (SD) and were analyzed using the 
paired Student's t test for comparisons between the same animals at different time points 
with the preoperative value, and the Student's t test for two means for comparisons 
between the various groups at the same time point. A p-vaJue less than 0.05 was 
considered as the a priori level of significance. 
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Results 
Basal DAO levels 
In Figure 1, the basal plasma DAO activities of rats with a syngeneic (group 1) or 
allogeneic (group 2) small-bowel (SB) graft are shown monthly up to 6 months after 
surgery. Even the preoperative basal plasma DAD levels showed some variation. Basal 
DAD activity of syngeneically transplanted animals was significantly different from 
preoperative values 1, 3 and 5 months postoperative. For the allogeneically transplanted 
animals the basal DAD activity was statistically different from preoperative values at 3 
months. There were no significant differences between the experimen!al groups. 
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Postheparin DAO levels 
Figure 2 shows the DAO plasma levels in syngeneic (group 1) and allogeneic (group 2) 
total SB transplanted animals 15 minutes after stimulation with heparin. 
The animals with a syngeneic total SB graft had a significantly increased postheparin 
DAD activity during the total follOW-Up period compared to the preoperative value. 
In animals with an allogeneic total SB graft the postheparin DAO activity did not increase 
up to the fifth month after operation as compared with preoperative values. 
Between the experimental groups, significant differences in postheparin DAD activity 
could be found up to the fifth postoperative month, in that group 1 animals had higher 
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levels. Both 5 and 6 months after the transplantation, no differences between the groups 
were found. 
Un t'ts/rn I 
12 
10 
8 
6 
4 
2 
0 
0 
'" = pocO.OS v(!I"""sI.Is dey 0 
'" = pocO.O:; V(!I"""S\J$ syrogo~le 
1 2 3 4 
months postoperatIve 
iIIsy ngenelc _AllOgeneiC 
a 
5 6 
Fig.2. Postheparin DAO activities fallowing either syngeneic or allogeneic small·bowel transplantation. 
Discussion 
We have previously shown that one year after surgery recipients of syngeneic-, and 
allogeneic total SB transplants were not different from age-matched untreated control rats, 
except for decreased plasma triglyceride levels (U). Between animals grafted with a 
syngeneic or allogeneic graft, no such difference was foand. Extensive analysis showed 
that total serum protein and albumin concentrations, serum cholesterol values, fecal fat 
excretion, perceotage of split fatty acids, and weight gain were equal. 
DAO, located primarily in the villus tip, is involved in the regulation of mucosal growth 
(19). The enzyme seems to act as a negative feedback regulator in intestinal growth in 
that it inhibits crypt cell proliferation by degrading polyamines, essential components for 
cell division. Erdman et aI (20) have shown that DAO activity increases significandy 
early after SB resection, a period characterized by adaptive enterocyte proliferation. 
InInlJiting DAO, using aminoguanidine, enhanced the mOIphologic adaptation response 
indicating that DAO downregulates nonfunctional proliferative responses of the intestine. 
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Several investigators bave shown that following heparin administration, increase in 
peripheral blood DAO levels derives almost exclusively from the intestine and reflect the 
intestinal DAO content more sensitively than the basal plasma DAO levels (21,22). In 
cltapter 4 of thls thesis, it was demonstrated that postheparin DAO activity is a sensitive 
measnre for the adaptive response following resection, because it enables to quantify the 
degree of adaptation of resected rats fed different diets. 
In thls study we showed that basal plasma DAO activities bave a considerable variation 
and we could not frod alterations within the experimental groups in comparison with the 
preoperative values. We further demonstrated that measnring basal plasma DAO activity 
reveals no differences between animals that received a syngeneic (group 1) or allogeneic 
(group 2) graft. However, it appeared that the use of postheparin DAO activity as marker 
for the actual condition of the graft enables to reveal differences between pre and 
pcstoperative values as well as between group 1 and group 2. 
In group 1 the postheparin DAO activity was significantly higher during the follow-up 
period compared to the preoperative value. This rise can be seen as an adaptive response 
of the transplanted intestine to overcome the effects of the transplantation procedure. 
These non-immune mediated phenomena may disregulate the hormonal, neural, nutritional 
as well as the immunological function of the graft. The increase found in postheparin 
DAO activity can be seen as a sign that the repair-phase bas been started. 
No such rise was detected in allogeneic transplanted animals during the first 4 months 
after the operation. The heparin stimulated DAO activity was increased at 5 and 6 months 
following allotransplantation compared to values measnred preoperatively. 
This indicates that the addition of an immunologic compcnent delays the adaptation 
process after intestinal transplantation of the total SB. This finding may bave implications 
for the transplantation of a segmental bowel graft. In that case, the segment should adapt 
more rapidly to compensate for !lie shortened length. These findings suggest that 
segmental SBT may require enhancement of intestinal adaptation by means of specific 
stimuli. On the other hand, it cannot be excluded that the grafting of a segmental 
transplant may be the required trigger for the onset of the adaptive response of the 
intestine. 
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GENERAL DISCUSSION AND 
CONCLUSIONS 
A number of conditions in children, notably small-bowel (SB) a!resias, malrotation with 
midgut volvulus, gastroschisis, enterocolitis and extensive aganglionosis, may require 
resections that could result in the short bowel syndrome (SBS) (1,2,3). The common 
causes of the SBS in adults include Chrobn's disease and mesemetic infarction (4). Short 
bowel syndrome is characterized by irreversible small-intestinal failure, being defined as 
inability to maintain nuttition andlor positive fluid and electrolyte balance without special 
measures (Chapter 1). 
This dissertation deals with "therapeutic modalities for the short bowel syndrome", 
whereby emphasis is put on the value of these options for children. The experimeDlal 
work can be divided into two parts, each dealing with a different therapemic option: (A); 
enhancement of adaptation of the remaining bowel and (B); small-bowel transplantation 
(Chapter 2). 
Enhan~entofadaptation 
Extensive loss of intestine brings about functional as well as morphologic adaptive 
changes in the remaining intestine. Functional adaptation is determined by numerous 
factors, including the absorption per enterocyte, intestinal transit time, the presence of the 
ileocecal valve, intestinal contents andlor specific activities of brush border enzymes, and 
bacterial colonization of the remaining SB (5,6,7). lncreasecI exposure to (specific) 
luminal nuttients, pancreatico-biliaty secretions, trophic effects of enteric hormones, and 
neurovascular effects on the remaining intestine are major factors that stimulate mucosal 
growth (8). The overall process is still unknown, but some factors that regulate the 
morphology and function of the gut may be directly interrelated, the overall process is 
still unknown. 
In an attempt to unravel the interrelationship between active electrolyte transport 
mechanisms and mucosal growth, we evaluated the value of in vivo electrophysiologic 
measurements for intestinal functional adaptation in rats following near-total SB resection 
(Chapter 3). Using in vitro teclmiques, other investigators (9,10) have already shown that 
morphologic growth precedes functional adaptation. We found that histologic cbanges 
precede functional adaptation of both sodium-coupled glucose absorption and theophylline-
stimulated chloride secretion, and that cbanges in the ileum precede changes in the 
jejunum. At 3 weeks after resection the electrophysiologic responses to both glucose and 
theophylline in jejunum as well as ileum of resected animals were siguificantly lower than 
176 
in sham-operated control animals. These findings suggest that the complexity of the 
adaptive events is indicated by region-related differences in mechanisms controlling 
mucosal growth and function as well as by the existence of dissociation between mucosal 
growth and components of functional adaptation. One explanation for the impairment of 
the electrophysiologic response at this time point is an alteration in tight junction 
permeability. Madara (11) highlighted the intportant role of tight junctions in intestinal 
barrier function as well as the maintenance of epithelial cell polarity, as prerequisite for 
vectorial transcellular transport. The analysis of possible changes in occluding junction 
structure and function should be the subject of future experiments. 
Studies on biochemic and biophysic aspects responsible for functional alterations 
following resection have received little attention so far. These aspects include alterations 
in brush border membrane composition (contents of cholesterol, total and individual 
phospholipids, and fatty acyl constiments should be assessed), transporter activity as well 
as protein and mRNA levels of the transporter. These aspects have been studied already 
in other types of intestinal adaptation like response to aging, variations in and composition 
of the diet, and models of disease such as diabetes and chronic ethanol digestion 
(12,13,14). 
Increases in absOIptive capacity of the residual gut in response to bowel resection have 
been found with regard to carbohydrate, lipid, and antino acid absorption, and alterations 
in absorption following dietary modifications have been recognized (15,16). 
in chapter 4 of this thesis, a rat study is presented in which the effect of a wet with 
partial hydrolyzed proteins on intestinal adaptation is compared with an identical diet with 
intact proteins. This smdy indicates that a wet with partial hydrolyzed proteins has no 
clear superiority over a complex diet with regard to improvement of the adaptation 
process. The necessity of a precligested wet in the standard treatment of the SBS is 
probably one of the many fallacies of enteral feecling (17,18). The results give an 
experimental basis for a clinical trial in SBS patients in which diets with partial 
hydrolyzed proteins are compared with diets with intact proteins. The high costs and the 
possible side effects of specialized food products are additional reasons 10 start a clinical 
trial. 
in future studies, the emphasis should be put on determining the potential factors leading 
to enhanced lipid uptake such as: alterations in the passive permeability properties of the 
brush border membrane, and the factors leading to enhanced glucose uptake (alterations in 
the activity, the protein or the mRNA level of the glucose transporter). These smwes will 
give insight into the mechanisms responsible for upregulation of nutrient transport 
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following resection. Based on this knowledge, it may be possible to maximize the process 
of adaptation to resection by feeding nutrient components that have the ability to 
upregulate in a synergistic manner. 
Small-bowel transplantation 
Experimental basis 
From the literature and previous work in our laboratoty (19,20,21), it can be concluded 
that SB grafts can survive for at least one year in both rat and dog. Clinical efforts to 
undertake SBT in humans have started over the last few years although the optimal 
requirements are still unknown (22,23). Therefore, it is not vety smprisingly that both in 
Paris and in Pittsburgh one has to decide to stop the clinical programs because of the bad 
overall results. Before starting again, it would be worthwile to have available an 
immunosuppressive protocol that achieves successful graft survival without rejection and 
toxic side-effects, as well as clarity about the long-term physiologic consequences of SBT. 
In a pre-clinical animal model using adult Beagles, we demonstrated that MHC-matching 
had a beneficial influence on the survival of segmental SB grafts transplanted in a two-
stage manner, and that it is possible to achieve long-term survival with an oral dose of 30 
mg/kg/day of cyclosporine A (CsA) (24,25). Using this dose, we were confronted with 
the toxic side-effects of CsA like wart formation and infections. Furthermore, in children 
there was no experimental evidence that an intestinal graft is able to maintain growth, 
development and maturation. Thus, we felt that before making SBT a practical therapeutic 
option for children further research in a young growing animal was required. 
Necessity of selective decontamiruztion of the graft 
In chapter 5 of this thesis, we examined the role of one-stage total orthotopic small-
intestinal autotransplantation in growing individuals. The one-stage transplantation 
procedure was fraught with inordinate mortality of 75%, due to postoperative 
complications including electrolyte problems, invagination and infections. A two-stage 
segmental allotransplantation procedure in young dogs (chapter 6 and 7) showed that 
SBT in a young individual gives a "stormy" postoperative course and that selective 
decontamjnation of the gut and early gastrostomy feeding are necessary to overcome the 
postoperative problems. This is in accordance with the reported high incidence of 
infectious episodes after human SBT (26). The few long-term surviving dogs that received 
an autotransplant showed a normal growth pattern and normal D-xylose and fat absorption 
despite the presence of bacterial overgrowth in the graft. The bacterial overgrowth was 
not caused by extremely discoordinated motor complexes as a normal transit time was 
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found. This study suggests that the non-immunologic effects of intestinal transplantation, 
although causing bacterial overgtowth, do not promote bacterial translocation in the long 
run. There is, however. some evidence indicating that the combination of intestinal 
bacterial overgtowth and host immunosuppression synergistically promotes translocation 
of gastrointestinal bacteria (27). This may imply that selective decontamination of the 
digestive tract is needed at least temporarily before and after allogeneic transplantation to 
avoid episodes of infection, and tlrus underscores the above- mentioned results following 
two-stage segtnental allotransplantation. 
MHC Matching 
In chapter 7, we examined whether MHC matching paves the way for using a reduced 
immunosuppressive regimen of 20 mglkg/day of CsA in growing Beagle puppies, 
weighing 5 - 6 kg, that underwent a two-stage segtnental allotransplantation. The graft 
was 1 meter jejunoilenm, MHC-matched for 2 haplotypes, deriving from an adult donol. 
It was shown that this modality effectively prolonged intestinal graft survival without the 
toxic effects of the higher CsA dose. It might well be that matching in human SBT, in 
adults as well as in children, also provides a basis for using an immunosuppressive 
protocol that leads to long-term graft survival without the complications of administering 
high doses of immunosuppressiva. 
Functional assessmenI of the graft 
Follow-up of graft function following transplantation of I meter jejunoileum showed 
nonna! D-xylose absorption, nonna! values of serum parameters, but increased fecal fat 
excretion and lactulose/mannitol excretion ratios as well as compromised gtowth. It Was 
concluded that a segmental graft under CsA regimen is unable to maintajn the normal 
gtowth pattern without specific nutritional interference in the critical postoperative phase. 
After CsA treannent was stopped, a catch up growth was found before rejection took 
place. This finding indicates that a segtnental SB graft under CsA regimen functions 
suboptimally to allow nonna! gtowth and development and that the condition of the graft 
is more important than the length of transplanted bowel. However, it seems reasonable 
that if a segtnental graft under CsA regimen functions and adapts suboptimally, as much 
bowel length as possible should be transplanted. The importance of this is further stressed 
by findings in rat models (20,28) in which rats transplanted with a segtnental allograft 
developed impalled nutritional parameters, in contrast to rats that received a total SB 
graft. 
Sigalet et al (29) found that CsA had a significant effect on bowel function in the nonna! 
rat. CsA administration, independent of route of administration, caused a reduction in 
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both active glucose transport and passive fatty acid absorption by the bowel. 
No experimental data on the use of FK 506 in SBT in growing recipients are available. 
Future research should be aimed to a better understanding of the influence of FK 506 and 
CsA on the mechanisms of nutrient absorption and intestinal adaptation., so that strategies 
to minjmize the effects on bowel function can be devised. Nutritional intervention by 
adding polyantines, short chain fatty acids or glutamine to improve the degree of 
adaptation of a segmental graft may be of value (30,31,32). However, one should not 
consider these components as trophic factors per se. A recent study reported that adding 
glutamine to TPN enhances the intestinal mucosal inunune function by preserving the 
ability to produce slgA-synthesizing plasma cells (33). In other studies it was noted that, 
for example, arginine supplementation increases thymic weight and enhances the 
responsiveness of T-Iymphocytes to ntitogens (34). This may have further implications for 
application in SBT in that so called inununonutrition could improve the overall inunune 
function of a recipient and may therefore be associated with increased risk of graft 
rejection. Further studies are needed to select nutrients that preserve or enhance imestinaJ. 
function but do not have a stimulating influence on the immune staros of the transplant 
recipient. 
Advanced graft monitoring 
Now SBT in the near future is expected to become a widely applied tecbnique in patients 
suffering from irreversible intestinal failure, it has been realized that monitoring the 
imestinaJ. graft is important. 
In chapter 6, we examined the value of ultrasonography for monitoring the postoperative 
course after SBT. Regular monitoring proved to be useful in detecting early 
complications, including imussusception, thrombosis and postoperative ileus. Therefore 
we do recommend ultrasonography as a useful tool in the multidisciplinaity support after 
SET. Using in vitro ultrasonography, we identified villous sloughing associated with 
rejection in one case. A recent study of Cheung et al (35) confirms this finding by 
demonstrating that it is possible to differentiate between normal and abnormal changes in 
the bowel waIl after SBT with acceptable sensitivity and specificity. 
In addition, monitoring the graft during the postoperative course following SBT is 
necessary for early detection of acute rejection and the adjustroent of treatment. The value 
of mucosal biopsies as a tool to monitor rejection has lintitations because of its patchy 
character and invasiveness (36). Although intestinal permeability studies are now available 
to assess rejection (37), studies are still focussed on the search for a simple sensitive 
serum marker. We previously examined the value of monitoring the enzyme N-
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acetylhexosamiJJidase in acute rejection and found that substantial ischemic damage 
occurred before enzyme levels rose (38). In chapter 8.2, we evaluated the prognostic 
value of serum diarnine oxidase in acute SB rejection in rats. Monitoring this enzyme was 
of no value because the SBT procedure itself is responsible for fluctuating serum DAO 
levels in the early postoperative period in rats. 
The long-term follow up of patients after orthotopic SB grafting should include a number 
of functional and permeability tests to study graft function and to diagnose chronic 
rejection in an early phase to rescue the graft. Routine absorption tests, including the 
lactulose-mannitol test and fecal fat analysis may indicate good functioning of the graft 
(39). In chapter 8.3, we exantined whether plasma and postheparin DAO values could 
serve as a sensitive marker of the functional status of the graft after intestinal allografting 
in rats. We concluded that measuring postheparin DAO activity has potential value in 
assessing the condition of the graft. Whether a specific test alone provides sufficient 
information on the behavior of the graft or whether combined results of some of the 
above mentioned tests gives more specific and/or sensitive information is a question that 
will have to be clarified by further experiments. 
Future prospects 
There are a number of gaps in our fundamental knowledge. These include the optintal 
solution for intestinal preservation, the factors responsible for the severity of SB rejection, 
the immunologic mechanism responsible for reduced immunogenicity of a combined small 
bowel-liver graft, the value of an auxiliary liver graft in combination with a SB graft, the 
role of GVHD, the role of nticrocltimerism (40), and the metabolic profile of transplanted 
intestine and the effect of nutritional intervention on it. 
Despite these gaps, clinical experience takes up the running from experimental studies by 
now. It can be questioned whether it is justifiable to start a clinical SBT program before 
the hasic requirements as optintal immunosuppression and knowledge about the long-term 
consequences of the transplantation procedure have been extensively studied in a pre-
clinical anintal model. It is questionable whether these reqnirements had been met at the 
time the clinical programs in Pittsburgh, Toronto and Paris were started. However, seeing 
that they have already begun, the insights that will be derived from the current clinical 
cases in SBT will be highly valuable because the patients are extensively monitored. 
These insights, together with the experimental studies that are now being performed, will 
give direction to the experimental need of SBT and to the way in which it can be achieved 
succesfully. 
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New avenues that deserve furthet experimental attention as potential alternatives to 
intestinal transplantation include the tI3IlSpiantation of selective enterocytes (41) or 
tI3IlSplantation of the colon. Preliminary results suggest that colon tI3IlSpiantation 
produces a milder rejection response than tI3IlSplantation of the small intestine (42). 
Moreover, from a physiologic point of view a large bowel would probably be a wonderful 
tI3IlSplant, having enormous adaptive capacity, especially if supplemented with fiber. 
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SlJlVll\tlARy 
Chapter 1 
This chapter treats the role of non-nutritive and nutritive factors in promoting adaptation 
of the remaining small-bowel (SB) after massive SB resection, and summarizes the 
preseD! state of experimental and clinical small-bowel tr:msplantation (SB1) in growing 
individuals. Following extensive SB resection, total paremetal nntrition (TPN) is 
indispensable for a short or long rime. The influence of entetal nntrition on the intestinal 
adaptation process has been widely recognized, although little information is available on 
the precise functioning of the complicated process of intestinal adaptation found after SB 
resection. It is unknown whether the adaptative response can still be oprimaJj:wJ and 
which diet is most suited in the adaptive phase. About 2-3 patients per million of 
popttlation per year Illm out to have irreversible intestinal failure and remain totally 
dependeD! on TPN. These patients have a considerable risk of serious complications, and 
the long-term outlook for children is even less favorable because they have a higher risk 
of liver impairment than adults. Moreover, children have even limited adequate venous 
access and need specific nutrition to grow and develop nonnally. One reasonable 
alternative to TPN is. SB1,'. This technique is on the verge of becoming an established 
technique in tr:msplant medicine, although there is still no experimental evidence that an 
intestinal graft is able to majnmin growth, development, and maturation in juvenile 
recipients. Thus, for now, ethical decision malting has to be on basis of full awareness 
that the tr:msplantation procedure still has an experimental character. 
Chapter 2 
In this chapter, the aims of the experimental work are fonnulated. On the one hand, 
adapmtion-related experimems are performed to get insight in the intestinal adaptation 
process and the contribution of predigested nutrition. On the other hand, tr:msplantation-
related experiments are performed. 
Chapter 3 
An in vivo electrophysiologic technique, by which transepithelial potential differences in 
response to theophylline- or glucose comaining test solution are measured, was used to 
monitor intestinal adaptation both 3 and 10 weeks following 90% SB resection in rats. 
The experiments reveal that in the early phase of adapmtion the histologic changes 
precede in vivo electrophysiologic parameters. This points at a separation between 
morphologic and functional adaptive changes, and indicates that differeD! factors (both 
nntritive and non-nutritive) may regulate the morphologic andlor functional adapmtion 
differently. 
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Chapter 4 
This chapter examines the relative importance of food complexity and food composition in 
promoting imestinal adaptation after SB resection in rats. To this end the rats were fed 
either nonna! rat chow, an diet with partial hydrolzed proteins, an identical diet with 
intact proteins, or a non-identical diet with intact proteins. Two and 10 weeks after 
resection the adaptive state was evaluated by means of the following parameters: 
metabolic status, nutritional serum parameters, postlleparin DAO activity, lristology, and 
crypt cell proliferative activity. The results show that a diet with partail hydrolzed 
proteins is as effective as an identical diet with intact proteins in initiating and supporting 
adaptation. In the fIrst two weeks, the non-identical diet with intact proteins was superior 
to these diets, suggesting that the influence of diet composition on the early adaptive 
phase following resection is superior to that of diet complexity. 
Chapter 5 
The non-immunologic effects of SET in a growing individnal were investigated by 
performing one-stage total orthotopic SB autotransplantation in dogs. This operation 
teclmique had an high mortality rate due 10 non-technical complications (80%). Analysis 
of the surviving artimaIs showed that the function of an autotransplanted bowel is not 
impaired, neither in the short tenn (paragraph 5.1) nor in the long rue (paragraph 5.2). 
Adaptive functional and morphologic changes were seen after one year together with 
bacterial overgrowth in terminal ileum and colon. 
Chapter 6 
The value of ultrasonography for mOnitoring the postoperative course after SET was 
detertnined in growing dogs. It appeared that this technique is useful in monitoring early 
complications following SBT. 
Chapter 7 
In this chapter, the role of a two-stage segmental SB allotransplantation in the treatment 
of the short bowel syndrome in growing dogs was investigated. The dogs received 
cyclosporine A; esA (20 mg/kgld) as immunosuppressive agent. It appeared necessary to 
add selective decontamination and early gastrostomy feeding to the perioperative 
management protocol. Six months follow-up learned that a segmental intestinal transplant 
with CsA functions suboptimally in maintaining the nonna! growth and development. This 
means that without specific nutritional interference in the early postoperative phase, a 
segmental intestinal allotransplant, under CsA, has not the potential to maintain nonna! 
growth in a growing individnal. 
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Chopter 8 
Paragraph 8.1 presents a review of the historical background and the biochemic- and 
functional aspects of DAO. The value of this enzyme as serum marker of acute rejection 
following allogeneic total orthotopic SET was studied in rats (paragraph 8.2). The results 
indicate that monitoring of serum DAO has no value in early detection of acute rejection 
of SB grafts. The significance of postheparin DAO assessment for the evaluation of graft 
function was investigated in paragraph 8.3. It appeared that postheparin DAO activity is a 
reliable indicator for graft function, showing that syngeneicaJJy transplanted rats had a 
higher activity during the first 4 months compared to allogeneic anintaIs. This implies that 
inununologic factors have a negative effect on the adaptive response of the imestine 
following SBT. 
SAMENV ATTING 
Hoofdstuk 1 
In <lit hoofdstuk wordt uiteengezet welke rol voeding en andere componenten spelen bij 
stimulatie van het adaptatieproces van de overgebleven dunne darm na uitgebreide dunne-
darm resectie. Daarnaast wordt de hui<lige stand van zaken besproken van zowel de 
experimentele aIs de kl.inische dunne-darm transplantatie bij kinderen. Na uitgebreide 
dunne-darm resectie is totale parenterale voeding (TPV), vocr konere of Iangere tijd, 
omuisbaar. Dat enterale voeding van betekenis is voor het intestinaIe adaptatieproces is 
algemeen bekend, hoewel we weinig weten over hoe de adaptatie nu eigenlijk tot stand 
komt. Het is daarom onduidelijk of de adaptatierespons nog kan worden verbeterd en met 
welke voeding een optimaal resultaat behaald kan worden. Ongeveer 2-3 patienten per 
miljoen inwoners per jaar blijken onotukeerbaar dartnfalen te hebben, en derhaive 
levenslang afhankelijk te zijn van TPV. Deze patienten lopen eon groot risico om een van 
de vele complicaties te ontwikkelen <lie met TPV gepaard gaan. V ooral voor kinderen zijn 
hierdoor de uitzichten op de lange termijn beperkt. Het transplanteren van de dunne darm 
lOU eon alternatief kunnen zijn voor behandeling met TPV. Darmtransplantatie staat op 
het punt om een erkende techuiek te worden in de transplantatiegeneeskunde, hoewel er 
momenteel nog geen experimenteel bewijs is dat eon darmtransplantaat in staat is om de 
groei en ontwikkeling van een kind te waarborgen. Daarom zaI hOOen ten dage een 
beslissing over het uitvoeren van een dunne darmtransplantatie bij een groeiend individu 
genomen moeten worden op basis van een ethlsche afweging. 
Hoofdstuk 2 
In <lit hoofdstuk worden de doelstellingen van her experimentele werk geformuleerd. 
Enerzijds zijn er experimenten uitgevoerd om inzicht te verkrijgen in het intestinale 
adaptatieproces en de rol van voorverteerde voeding op <lit proces. Anderzijds zijn er 
experimenten uitgevoerd om eon aaniaI aspecten van dunne darmtransplantatie te 
bestu.deren. 
Hoofdstuk 3 
£On in vivo e1ectrofysiologische techuiek, waarmee transepitheliale potentiaalverschillen 
aIs reactie op een theophylline of glucose bevattende testoplossing worden gemeten, werd 
gebruikt om lowel drie als tien weken na een 90% dunne-darmresectie het intestinaIe 
adaptatieproces in de rat te bestuderen. In een vroeg staWUtu van de adaptatie bleken de 
histologische veranderingen v~~r te lopen op de in vivo electrofysiologische parameters. 
Hiermee wordt aangetoond dat er een verscbil is tussen de morfologische .en functionele 
aanpassingen. Verschillende factoren (lowel nutritionele als andere) kunnen deze vormen 
van adaptatie op verschillende wijze beinvloeden. 
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Hoofdstuk 4 
In <lit hoofdstuk wordt in de rat bestndeerd wat het relatieve belang van voorvetteerde 
voeding is bij de bevordering van het adaptatieproces na dunne-darmresectie. Vier 
groepen ratten kregen respectievelijk nonnaal ratten-voer, een voeding met partieel 
gehydrolyseetde eiwitlen, of een qua sameDStelling hieraan identieke dan wei Diet 
identieke voeding met intacte eiwitten. Twee en tien weken na de resectie vond evaluatie 
van de adaptatie plaats met behulp van de volgende parameters: het stofwisselingspatroon. 
nuttitionele serum-parameters, de postheparine DAO activiteit, de histologie en de 
delingsactiviteit van de crypt eel. De resultaten tonen aan dat de voeding met partieel 
gehydrolyseerde eiwitten even effectief is als de hieraan identieke voeding met intacte 
eiwitten bij het initioren en in stand honden van het adaptatieproces. In de eerste fase 
bleek de Diet-identieke voeding met intact eiwitten superieur te zijn aan de andere geteste 
voedingen, hetgeen impliceert dat tijdens deze fuse de sameDStelling van de voeding een 
grotere rol speelt dan de mate van voorvertering. 
Hoofdstuk 5 
In <lit hoofdstuk worden bij de Beagle pup de Diet-innnunologische gevolgen beschreven 
van een .:en-staps autottansplantatie van de gehele dunne darm, <lie or!hotoop gepiaatst is. 
Doze operatietechniek bleek gepaard te gaan met een hoge postoperatieve mortaliteit 
(80%). Uit een analyse van de funktie van het ttansplantaat bij de overlevende <lieren 
bleek dat de funktie van een antottansplantaat zowel op de korte terntijn (paragraaf 5.1) 
aIs op de lange termijn (paragraaf 5.2) gewaarborgd blijft. Een jaar na ttansplantatie 
werden functionele en ook morfologische aanpassingen gevonden mast een bacterieJe 
overgroei in het terminaaI ileum en colon. 
Hoofdstuk 6 
In <lit hoofdstuk wordt de waarde van sonographie in de postoperatieve fase na een dunne-
darmttansplantatie vastgesteld. Deze techniek is zeer bruikbaar om vroege complicaties 
vast te stellen. 
Hoofdstuk 7 
In <lit hoofdstuk wordt onderzocht wat het effect is van een twee-staps, MHC getypeerde, 
allottansplantatie van een gedeelte van de dunne darm op het groeiparroon van de Beagle 
pup met het korte darmsyndroom. Cyclosporine A (20 mg/kg/d) werd gebruikt aIs 
innnunosuppressivum. Duidelijk is geworden dat het noodzakelijk is selectieve 
decontaminatie van de tractus digestivus en, in een vroeg stadium, voeding via een 
gastrostontie toe te voegen aan het behandelingsprotocol. Observatie gedurende een half 
jaar wees uit dat tijdens de behandeling met cyclosporine A een suboptimaal groeipatroon 
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aanwezig is. Hieruit lean worden geconc1udeerd dat zonder speciale voeding in de vroege 
postoperatieve fuse een segmentaal danntransplan!aat onder cyclosporine geen normale 
greei kan waarborgen. 
Hoofdstuk 8 
In paragraaf 8.1 wordt de historische achtergrond en de biochemische en functionele 
aspecten van het enzym Diamine oxidase (DAO) besproken. De waarde van de serum 
DAO concentratie voor het aantonen van acute transplantaatafstoting werd onder.zocht bij 
de rat na een alIogene totale ortbotope dunne dann transplantatie. Serum DAO blijkt geen 
geede indicator te zijn voor het aantonen van acute afstoting van een dunne dann 
transplantaat (paragraaf 8.2). In paragraaf 8.3 wordt de betekenis van de poSlheparine 
DAO akiiviteit als indicator veor het funktioneren van het transplan!aat vastgesteld. Bij dit 
experiment werden syngeen getransplanteerde ratten vergeleken met alIogeen 
getransplanteerde ratten. De poSlheparine DAO akiiviteit bleek bij syngeen 
getransplanteerde ratten gedurende de eersle 4 maanden significant hoger te zijn. Dit 
belekent dat de bijkomende innnunologische factoren bij alIogeen getranspianteerde ratten 
een vemagend effekt op de adaptatieresponse hebben. 
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LIST OF ABBREVIATIONS 
AF 
ALB 
ALT 
ASAT 
BN 
BUN 
<-AMP 
CCK 
CFU 
mOL 
CsA 
DAO 
DLA 
GVHD 
HLA 
i.m. 
i.v. 
LCT 
MCT 
MIIC 
MLC 
MLN 
MMC 
ODC 
n 
p 
PBS 
PD 
SB 
SBT 
SBS 
SET 
sc 
SCFA 
SCT 
SD 
SDD 
SH 
sIgA 
TElL 
TP 
TPN 
TRIG 
U 
WAG 
alkaline phosphatase 
albumin 
alanine aminotransferase 
aspartate aminotransferase 
Brown Norway 
blood urea nitrogen 
cyclic adenosine monophosphate 
Cholecystokinin 
colony forming units 
cholesterol 
cyclospotioe A 
diaInine oxidase 
dog leucocyte antigen 
graft-versus-host disease 
human leucocyte antigen 
intt:lmuscular 
intravenous 
long chain triglycerides 
medium crutin triglycerides 
major lristo~ompanbility complex 
mixed lymphocyte culture 
mesenterial lymph node 
migratiog motor complex 
ornithine decarboxylase 
number of observations/animals 
level of significance 
phosphate buffered saline 
potential difference 
small bowel 
small-bowel liver transplantation 
short bowel syndrome 
small-bowel transplantation 
subcutaneous 
short chain fatty acids 
short chain triglycerides 
standard deviation 
selective decontamination of the digestive tract 
sham operation 
secretory immunoglobulin A 
total bilirubin 
total protein 
total parenteral nutrition 
triglyceride 
unit 
Wistar Albino Glaxo 
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NAWOORD 
De totstanc!koming van elit proefscbrift is zeker Diet he! werk van de promovenda alIeen 
en daarom wi! iI:: hier de gelegenheid aangrijpen om een aantal van hen te noemen. 
AIIereerst wi! ik mijn promotor, Prof. J.C. Molenaar hedanken, uw steun was 
onontbeerlijk voor de totstandkoming van dit proefscbrift. 
Erik Heineman, voor de wijze waarop je ondanks de verhuizing naar Maastricht bij het 
onderzoek betrokken bleef en telefoDisch consulten meld !! Richard Marquet, voor je 
srurende, maar zeker Diet overheersende, aanwezigheid. Bedankt mervoor. Het is daarom 
Diet meer dan rechtvaarelig dat jullie beiden mijn co-promotoren zijn. 
Kas CJaap Kasbergen), Amelie Bijma, Jannie de Kam, Erik Ridderhof, Erma Collij en 
Rob Meyer voor de manier waarop jullie ervoor zorgden dar een pasgeboren hondje 
uiteindelijk een dunne darmtransplantatie patient werd. Roy Spruyt, ik heb bewondering 
voor de manier waarop je altijd troUW onze "kinderen" verzorgde. zelfs toen je het zelf 
Diet al te makkelijk had. Pim v Schalkwijk en Lydia v Gastel, voor het uitvoeren van de 
talIoze bloedbepalingen. Pim, hoe staat het met de bloedjes ? Ron Briegoos, bedankt voor 
de verleende hulp bij de ratten~erimenten. 
John Kong A San en Piet Kreeft, voor de tijd die ik bij jullie op de kamer heb mogen 
doorbrengen. 
Simon Robben, voor je welwillendheid om vlak na zonsopgang het Echo-apparaat te 
komen beelienen en dat terwijl een Beagle toch echt geen varken is. Ko Haagoon, voor de 
constructi.eve verbeteringen van het Engels. AIle Marqueto·s. want een prettige werksfeer 
is een conditio sine qua non voor het behalen van goede onderzoeksresultaten. Mijn 
Leidse collega's, Annemiek Tons en Marie-Therese te Bulte, zij hebhen zonder geldaag 
mijn afwezigheid opgevangen als ik weer eens een <lagje thnis zat te scbrijven. 
Pa en Ma, behalve om de triviale reden dat zander jullie elit boerge er nooit zou zijn 
geweest denk ik dat de manier waarop jullie mij "gegidst" hebben minstens even zwaar 
weegt. 
Mijn paranimfen Ronald en £Oleo, bedankt voor de morele steun bij de Iaatste loodjes. 
En vooral Roon. want zonder jou had ik de finish in ieder geval niet op deze manier 
gehaald. 
Tot slot Peter, bedankt dat je mijn uitlaarldep hebt willen zijn voor alIe 
proefscbriftperikelen maar nog meer voor je liefde en geloof in mij. Dankzij jou ben ik 
nu in staat de grenzen te verleggen voorbij mijn eigen horizon. 
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CURRICULUM VITAE 
De auteur van dit proefschrift werd geboren op 30 maart 1968 te Rotterdam. Het VWO-
diploma werd behaald in JUDi 1986 aan de Thorbecke Scholengemeenschap te Rotterdam. 
In september van datzelfde jaar word de studie Medische Biologie hegonnen aan de 
Medische Faculteit van de Rijksuniversiteit te Utrecht. De hoofdvakstage (10 maanden) 
werd bij de vakgroep Algernene Heelkunde van het Acadenrisch Ziekenhuis Dijkzigt 
(hoofd: Prof.dr.J. Jeekel) te Rotterdam gelopen, a1waar xenotransplantatie onderzoek 
werd verricht. Een tweede stage (5 maanden) werd gelopen bij de vakgroep Medische 
Fysiologie van het Academisch Ziekenhuis Utrecht; hier werd kinematische en kinetische 
ganganalyse verricht bij kinderen met stoornissen in het looppatroon. Daarnaast word een 
stage (3 maanden) gelopen bij de Raad voor Gezondheidsonderzoek, in het keder van het 
gevolgde bijvak "Algernene Gezondheidszorg en Epidemiologie". Het doctoraalexamen 
word behaald in december 1990. In januari 1991 werd zij voor een periode van twee jaar 
aangesteld aIs weteDSchappelijk onderzoeker bij het instinrut Kinderheelkunde van het 
Sophia Kinderziekenhuis, te Rotterdam (hoofd: Prof.dr.J.C. Molenaar) waar het 
promotieonderzoek begelei<i word door Dr. E. Heineman en Dr. R.L Marquet. Vanaf 15 
april 1993 is zij werkzaam aIs wetenschappelijk onderzoeker bij de vakgroep Algernene 
Heelkunde van het Academisch Ziekenhuis Leiden (hoofd: Prof.dr.O.T. Terpstra). 
Per 1 juli 1994 zaI zij eon postdoc plaats gaan bekleden in het Prince Henry's Institute for 
Medical Research in Melbourne. Hier zaI zij met behulp van moleculair biologische 
tecbnieken het adaptatieproces van de dunne darm na uitgebreide resectie verder gaan 
onderzoeken. 

